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The aim of this study was to investigate the stability of positional identity markers and 
phenotypic differences in isolated osteoblasts from distinct anatomic regions.  In 
addition, the ability of heterotypic co-cultures to reprogramme site-specific Hoxa gene 
expression also tested. 
 
Rat osteoblastic cells from femurs and calvariae were harvested as matched pairs of 
cultures from 4 male rats.  Cells were expanded extensively in medium supplemented 
with FGF-2, and were shown to maintain their osteoblastic phenotype as characterised 
by alkaline phosphatase (ALP) staining, osteopontin (OPN), osteocalcin (OCN) 
expression and osteoblast-associated gene expression in long term culture. 
 
Gene expression of cells was determined by quantitative RT-PCR.  Differences in Hoxa 
gene expression as markers of positional identity were maintained for up to at least 10 
passages, with calvarial cells remaining Hoxa-ve throughout.  The transcription factors 
Msx2 and Irx5 were consistently more highly expressed in calvarial cells, whereas Tbx3 
expression was elevated in femoral cells.  Expression of the osteoblast-associated genes 
Bglap and Spp1 were elevated in femoral cells, and also associated with increased 
osteopontin secretion and bone nodule formation.  Runx2 was elevated in calvarial cells.  
Cells were also pre-labelled with fluorescent vital staining and co-cultured for 7 days 
prior to separating by fluorescence activated cell sorter to investigate the possibility of 
re-programming of Hoxa negative cells by direct contact with Hoxa +ve cells.  However 
no evidence was seen of modulation of positional identity genes and phenotypes in 
these heterotypic cultures. 
 
In conclusion, the results demonstrate persistence of expression of positional identity 
gene markers and phenotypic differences between femoral and calvarial osteoblasts for 
prolonged periods in culture.  These data suggest that these differences in regionally 
defined osteoblasts are inherently programmed in the cells as a result of their 
embryological position.  The results may have considerable implications when 
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1.1 Introduction  
Tissue engineering is a rapid growing multidisciplinary research field which offers the 
opportunity to restore form and function of tissue concerning biology, medicine and 
engineering to improve health and quality of life (National Institute of Health, 2012).  
The novel therapeutic strategies have been developed according to cellular and 
molecular works in the past 2 decades.  Tissue engineering involves three keys 
elements: scaffolds, signaling molecules, and cells which aims to induce tissues or 
organs to regenerate themselves, by providing mechanical, cellular, and molecular 
signals.   
 
Therefore, focusing on bone and tissue engineering could be advantageous to improve 
clinical treatments such as bone grafting.  Bone tissue engineering may be a ground 
breaking technology for reconstructive and regenerative treatments.  Understanding the 
anatomy and processes of bone formation and regeneration not only at the cellular level, 
but also at the molecular level, may help to comprehend all the critical criteria.  
Mimicking the natural environment will allow cultured cells to behave in a more 
realistic way, and give a chance to study these biological systems in laboratory.  The 
attempt to mimic nature may further develop bone grafting materials or bone grafting 
procedures to improve a predictable clinical outcome.  
 
Bone is one of the most frequently considered options for transplantation (Giannoudis et 
al., 2005).  Bone grafts have been used to replace, reconstruct or regenerate impaired 
bony defects for patients both in medical and dental fields.  Autologous bone grafts are 
recognised as the gold standard for bone grafting procedures (Kneser et al., 2002).  The 
success rate of implanted grafts which may incorporate to host skeletal sites through 
osteconduction, osteoinduction, osseointegration, osteogenesis processes are varied and 
depended on many circumstances such as recipient-site defects, donor-site morbidity, 
the need for vascularisation and the ability of osteogenic potential in grafted materials, 
local and systemic factors.  Allograft, xenograft or alloplast materials have become an 
alternative option when an autograft is not available (Giannoudis et al., 2005; 








Recently, evidence has shown that committed cells in adult mammals such as 
fibroblasts and mature osteoblasts do not have adequate diversity of their phenotypes 
when compared to embryonic stem cells.  However, they may show considerable 
functional diversity according to their anatomical positions (Rinn et al., 2008a).  For 
example, the human skin shows notable diversity in its structure and function across the 
body (Rinn et al., 2008a).  Although all fibroblasts are morphologically similar, the 
comprehensive gene expression analysis of primary human fibroblasts from distinct 
anatomical sites has shown that gene expression patterns of cultured fibroblasts from 
different sites are remarkably distinct (Chang et al., 2002).  Over many years, not only 
fibroblasts, but osteoblasts have also been studied.  In fact, factors leading these signals 
to the diversity of osteoblast gene expression profiles remain unknown.  Understanding 
the functional diversity between regionally committed cells may be needed to taken into 
consideration for selecting appropriate sources and methods when transplantation is 
required. 
 
1.2 Bone formation 
Bone is a highly organised, specialised form of connective tissue, metabolically active 
and constantly remodelled throughout life (Hughes et al., 2006).  Bone is divided into 
compact bone and cancellous bone.  There are two different ossification processes.  
Intramembranous ossification is formed by condensations of mesenchymal cells at the 
centre of ossification which transform into osteoblasts e.g. flat bones of the skull, parts 
of the clavicle, mandible, maxilla and periosteal surface of long bone.  The other 
process is endochondral ossification which requires the formation and degradation of 
cartilaginous templates which occur in long bones (Ng et al., 1997). 
 
Bone matrix is composed of approximately one-third of organic matrix and two-third of 
inorganic matrix by weight (Sodek and McKee, 2000).  The main structural protein of 
the organic matrix is Type I collagen, which makes up approximately 90% of the 
matrix.  It provides structure, strength, and elasticity of the mature bone and acts as a 
scaffold or template for initiation and preparing for later matrix mineralisation (Rossert 
and de Crombrugghe, 2002).  The remaining 10% of the organic matrix consists of non-
collagenous proteins such as osteopontin, osteocalcin, bone sialoprotein, osteonectin, 
and other components.   
 




Osteopontin, also known as bone sialoprotein I (BSPI) or secreted phosphoprotein 
(SPP), is a glycoprotein (Oldberg et al., 1986).  It is synthesised by a variety of cell 
types and is not only limited to bone cells.  Along with bone sialoprotein, this appears to 
control nucleation and crystal growth during mineralisation including mediating 
attachment of bone cells to their matrix (McKee and Nanci, 1996).  Its role in 
modulating osteoblast responses to mechanical loading is considered further in Chapter 
6.   
 
Osteocalcin or bone Gla protein (BGP) is a calcium binding protein.  It makes up above 
10% of the non-collagenous protein in the mature bone, but is present at much lower 
concentrations in embryonic bone.  It is recognised to be the most bone-specific marker 
and its expression is restricted to mineralised tissue cells (Hughes and Aubin, 1998).   
 
Bone sialoprotein, also referred to as bone sialoprotein II (BSPII), is not as extensively 
distributed in non-mineralised tissues as osteopontin. Both osteopontin and bone 
sialoprotein contain the Arg-Gly-Asp (RGD) peptide cell which have a crucial role 
during mineralisation in mediating attachment of both osteoblasts and osteoclasts to the 
bone matrix (Oldberg et al., 1986, 1988).   
 
Osteonectin, or Secreted Protein Acid Rich in Cysteine (SPARC), was originally 
isolated from bone matrix (Termine et al., 1981) and serves as a nucleus for 
mineralisation and links collagen to hydroxyapatite which regulates the formation and 
growth of hydroxyapatite crystals.  It is expressed in a wide range of both embryonic 
and adult tissues, cultured cells, including fibroblasts, endothelial cells, lung, ovaries 
and testes.   
 
Other components of the organic matrix include the proteoglycans decorin and biglycan, 
which belong to the small leucine-rich proteoglycan (SLRP) family and consist of a 
protein core containing leucine repeats and chondroitin sulphate (CS) side chains.  Their 
particular function is unknown.  They can bind to transforming growth factor-β which 
may have an important role in their regulation.  They can also bind to other matrix 
macromolecules, including collagen and appear to be involved in fibrillogenesis and 
mineralisation (Hoshi et al., 1999).   
 




In addition, plasma-derived proteins such as albumin, small amounts of carbohydrate, 
and growth factors are also present in bone matrix, usually bound by other matrix 
molecules (Sodek and McKee, 2000).  In general, bone matrix proteins appear to have 
an important role in the regulation of hydroxyapatite crystal deposition, including 
crystal orientation and size formation.  Some of the components such as bone 
sialoprotein and osteopontin also mediate attachment of osteoblasts and osteoclasts to 
the bone matrix.  In addition, growth factors are bound within the matrix and may have 
an important regulatory role concerning bone remodelling (Hughes et al., 2006).   
 
The other two-thirds of bone matrix is an inorganic matrix consists of calcium and 
phosphate salts, mainly in the form of hydroxyapatite (Ca10[PO4]6[OH]2) crystals.  The 
mineral forms thin, plate-like crystallites showing an ordered orientation within the 
collagen fibrils.  It also has a major role in the bio-mechanical function of bone (Landis 
et al., 1996). 
 
1.3 Bone development 
In early development, the vertebrate skeleton is formed by cells from three distinct 
embryonic origins; cranial neural crest cells which form the craniofacial skeleton, 
paraxial mesoderm (somites) which forms the axial skeleton, and lateral plate 
mesodermal cells which form the limb skeleton (Olsen et al., 2000).  In addition, bone 
formation is controlled by transcription factors, growth factors, cytokines, and 
extracellular matrix molecules (Figure 1-1) (Olsen et al., 2000).   
 
Previous studies in mice and chick embryos have shown that crest cells from the caudal 
midbrain and rhombomeres 1 and 2 migrate into the first branchial arch, giving rise to 
maxilla, mandible, incus, malleus, and regions of the temporal bone, whereas cells in 
the second branchial arch give rise to stapes, styloid process of the temporal bone, and 
part of the hyoid bone, and are derived from rhombomere 4 (Olsen et al., 2000).  Many 
genes encoding for transcription factors, such as Dlx1, Dlx2, Dlx5, Msx1, Cart1, Hoxa1, 
Hoxa2, Hoxa3, Hoxb1, rae28, Twist, Pax; and for cytokines and growth factors such as 
BMP4, Fgf8, Tgf-α and endothelin-1 play important roles in craniofacial bone 
development (Olsen et al., 2000).   
 
 




Most of the craniofacial bones are of neural crest origin (Olsen et al., 2000).  However, 
studies in Wnt1-Cre mice using a conditional reporter gene, R26R, have demonstrated 
contributions of cells of distinct embryonic origins to the skull bones with neural crest-
derived frontal bone and paraxial mesodermal-derived parietal bone (Chai et al., 2000; 
Jiang et al., 2002).    
 
The somites give rise to the vertebrae and the dorsolateral portion of the ribs, the dermis 
of the dorsal skin, and the skeletal muscle of the body wall and the limbs.  
Somitogenesis occurs bilaterally, in a precisely timed rostro-caudal sequence.  The 
Notch-Delta pathway and genes such as Mesp2, Notch1, Dll, lunatic fringe Dll3, sonic 
hedgehog (Shh), Pax1, Pax9, and Hox play important roles in somitogenesis (Olsen et 
al., 2000).  
 
The limb bones are produced by cells derived from the lateral plate mesoderm.  The 
proximodistal growth patterning is directed by fibroblast growth factor signals from the 
specialised epithelial cells; anteroposterior patterning is directed by sonic hedgehog and 
dorsoventral patterning depends on secretion of Wnt7a (Olsen et al., 2000).  Gli3, Sall1, 
Hoxd13, Hoxa13, Bmp/Cdmp, Gdf and noggin are genes controlled by sonic hedgehog 
and genes related to BMP signalling; Fgfs are genes expressed by the apical ectodermal 
ridge; Tbx5 and Tbx4 are transcription factor genes associated with establishment of 
limb identity; Wnt7a, radical fringe, engrailed and Lmx1b are genes associated with 











Figure 1-1: Diagram shows the formation of cartilage and bone controlled by transcription 
factors, cytokines, growth factors, and extracellular matrix molecules. Mostly transcription 
factors regulate the patterning of cells from cranial neural crest, somites, and lateral plate 






Figure 1-2: Diagram shows how cartilages in the developing forelimb are formed in a 
proximodistal sequence with increasing developmental time (arrow). The elements formed arise 
through a series of bifurcations and segmentations of mesenchymal condensations along the 
posterior (ulnar) axis of the limb. The limb genes are listed outside the diagram. On the right are 
genes controlled by sonic hedgehog and genes related to BMP signaling. At the top are genes 
expressed by the apical ectodermal ridge; at the bottom are transcription factor genes 
associated with establishment of limb identity. On the left are genes associated with 








A recent study by Quarto and co-workers has also demonstrated that frontal bone 
derived from neural crest displays a higher potential for osteogenic differentiation and 
higher capacity to undergo osseous healing compared with calvarial bone derived from 
paraxial mesoderm (Quarto et al., 2010).  
 
The presence of neural crest-derived stem cells (NCSCs) within different adult 
craniofacial tissues such as the skin, periodontal ligament and the lamina propria of the 
palate, oral cavity and nasal turbinates indicates that these cells can differentiate into 
many cell types (Figure 1-3) (Kaltschmidt et al., 2012).  Interestingly, the persistence of 
cell plasticity into adulthood could explain the regenerative potential of many 





Figure 1-3: During the process of development in vertebrate embryo, neural crest cells migrate 
out between the newly formed ectoderm and the neural tube. The neural tube gives rise to a 
number of specialized cells such as ectodermal neurons, melanocytes, Schwann cells, 
mesodermal osteoblasts, adipocytes and smooth muscle cells. The new data suggest that 
embryonic neural crest-derived stem cells (NCSCs) not only contribute to terminally 
differentiated tissues, but also persist as uncommitted adult NCSCs which can undergo self-
renewal, as well as multi-lineage differentiation. From: (Kaltschmidt et al., 2012, p. 659) 
 
  




1.4 Osteoblast lineage 
Bone is composed of four cell types.  They are osteoblasts, osteocytes and bone lining 
cells which are derived from mesenchymal origin (Figure 1-4), and osteoclasts which 
are derived from a haemopoietic origin.  The osteoblast lineage includes pre-osteoblasts, 
osteoblasts or mature osteoblasts, bone-lining cells and osteocytes (Long, 2012; Singer 
and Caplan, 2011).   
 
 
Figure 1-4: The mesengenic process of human mesenchymal stem cells (hMSCs) may develop 
into bone, muscle, or adipose tissue depending on the stimuli. Adapted from: (Singer and 




Osteoblasts are specialised cells responsible for bone formation and bone maintenance.  
They are derived from multipotent mesenchymal stem cells which may then undergo a 
sequence of proliferation and differentiation stages before expressing recognisable 
specific-bone markers, producing the organic matrix of bone, regulating mineralisation 
and regulating bone remodelling (Hughes et al., 2006). 
 




The periosteum consists of two layers e.g. fibroperiosteum on the outside most distant 
from the bone surface, and an inner osteogenic periosteum where the pre-osteoblast, a 
directly recognisable cell of the osteoblast lineage,  is found (Hughes et al., 2006).  Pre-
osteoblasts retain some proliferative capacity, but express many proteins associated with 
the mature osteoblast phenotype, including alkaline phosphatase and osteopontin 
(Owen, 1970).  The other layer, the mature osteoblast layer, lies immediately adjacent to 
the bone (Hughes et al., 2006).   
 
Osteoblasts are cuboidal or slightly elongated cells.  They show the features of protein-
producing cells containing rough endoplasmic reticulum, Golgi apparatus, secretory 
granules and microtubules in cytoplasm (Marks and Odgren, 2002; Sodek and McKee, 
2000).  Other organelles such as mitochondria, endosomal/lysosomal elements and 
cytoskeleton are also present (Marks and Odgren, 2002). 
 
Osteoblasts are polarised cells which secrete matrix towards the bone surface (Marks 
and Odgren, 2002).  They can release collagen filaments which assemble extracellularly 
into fibrils to form the osteoid or unmineralised bone matrix (Marks and Odgren, 2002; 
Sodek and McKee, 2000).  The mature osteoblasts have an average 1-month lifespan, 
after which they undergo apoptosis and are replaced by newly differentiated osteoblasts 
or approximately one-third of these cells may be embedded into their deposited bone 
matrix and become osteocytes (Hughes et al., 2006).   
 
Owen and co-workers (1990) hypothesised that genes responsible for production and 
deposition of extracellular matrix must be expressed during the proliferative period in 
order to initiate the onset of differentiation.  This study provides the information on the 
three principle stages of osteoblast differentiation e.g. proliferation, matrix development 
and maturation, and mineralisation.  A functional relationship has been described 
between the down-regulation of proliferation and the initiation of extracellular matrix 
maturation, based on stimulation of alkaline phosphatase and osteopontin gene 
expression when proliferation is inhibited (Owen et al., 1990). 
 
The osteoblast lineage starts from mesenchymal stem cells through to osteocytes, the 
most differentiated cell of this lineage.  Each transitional step requires the activation or 
suppression of signalling molecules to differentiate into osteoblast.  Runx2, the major 




transcription factor in osteoblastic differnetiation, is expressed in the late condensation 
stage of chondrogenesis and is substantially decreased in proliferating chondrocytes, but 
increases again in prehypertrophic and hypertrophic chondrocytes (Kronenberg, 2003).  
It is highly expressed in perichondrial cells and in osteoblasts and drives proliferating 
chondrocytes to differentiate further into hypertrophic chondrocytes(Kronenberg, 2003).   
 
Runx2 is synthesised in chondrocytes, controlled by BMP2 and other regulatory factors, 
and causes a stage-dependent increase in the structural and functional proteins such as 
b-ALP, COLI, OP, ASP, BSP and OC.  At a late stage, osteocytes become embedded in 
the mineralised matrix (Figure 1-5) (Wang et al., 2012). 
 
 
Figure 1-5: Osteoblastogenesis. Osteoblast differentiation starts from the mesenchymal stem 
cells to osteocytes at the end. From: (Wang et al., 2012, p. 572). 
 
Osteoblasts derived from human mesenchymal stem cells can trans-differentiate into 
adipocytes and chondrocytes, and vice versa (Song and Tuan, 2004).  In addition, fully 
differentiated osteoblasts, as shown by alkaline phosphatase (ALP) activity and 
osteocalcin synthesis, were able to undergo adipogenic differentiation after treatment 
with adipocyte inducing medium containing dexamethasone (Dex) and 
isobutylmethylxanthine (IBMX) (Nuttall et al., 1998), whilst osteoblasts were shown to 
transdifferentiate towards an adipogenic phenotype after 3 days of 18-α-glycyrrhetinic 
acid (AGRA) or oleamide-mediated inhibition of Gap-junctional communication (GJC) 
(Schiller et al., 2001). 
 
Runx2 activates osteocalcin, an osteoblast-specific gene, expressed by fully 
differentiated osteoblasts (Ducy et al., 2000) and other transcription factors such as 




OSX, MSX2, DLX5 and DLX6 also play important roles in the differentiation from a 
mesenchymal progenitor cell into a fully differentiated osteoblast (Stains and Civitelli, 
2003), whilst PPARγ plays a key role in mediating adipocyte differentiation by 
decreasing Runx2 expression in osteoblastic cells (Liu et al., 2010). 
 
In contrast, Homeobox-a2 genes (Hoxa2) act as negative regulators of Runx2 
expression (Kanzler et al., 1998) and are also known to provide the second brachial arch 
with regional identity which inhibits bone formation in this area, possibly by preventing 
Cbfa1/Runx2 expression (Ducy et al., 2000), whilst Special AT-rich sequence-binding 
protein 2 (SATB2) inhibits expression of Hoxa2, but increasing the activity of Runx2 
and Activating Transcription Factor 4 (ATF4) leading to osteoblast differentiation 
(Dobreva et al., 2006). 
 
Based on studies of the limb skeleton, the developmental signals regulating key steps of 
mesenchymal progenitor cell differentiation to osteoblasts through distinct 
developmental stages are regulated by various developmental signals such as Hedgehog 
signalling, Notch signalling, WNT signalling, BMP signalling, and FGF signalling as 
recently reviewed by (Long, 2012) (See Figure 1-6). 
 
During mammalian development, TGF-β/BMPs have essential roles in bone formation 
and exhibit useful regulatory functions in the body by signalling through both canonical 
Smad-dependent pathways and non-canonical Smad-independent signaling pathway 
(Chen et al., 2012).  Bone morphogenetic protein (BMP) signalling stimulates 
osteoblast differentiation and function by the binding of BMP2 or BMP4 to their 
receptors resulting in phosphorylation of SMAD1, SMAD5 or SMAD8 which form a 
complex with SMAD4 and then enter the nucleus to regulate gene expression which 
eventually promotes the transition to RUNX2+OSX+ cells and enhances the function of 
mature osteoblasts (Long, 2012). 
 
Fibroblast growth factor (FGF) signalling functions by binding to cell surface Tyr 
kinase FGF receptors and leads to the activation of multiple signalling modules by 
regulating pre-osteoblast proliferation, osteoblast differentiation, and the function of 
mature osteoblasts (Long, 2012).   FGF also regulates chondrocyte proliferation and 
differentiation by shortening proliferative columns by decreasing chondrocyte 
proliferation directly and by suppressing Ihh expression (Kronenberg, 2003). 




Indian hedgehog (Ihh) is a master regulator of bone development by coordinating 
chondrocyte proliferation, chondrocyte differentiation and osteoblast differentiation.  
Ihh is synthesised by chondrocytes during endochondral bone development and binds to 
Patched-1 (Ptc-1) which leads to activation of Smoothened (Smo), a membrane protein 
required for the cellular actions of Ihh.  The active Smo triggers a cascade that leads to 
gene activation (Kronenberg, 2003).  In the absence of Ihh, Runx2 was not expressed, 
but forced expression of Runx2 in the skeletogenic cells restored bone formation in the 
Runx2-null, but not in the Ihh-null embryo suggesting that Indian hedgehog requires 
additional effectors besides Runx2 to induce osteoblast differentiation (Tu et al., 2012). 
IHH binds to the receptor Patched homologue 1 (PTCH1), activates signalling through 
Smoothened (SMO), inhibits proteolytically cleaved GLI3 repressor (GLI3R), and 
promotes the full-length GLI2 activator (GLI2A), whilst derepression of GLI3R is 
sufficient to generate RUNX2+ cells. Both derepression of GLI3R and activation of 
GLI2A are necessary for progression to the RUNX2+OSX+ stage. The Hedgehog 
signalling through Indian hedgehog (IHH) is required for osteoblast differentiation 
through endochondral ossification (Long, 2012).  
 
Notch signalling inhibits osteoblast differentiation by binding to their ligands Jagged 
(JAG) or Delta-like (DLL). Notch receptors are proteolytically cleaved by the 
γ-secretase complex, Notch intracellular domain (NICD) released from the plasma 
membrane and interacts with RBPJκ to activate downstream target genes, including 
HES (Hairy and Enhancer of Split) and HEY (HES-related with YRPW motif) family 
transcription factors and eventually inhibits osteoblast differentiation before OSX 
activation (Long, 2012).  
 
WNT signalling promotes osteoblast differentiation by stabilisation of β-catenin 
followed by binding of WNT to its receptors Frizzled (FZD) and lipoprotein receptor-
related protein 5 (LRP5) or LRP6 and leading to the transcription of β-catenin target 
genes and stimulating the RUNX2+ stage to the RUNX2+OSX+ stage, and from 
RUNX2+OSX+ cells to mature osteoblasts.  In addition, WNT can also independently 
signal β-catenin through protein kinase Cδ (PKCδ) and promote the RUNX2+OSX+ 
stage through an unknown mechanism (Long, 2012). 
 




The developmental signals regulating osteoblast differentiation are summarised in the 




Figure 1-6: Developmental signals regulate osteoblasts to differentiate from mesenchymal 
progenitors through distinct developmental stages which regulated by various developmental 
signals; (a) Hedgehog signalling through Indian hedgehog (IHH) which binds to the receptor 
Patched homologue 1 (PTCH1) and activates signalling through Smoothened (SMO); (b) Notch 
signalling by binding to their ligands and leading to inhibition of osteoblast differentiation before 
OSX activation; (c) WNT signalling promotes osteoblast differentiation; (d) Bone morphogenetic 
protein (BMP) signalling stimulates osteoblast differentiation and function by the binding of 
BMP2 or BMP4 to their receptors results in phosphorylation of SMAD1, SMAD5 or SMAD8; (e) 
Fibroblast growth factor (FGF) signalling by binding to cell surface Tyr kinase FGF receptors 
(FGFRs; FGFR1–FGFR4 in humans and mice) and leading to the activation of multiple 










Osteocytes are mature osteoblasts embedded within the bone matrix.  They are the most 
abundant cell type found in bone, consisting of 90-95% of all bone cells in the adult 
skeleton (Bonewald, 2007).  They may have roles in the maintenance of bone mass, 
regulating osteoclastic resorption, blood-calcium phosphate homeostasis and 
modulating responses to mechanical stress.  In general, they are responsible for 
maintenance of the skeleton by regulating both matrix synthesis and resorption.  
However, the mechanisms of how osteoblasts become osteocytes remain unclear 
(Franz-Odendaal et al., 2006).  Each osteocyte in lacunae extends cytoplasmic processes 
through canaliculi in the matrix to contact processes of adjacent osteocytes and through 
gap junctions with osteoblasts on the bone surface for their communication.  The 
canalicular-lacunar system is essential for cell metabolism to diffuse nutrients and waste 
products and may be important for signal transduction due to mechanical loading and 
provide access to blood vessels (Bonewald, 2007). 
 
Bone lining cells 
 
Bone lining cells are flattened and found on bone surfaces when they become quiescent.  
They are inactive osteoblasts which show decreased protein secretion and undergo a 
process of morphological and functional changes.  The bone lining cells may be able to 
regain full capacity to produce bone matrix.  Bone lining cells and osteocytes appear to 





Osteoclasts are multinucleated cells derived from cells of the monocyte/macrophage 
lineage which fuse together.  They are responsible for bone resorption and regulate bone 
remodelling processes with osteoblasts (Hughes et al., 2006; Teitelbaum, 2000).  The 
ability of the osteoclast to degrade bone depends on a tight attachment to the bone 
surface together with ions and matrix-degrading enzymes secreted into the sealed 
lacunae, break down the inorganic and organic matrices, thus releasing bone-derived 
factors including Ca2+ ions and matrix proteins such as transforming growth factor-β 
and osteocalcin into the marrow cavity (Edwards and Mundy, 2011).   




Bone cell types and their functions are summarised in Table 1-1. 
 




Osteoblasts cuboidal shaped - synthesis and regulation of bone ECM 
deposition and mineralization 
- respond to mechanical stimuli 
 
Osteocytes stellate shaped - calcification of osteoid matrix 
- blood-calcium homeostasis 
- mechanosensor  
 
Bone lining cells flat shaped - may be able to regain full capacity to 
produce bone matrix 
- homeostatic network with osteocytes 
 
Osteoclasts multinucleated cells - bone resorption 
 
 
Table 1-1: Summary of bone cell types and their functions. Modified from: (Salgado et al., 
2004). 
 
1.5 Regulatory signals 
There are many extracellular signalling molecules which may participate in the 
regulation of osteoblast differentiation and bone formation.  These include locally acting 
growth factor molecules and systemic hormones, some of which are reviewed briefly 
below. 
 
1) Local regulators of osteoblasts 
A wide range of locally acting growth factors has been shown to be able to regulate 
osteoblast function.  These include the BMPs, wnts, hedgehog family, notch, FGFs, 
PDGF, IGFs, TGFß and EGF.  These have been reviewed by Hughes and co-workers 
(Hughes et al., 2006).  Some of these signalling molecule families which particularly 
influence early stages of osteoblast differentiation include the BMPs, wnts, and 
hedgehog. 
 
Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-beta 
(TGF-β) superfamily are multi-functional growth factors (Hughes et al., 2006).  BMP 
signals not only shape tissues ranging from embryonic patterning through stem cells and 
their niches, they also regulate stem cell fate and are involved in tissue regeneration 
throughout the whole body (Wagner et al., 2010). 
 




BMP was first identified and named "bone morphogenetic protein" by Urist in 1965 
based on their ability to induce the full cascade of endochondral ossification when 
implanted to ectopic sites such as rat muscle (Urist, 1965).  Up to 20 BMP family 
members have now been identified, characterized and their properties have been 
extensively further studied (Chen et al., 2004) such as their induction of BMSCs to 
become osteoblasts, promote osteoblast differentiation and induce orthotopic and 
heterotopic bone in vitro and in vivo.  The immediate downstream molecular targets of 
BMP receptor binding are Smad1, 5 and 8 and these play an important role in BMP 
signal transduction and postnatal bone formation (Wagner et al., 2010). 
 
Wnts are a large family of at least 19 secreted glycoproteins that trigger multiple 
signalling during embryonic development.  The effects occur in cells via canonical or 
non-canonical
 
pathways through binding to the Frizzled (Fzd) receptor
 
family members 
(Galli et al., 2010; Monroe et al., 2012).  Stages of differentiation are indicated by 
transcription factors expression e.g. Prx1, Runx2, osterix (Osx), and osteocalcin (OCN) 
at low or at high levels.  Wnt signaling promotes the early phases of commitment, 
differentiation, and the expression of osteoprotegerin (OPG), but inhibits high levels of 
osteocalcin expression.  In addition Sclerostin (Scl) may inhibit Wnt signaling in a 
negative feedback loop (Galli et al., 2010; Monroe et al., 2012) (Figure 1-7). 
 
Low-density lipoprotein receptor-related proteins (Lrp) are evolutionarily conserved 
plasma membrane receptors with many functions including lipid metabolism, cargo 
transport, and cellular signalling.  Lrp5/6 are low affinity co-receptors for Wnts and 
high affinity receptors for soluble Wnt antagonists: Scl, Sost-dc1, and Dkk1.  Lrp4 is 
also emerging as a regulator of bone mass density (Monroe et al., 2012).  Wnt/LRP5/b-
catenin pathway (Low-density lipoprotein receptor Related Protein 5) also plays a 
critical role in promoting osteoblast differentiation and maintaining bone mass (Li and 











Figure 1-7: Signalling involved in cell lineage in bone development. Mesenchymal progenitor 
cells give rise to osteoblasts and chondrocytes, whereas hematopoietic precursors give rise to 
osteoclasts. At different stages of their maturation, various promoters can be used to drive 
transgene or Cre expression in these cells. Mature osteoblasts and osteocytes stimulate 
osteoclast maturation through RANKL/RANK/OPG system. In addition, osteocytes secrete Scl 
to inhibit Lrp5 activities, but Scl production is suppressed by PTH and mechanical loading to 
increase bone formation. From: (Monroe et al., 2012, p. 6). 
 
 
Hedgehog (Hh) signalling is involved in regulating verterbrate osteoblastogenesis such 
as digit growth.  There are three Hh proteins in the mammalian genome namely sonic 
Hedgehog (Shh), Indian Hedgehog (Ihh) and desert Hedgehog (Dhh) (Dorus et al., 
2006).  Disruption of the Hh signalling pathway resulted in failure of cells to undergo 
osteoblast differentiation (Long et al., 2004).   
 
Fibroblast Growth Factor-2 (FGF-2) supported osteogenic precursors cells derived from 
human bone marrow for their expansion and maintenance (Martin et al., 1997). 
However, FGF-2 will be further discussed in Chapter 3. 
 
2) Systemic regulation of osteoblasts 
There are many systemic hormones that have roles in osteoblast regulation as 
summarised in Table 1-2.  However, our particular interest is the role of oestrogen in 
regulating bone, for example as is seen in postmenopausal osteoporosis. 
 
 




Oestradiol is transduced by two receptors belong to the superfamily of nuclear receptors 
known as oestrogen receptor (ER)-α or  and ER-β (according to the Nuclear Receptors 
Nomenclature Committee; NR3A1 and NR3A2, respectively) (Bonnelye and Aubin, 
2005; Bonnelye et al., 2011).  The nuclear receptors are transcription factors comprising 
of both ligand-dependent molecules such as steroid hormone, thyroid hormone, retinoic 
acid, vitamin D receptors, and a large number of so-called orphan receptors (Bonnelye 
and Aubin, 2005). 
 
Postmenopausal osteoporotic bone loss is due to oestrogen deficiency resulting in 
decreased bone formation with increased of bone turnover (Turner et al., 1994).  
Lajeunesse et al. (1994) examined the effect of 17β-oestradiol on the human 
osteosarcoma cell line MG-63.  They found that 17β-oestradiol upregulates osteocalcin 
secretion and alkaline phosphatase synthesis in a dose-dependent manner (Lajeunesse, 
1994).  In addition, they also suggested that oestrogens may regulate bone remodelling 
by modulating hormonal-induction of protein involved in bone mineralisation.  This is 
an indirect effect as it did not modify basal activities, instead involving a regulation of 
1,25(OH)2D3 receptor level in MG-63 cells. 
 
Oestrogen and parathyroid hormone (PTH) enhance Runx2 expression and activity 
through anabolic effects, however, oestrogen negatively regulates Runx2 in 
osteoclastogenesis (Komori, 2008). 
 
  




Hormones General Functions Specific Functions References 
Oestrogens -regulators of bone mass -receptors activation leading 
to specific gene 
transcription 
(Liedert et al., 
2010) 





Androgen -skeletal development and 
maintenance of bone 
mass in men and women 
-influence growth plate 
maturation and closure 
(Wiren et al., 
2002) 
PTH, PTH1R -maintenance of calcium 
homeostasis 
-promote calcium release 
from bone 
-Enhance kidney calcium 
reabsorption 
(Hock, 2002) 
Growth Hormone -longitudinal bone growth -enhance bone remodelling (Karaplis, 
2002) 




-promote differentiation,  
-increase alkaline 
phosphatase activity,  




and other steroids 
-regulate bone metabolism -differentiation and function 




Insulin -influence the physiology 
of cartilage and bone 
-stimulate endochondral 
bone growth and osteoblast 




Vitamin D -development and 
maintenance of bone 




Leptin -may control bone 
metabolism 
-controlling bone mass (Lerner, 
2002)  
 
Table 1-2: Summary of hormones that may regulate bone and osteoblasts 
 
3) Transcription factors regulating osteoblast function 
Both local and systemically acting extracellular signalling molecules act ultimately by 
ligand binding and modulating cell gene expression.  There is now considerable 
information on a range of transcription factors which appear to have important roles in 
regulating osteoblast differentiation and function. 
 
The essential regulators of osteoblast lineage cells are the core binding protein from the 
runt family of transcription factors (Runx2) and osterix (OSX).  Runx2 is a major 
regulator of bone formation and its expression is absolutely required for osteoblast 
differentiation.  Osterix is a downstream target of Cbfa1/Runx2 and required for normal 
osteoblast differentiation as demonstrated in KO-mice study (Nakashima et al., 2002).  
The mammalian Runx (runt-related transcription factor x) genes encode a family of 
transcription factors; including Runx1, Runx2, and Runx3, are homologous to 




Drosophila runt.  Multiple signalling pathways regulate Runx gene expression and 
protein function at multiple levels (Ducy et al., 1997).   
 
Runx2, a member of a family of transcription factors which shares the DNA binding 
domain of the Drosophila pair rule gene runt (Kronenberg, 2003), is an osteoblast-
specific transcription factor and a regulator of osteoblast differentiation (Ducy et al., 
1997) which directs mesenchymal cells to differentiate into osteoblasts and inhibits 
adipocyte differentiation (Komori, 2006).  The expression of bone matrix protein genes 
such as Col1a1, Spp1, Ibsp, Bglap, and Fn1 were upregulated by RUNX2 during 
osteoblast differentiation in vitro and many promoters such as Col1a1, Col1a2, Spp1, 
Bglap, and Mmp13 were also activated (Komori, 2010).  Importantly, RUNX2 induces 
osteoblast differentiation and increases the number of immature osteoblasts, whilst 
Runx2 expression must be down regulated for differentiation into mature osteoblasts to 
occur to form mature bone (Komori, 2010). 
 
Runx2 expression in bipotent progenitor cells differs in skeletal elements that ossify by 
the intramembranous route from those elements that ossify by the endochondral route.  
The transition to functional osteoblasts expressing high levels of osteoblast marker 
genes requires Osx.  This transcription factor cooperates with Runx2 to activate bone-
specific genes and inhibit Sox9 expression.  Thus, preventing the cells from entering the 
chondrocyte differentiation pathway (Owen et al., 1990). 
 
Msx2 (mesh-less 2) is a mammalian homologue of Drosophila muscle segment 
homeobox gene (msh) (Li and Xiao, 2007).  Msx2 regulates early osteoblast 
development (Schinke, 2002), whilst Dlx5, a homologue of the Distal-less (Dll) in 
Drosophila, is a BMP-inducible homeoprotein which induces the transcriptional activity 
of osteoblast differentiation.   
 
The transcriptional properties of Msx and Dlx proteins display reciprocal actions where 
Msx2 acts as repressor of transcription and is essential for normal ossification (Marie, 
2008), whilst Dlx5 acts as a transcriptional activator (Schinke, 2002).  Msx1 and Dlx5 
synergistically regulate osteogenesis during frontal bone development particularly in 
closure of the suture (Chung et al., 2010).  Studies on primary culture of chick calvarial 
osteoblasts revealed that Msx2 stimulates cells proliferation, but suppress differentiation 




via repress Runx2 transcription activity (Li and Xiao, 2007).  Cellular and genetic 
analyses showed that several transcription factors that belong to homeobox proteins 
(Msx1, Msx2, Dlx5, Dlx6) may play a role in osteoblast differentiation.  
 
Iroquois related homeobox genes (Irx) 5 and 6, a family of homeodomain-containing 
transcription factors involved in patterning and regionalisation of embryonic tissues; 
Irx5 expressed in an osteocyte like cell line (Paic et al., 2009). 
 
T-box (Tbx) 3, a transcriptional repressor that regulates osteoblast proliferation, its 
expression increases during osteoblast differentiation (Govoni et al., 2009).  The 
mutation of Tbx3 results in limb malformation, but transgenic overexpression of Tbx3 in 
osteoblasts can promote proliferation, but suppress differentiation and may involve in 
regulating key transcription factors in osteoblast differentiation (Govoni et al., 2009). 
 
A summary of transcription factors that may have specific roles in regulating osteoblast 

















Transcription Factors Functions References 
Runx2 or Cbfa1 osteoblast differentiation  (Ducy et al., 1997; 
Schinke, 2002) 
Msx2, Dlx5 osteoblast differentiation 
 
(Schinke, 2002) 
Irx5 embryonic patterning and regionalisation 
 
(Paic et al., 2009) 
Tbx3 regulates osteoblast proliferation (Govoni et al., 
2009) 
Osx osteoblast differentiation (Nakashima et al., 
2002) 
Taz osteoblast differentiation act on bipotent 
osteoblast and adipocyte stem cells 
 
(Hong et al., 2005) 
Fra-1  regulate bone mass by osteoblasts and 
chondrocytes through bone matrix production 
 
(Eferl et al., 2004) 
deltaFosB overexpression increases bone formation and 
inhibits adipogenesis 
 
(Sabatakos et al., 
2000) 
c-Abl osteoporotic and defects in osteoblast 
maturation in Abl deficient mice 
 
(Li et al., 2000) 
RORα direct modulation of a bone matrix component (Meyer et al., 
2000) 
 
Table 1-3: Summary of some important transcription factors that regulate bone and osteoblasts 
 
1.6 Regional specification of spatial and positional identity 
 
As previously discussed, differences in functional characteristics of similar cell 
phenotypes might be determined by their embryological origins and their anatomically 
diverse positions within the mature organisms.  Body morphogenesis in development 
and
 
evolution is regulated by Hox genes.  Therefore, mutations in Hox genes transform 
one body segment
 
into another (Wolpert, 1994).  In mammals the Hox genes, which 
were first discovered in fruit flies, comprise 39 transcriptional factors and are grouped 
into four clusters arranged on different chromosomes (Iimura and Pourquie, 2007).  Hox 
genes encode transcription factors that regulate body formation during development.  




They belong to a homeotic genes family called the homeobox which characterised by 
approximately 180 base pairs of a DNA sequence and codes for the homeodomain, 
about 60 amino acid residues in DNA-binding domain.  
 
Hox genes have essential roles in controlling time and route of body development to 
identify embryonic segment, different Hox genes being expressed in different segments.  
Vertebrates have four distinct Hox genes clusters, called A, B, C and D, which are 
involved in similar developmental processes (Iimura and Pourquie, 2007).  Their spatial 
pattern of expression along the anterior-posterior and proximal-distal axes of the 
embryo reflected by their order on the chromosomes called colinearity (Rinn et al., 
2008b).  
 
The positional identity of skin by “HOX code” may dictate and influence site-specific 
epidermal differentiation (Chuong, 1993).  For example, expression of HOXA13 is 
required to maintain epidermal inductive properties of distal fibroblasts (Rinn et al., 
2008a).  The evidence in HoxA13 knockout limb showed that Wnt5a expression is 
substantially reduced, but not completely absent and also expressed more proximally 
than the HoxA13 expression domain suggesting that other transcription factors also 
directly induce Wnt5a expression via more distant enhancer sequences or indirectly via 
HOXB6 (Rinn et al., 2008a).  In this context, Wnt5a is specifically expressed in distal 
fibroblasts. 
 
The polarity of the embryo, formation of the anterior-posterior body axis, and body 
segmentation are controlled by Hox gene clusters during embryogenesis in all species.  
Specific Hox genes are expressed and demarcate different positional identities that lead 
to cellular differentiation and tissue morphogenesis in site-specific manner. 
 
The homeobox genes are expressed in a site-specific manner to specify spatial and 
positional information.  Knocking out individual Hox genes in Drosophila causes 
homeotic transformations which one body part develops into another such as the 
Antennapedia mutant, in which legs develop on the fly's head instead of antennae 
suggesting that Hox genes control development of morphologically distinct regions in a 
segmented animal (Kaufman et al., 1990; Lewis, 1978).  
 




The markers of regional development and bone metabolism are differentially expressed 
site-specifically.  Hoxa gene expression patterns are one example of markers of 
embryologically determined “positional identity”, although other Hox genes family 
members (Hoxb, Hoxc and Hoxd families) may be expressed in a co-linear fashion with 
Hoxa and also reflect embryological positional identity. 
 
1.7 Hoxa genes and positional identity 
1) Persistence of positional identity in the adult organism 
Bones from different anatomical sites in the adult organism behave differently.  For 
example, long bones are dependent on mechanical loading for maintenance of bone 
mineral density and are susceptible to osteoporosis, whereas calvarial bones are not 
subject to extensive mechanical loading, but still maintain a high bone mineral density 
and are generally not affected by osteoporosis.  This raises the question as to whether 
the osteoblasts in these regions are pre-programmed to be phenotypically distinct 
because they retain their embryonic positional identities. 
 
In a recent study from our lab, Rawlinson and co-workers investigated the expression 
and maintenance of positional identity markers in adult rat bones from different   
regions.  Mouse Genome and Rat Genome GeneChips were used to compare gene 
expression profiles from long bones and parietal skull bones samples, and also on 
osteoblastic cells isolated from these bones (Rawlinson et al., 2009b).  In that study 
1,236 genes (approximately 4% of the genome) were found to be at least two-fold 
differentially expressed between ulna limb and parietal skull bone, and most 
remarkably, in cultured cells derived from ulnae and calvariae also showed significant 
differences in expression levels of 249 genes.  Dendrograms generated by gene tree 
clustering analysis in GeneSpring 6.1 compared basal expression of all filtered genes in 
skull and limb bone organs and in cell cultures are shown in Figure 1-8 a-c.   
 
Strikingly, amongst these differentially expressed genes were those associated with 
embryological positional identity including Hox genes, which were preferentially 
expressed in ulna cells, and functionally relevant osteoblast associated genes such as  
 




Spp1 (osteopontin), Alcam (activated leukocyte cells adhesion molecule), Sfrp2 
(secreted frizzled-related protein 2); Apo-E, (apolipoprotein E), Smoc2 (SPARC related 
modular calcium binding 2), and Fst, (follistatin). 
 
Figure 1-8: Bones from different skeletal sites represent distinct populations. (a) Using 
GeneSpring 6.1 for Gene tree clustering analysis to generate dendrogram compared all filtered 
genes expressed in skull and limb bone organs, (b) Dendrogram signified genotypic differences 
between skull and limb adult bone-derived cells (S-Bdc= skull bone-derived cells and L-Bdc= 
limb bone-derived cells) in 5 matched pairs, (c) Heat map for markers for regional development 
shows cultured S-Bdc (S1–S5) preferentially express genes associated with the craniofacial 
development of neural crest derived cells (red), whilst L-Bdc (L1–L5) preferentially express 
genes for limb development and patterning. Adapted from: (Rawlinson et al., 2009b, p. 2, p. 6). 
 
In support of the idea that adult cells retain their embryological functional identity are 
studies that demonstrate similar findings in fibroblasts.  Fibroblasts have been shown to 
have consistent and distinct site-specific variations in gene expression including 
expression of “positional identity” genes such as Hoxa.  An experiment by Rinn and 
colleagues characterised the diversity of human fibroblasts testing from 47 primary 
cultured fibroblasts derived from 43 anatomical sites for their maintenance in site-
specific differentiation (Rinn et al., 2006).  These fibroblasts were cultured for at least 5 
passages to remove the effect of their native environment and the microarray of gene 
expression was analysed.  Their findings confirmed that site-specific variation in 
fibroblast gene expression was related to their positional identity with respect to 
anatomical regions; anterior-posterior, proximal-distal, and dermal-nondermal (Rinn et 
al., 2006).   
 




The positional identity study of differentiated fibroblasts has demonstrated the stability 
after long-term passage of transcriptional patterns in vitro, suggesting that differentiated 
fibroblasts have mechanisms to maintain the epigenetic information which is important 
for anatomically specific differentiation as the embryonic pattern of HOX gene 
expression appears to be retained in diverse sampling of cultured adult fibroblasts (Rinn 
et al., 2006). 
 
2) Evidence that “positional identity” may be reprogrammed 
 
In Drosophila, Hox gene expression is regulated by Polycomb group (PcG) and 
trithorax group (trxG) proteins, which are also called maintenance proteins (MPs).   
Thus, the interplay between PcG and TrxG/MLL complexes is essential for proper 
maintenance, silencing and activation of Hox and many other genes in vertebrates 
(Soshnikova and Duboule, 2008).  H3K27me3/me2 at Hox promoters was removed by a 
new family of histone demethylases for induction of Hox gene transcription during 
differentiation of totipotent embryonic stem cells (Soshnikova and Duboule, 2008).  
 
The retention of positional identity in adult differentiated cells might contribute to its 
faithful homeostasis but may also limit its plasticity, leading to a loss of regenerative 
ability in higher vertebrates (Wang et al., 2009).  In support of this concept Leucht et al. 
studied the effect of transplanting tibial and mandibular skeletal stem cells into bony 
defects in mandibles and tibia (Leucht et al., 2008a).  They used transgenic mice using 
GFP-labelled cells to isolate cells, and follow them when re-implanted into the defects. 
The experiment was designed to have 4 different groups e.g. tibia-Hox+ve cells placed 
into mandibular-Hox-ve recipient site, mandibular-Hox-ve implanted into tibia-Hox+ve 
recipient site in order to mimic mismatch grafting, whilst the other two groups were 
matched Hox-expressed cells grafts e.g. tibia-Hox+ve cells placed into tibia-Hox+ve 
site and mandibular-Hox-ve cells placed into mandibular-Hox-ve sites for controls 
(Leucht et al., 2008a).  The results showed that Hox+ve cell grafts were not able to 
contribute to the repair of a Hox-ve injury site.  In contrast, Hox-ve grafts when 
transplanted into a Hox+ve injury site were able to contribute to bone regeneration.  
They concluded that Hox-ve skeletal stem cells can only heal orthotopic Hox+ve bone 
injury site (Figure 1-9). 
 




Furthermore using in situ hybridization, they showed that mandibular-Hox-ve cells 
when transplanted to the (Hoxa +) tibia exhibited Hoxa11 expression.  These results 
strongly suggest that the neural crest-derived Hoxa- cells showed greater plasticity and 
could be reprogrammed by some aspect of their local environment to express the 
positional identity of the location of the recipient site.   In contrast, Hoxa positive cells 
continued to express their original positional identity, were not reprogrammed by 




Figure 1-9: Hox status and bone regeneration in mouse. Cells expressing Hox genes are Hox+ 
and not expressing Hox are Hox-. Hox+
 
cells can only heal orthotopic Hox+
 
bone injury site 
(tibia). (a) Hox+
 
cells cannot repair a Hox- injury site (mandible). (b) On the other hand, Hox-
 
cells will express the ectopic Hox gene when transplanted into a Hox+
 
injury site and regenerate 








In support of the idea of reprogramming of positional identities in the studies of 
fibroblast positional identity described by Rinn and co workers in 2008, they suggested 
that fibroblasts may be reprogrammed by co-culture and physical contact between 
heterotypic fibroblasts (Rinn et al., 2008a).  In addition, a co-culture study of primary 
dermal fibroblasts derived from palms or soles described by Yamaguchi and co workers 
suggested that this co-culture could reprogramme keratinocytes from other sites to 
express acral specific differentiation genes, such as Keratin9 (K9) (Yamaguchi et al., 
1999). 
 
3) Role of Hox in regenerative capacity 
To date, data suggest that Hoxa genes, and other genes associated with positional 
information in the embryo, have a role in specifying transcriptional memory which 
continues into the adult organism.  This may limit their plasticity and bone regenerative 
potential.  A clinical implication of these findings is that this may lead to improved 
success rate of grafted cells which could be influenced by distinguishing one type of 
adult stem or progenitor cell from another.  Plasticity of positional identity may be 
important in wound repair when cells need to integrate in the wound bed for appropriate 
regeneration (Leucht et al., 2008b).  Therefore, different locations of donor-sites for 
bone grafting may need to be taken into consideration for bone grafting procedures as 
these molecular differences may have an effect on bone regenerative capacity and the 
clinical outcome.  Although the data do suggest the possibility that positional identities 
might be reprogrammed, at least in some circumstances, there is little information on 
how these cells might be modulated during bone healing after grafting especially at the 
molecular level.  
 
Questions still remain about the mechanism and further studies would be needed to 
directly test whether adult stem cells actually retain a Hox code, and then whether these 
potential molecular differences are crucial features of successful tissue repair and 
regeneration.  This concept of cells regaining their plasticity which was found earlier in 
development and still be observed in induced pluripotent stem cells may increase our 








1.8 Positional identity: implication that bone cells are not all the same 
 
The nature of the signals leading to the diversity of osteoblast gene expression profiles 
is not known (Aubin, 2002).  Our recent evidence suggests that genes associated with 
mineral density and bone mass are differentially expressed in distinct skeletal sites.  Our 
observations for the first time reveal the developmental gene expression-based 
“positional identity” in the adult skeleton (Rawlinson et al., 2009b).  
 
We think of osteoblasts as bone forming cells, but this recent evidence suggests that 
osteoblasts from different sites are distinct.  Therefore, osteoblasts may be pre-
programmed and show phenotypic differences between different sites or origin.  Those 
findings mentioned in the literature review have raised interesting questions whether 
adult osteoblastic cells derived from different sites can retain their stability of Hoxa 
gene expression, transcription factors and osteoblast-associated genes in vitro, and 
whether mimicking grafting procedure by using heterotypic culture system in vitro may 
have an effect on bone cell phenotype, their osteogenic potentials and regenerative 




Figure 1-10: Hypothesis to test whether heterotypic culture may have an effect on different 
Hoxa genes expressed osteoblastic cells. 





The overall aims of the study are to test the hypothesis that persistence of positional 
identity markers in osteoblasts from distinct sites results in differences in osteogenic 
potential. 
 
Specific objectives of the proposed studies include: 
 
To investigate the stability of positional identity markers in isolated rat osteoblasts 
in vitro and in heterotypic culture of cells derived from distinct regions and 
expressing different Hoxa gene profiles; 
 
To establish a cell culture model derived from different sites, grown together in 
heterotypic culture and sorted by flow cytometry to address whether site-specific 
gene expression may be reprogrammed by heterotypic culture between Hox- and 
Hox+ cells; 
 
To determine if osteoblasts derived from distinct sites are phenotypically different; 
 
To investigate if positional identity of osteoblasts may influence their bone 
regenerative capacities constitutively and in response to specific hormone or growth 
factor stimulation. 
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This chapter describes general methods used in this study.  Specific experimental details 
are described in the appropriate chapters. 
 
2.2 Culture of primary cells 
All protocols for the use of animals followed Queen Mary University of London 
(QMUL) and King's College London (KCL) regulations for animal research and in 
accordance with Home Office protocols. 
 
2.2.1 Establishing adult mice osteoblastic cells using collagenase isolation method 
In the first experiment for establishing osteoblast primary cell cultures, 5 male mice 
(weigh 22.04 g±0.74) aged 47-54 days were obtained.  The mice were rendered 
unconscious by carbon dioxide (CO2) asphyxiation and killed by cervical dislocation.  
The tissue samples were placed on ice in ice cold transport medium using Dulbecco's 
Modified Eagle's Medium (DMEM) (Sigma-Aldrich Company Ltd., Gillingham, 
Dorset, UK) without Foetal Bovine Serum (FBS) (Gibco, Life Technologies 
Corporation, Paisley, Renfrewshire, UK) supplemented, containing 25mM HEPES, with 
glutamine (Gibco), 0.1mg/ml penicillin-streptomycin (Lonza Ltd, Slough, Berkshire, 
UK), and 0.3μg/ml Fungizone (Lonza).  
 
In the original protocol at QMUL for establishing osteoblast primary cell cultures, the 
bones were taken from mice calvaria and ulna.  They were cleaned and cut in to small 
pieces using sterile sharp blade.  Then the bone pieces were washed in sterile PBS.  The 
collagenase solution was prepared (Hughes and Aubin, 1998) (Table 2-1).  The bone 
pieces were digested using serial collagenase digestion method (Figure 2-1) as follows: 
first and second digestion for 10 minutes, third, fourth and fifth digestion for 20 
minutes.  For each round of digestion, the collagenase solution including cells was 
collected and put in centrifuged tube containing 100% FBS to stop collagenase action.  
The solution was centrifuged at 1,100 rpm at 4
o
C for 5 minutes.  The cells were re-
suspended in culture medium and grown in T-25 flasks in CO2 incubator.  
  




Collagenase solution (Hughes and Aubin, 1998) was prepared as follows: 
  For 1 mouse (mg) For 5 mice (mg) 
Collagenase 1.5 mg/ml 100 300 
DNAse 9.7 units/ml 0.25 0.75   (1,920 units) 
Chondroitin sulphate 0.12 mM 79 237 
Sorbital 100 mM 1,200 3,600 
KCl 111.2 mM 500 1,500 
MgCl2 1.3 mM 17.4 52.2 
Glucose 13 mM 170 510 
ZnCl2 0.5 mM 4.5 13.5 
Tris HCl pH 7.4 50 mM 66 198 
 
Table 2-1: Collagenase solution used for serial collagenase digestion method 
 
In later experiments, once the tissue had been stabilised 1 ml of culture medium warmed 
to 37°C was gently pipetted into each well.  All cell culture plates were incubated in a 
humidified 5% CO2 atmosphere at 37°C.  After 24 hours the plated wells had a further 1 
ml of medium added.  Media were replaced and growth of cultures checked every three 
days.  Culture medium for all cells consisted of DMEM containing bicarbonate buffer, 
supplemented with 10% FBS and glutamine, 0.1 mg/ml penicillin-streptomycin and 0.3 
μg/ml Fungizone. 
 
Once the cells in each well reached 80-90% confluence, they were passaged into T-25 
flasks (Nunc, Themo Fisher Scientific, Rochester, NY, US).  They were washed briefly 
with 2.5 ml of sterile PBS.  Following removal of the PBS, the cells were detached from 
the surface (trypsinised) using 500 μl of 0.5% Trypsin/0.2% EDTA (Lonza) at 37°C for 
approximately 2 minutes.  After checking microscopically that the cells had detached, 
2.5 ml of medium was added to each well and mixed thoroughly by pipetting to 
disaggregate the cells further.  The contents of each well were then placed into 
individual T-25 flasks.  All cultures were subsequently expanded and passaged using a 
seeding density of 5 × 10
5
 per flask until sufficient cells were available for experiments. 
 
 







Figure 2-1: The serial collagenase digestion method. The population I and II from the first and 
second round of collagenase digestion were discarded. The population III, IV and V from the 










2.2.2 Establishing adult mice osteoblast cells using explantation method 
The first group of 5 male mice (weight 22.74g±1.29) were obtained.  The bones were 
taken from calvaria and ulna matched pairs from each mouse using the explantation 
method (Hughes and Aubin, 1998).  At that first passage, osteoblast-like cells from ulna 
observed better proliferation when compared to osteoblast-like cells from calvaria.  
Then at passage 2, both osteoblast-like cells from calvaria and ulna showed slow 
proliferation and underwent senescence.  This method was tried on 5 separate occasions 
but in all cases cells did not survive beyond passage 2.  We were able to explant 3 
matched pairs of osteoblast-like cells from calvariae and ulnae from 30 mice.  
 
2.2.3 Establishing adult rat primary cell cultures using explantation and collagenase 
isolation methods 
The different methods used in this study to establish dermal fibroblasts, BMSCs, 
calvarial osteoblasts and femoral osteoblasts are described as follows: 
Skin:  
Primary dermal fibroblasts were prepared by explant culture (Kobayashi et al., 2008).  
Four different areas of connective tissues from scalp, tissue overlying shoulder, 
abdominal and ulna area were taken (about 2×2 cm) from male Wistar rat (210 g, 10 
weeks old, London, UK).  The hair and superficial part of skin were removed with a 
sharp scalpel.  The tissues samples were cut into 1×1 mm in size and placed onto the 
surface of sterile 6-well cell culture plates (Nunc).  The tissue from different animals 
was plated separately allowing comparison between cells from different animals.  
Approximately five pieces were placed in each well.  They were left undisturbed 3 days 
in DMEM with 10% FBS and glutamine, 0.1 mg/ml penicillin-streptomycin and 0.3 
μg/ml Fungizone at 37°C in a humidified 5% CO2 atmosphere.  Approximately 1 week 
later, the explanted rat dermal-derived fibroblasts were harvested by trypsinisation and 
continued culturing in T-25 flasks (Figure 2-2).  The rat dermal-derived fibroblasts were 












Figure 2-2: Tissues from 4 different sites were taken. The tissues were explanted and grown in 
fibroblast culture medium, characterised and later tested for Hoxa gene expression. 
 
In later experiments tissue from four rats were used.  In these experiments, only three 
different sites from each rat were taken - from the scalp, tissue overlying the abdomen, 
and tissue overlying the femur region.  Tissue overlying the ulna region was not taken, 
but tissue overlying femur was taken instead as it may provide more related data on 
osteoblasts derived from femurs (Rinn et al., 2006). 
 
Bone Marrow Stromal Cells (BMSCs):  
Initially, BMSCs were cultured, collected and kindly provided by I.J McKay.  Briefly, 
BMSCs were removed from the ulna, femur, tibia, humerus and ribs of five rats (100-
110 g), and plated separately into T-25 flasks.  After initial plating the non-adherent 
cells were removed and cells cultured until they were 90% confluent.  Cells were then 
lysed and total RNA extracted.  Hoxa gene expression was assessed by qRT-PCR 
(Taqman) to investigate levels of Hoxa1, Hoxa2, Hoxa4, Hoxa5, Hoxa7, Hoxa10, 
Hoxa13, Alp, Bglap, and Tgfbi.  
 
 




In later experiments, BMSCs were removed from femur from different groups of rats 
(Rats 1-4, Rats 5-8 and Rats 9-12).  Briefly, bony shafts were removed aseptically and 
transferred to normal culture medium.  Attached muscles and soft tissue were removed 
with care.  The ends of the bone were sectioned identically to leave a portion of the mid-
shaft.  The marrows were taken out by flushing culture medium using 1 ml syringe.  
The cells were aspirated followed by several flushes through the bone until all the bone 
marrow was flushed out of the bone.  The same procedure was performed from the other 
end of the bone (Polisetti et al., 2010).  The marrow thus obtained was suspended by 
pipetting the large marrow cores through a 1 ml pipette and plated separately for each 
rat into T-25 flasks in culture medium.  The cultures were maintained at 37
o
C in a 
humidified 5% CO2 incubator and left undisturbed for 48 hours.  After 48 hours of 
initial plating, the non-adherent cells were removed.  The media was changed every 
three to four days.  The adherent cells were cultured in normal growth medium.  When 
the cells reached 80-90% confluence, the cultures were passaged and continued to grow.  




The calvariae were aseptically removed from different groups of rats (Rats 1-4, Rats 5-8 
and Rats 9-12) immediately after death and transferred to culture medium.  The parietal 
skull bones were then cut with a scalpel to produce two equal sized rectangular portions 
of contralateral parietal bone free of suture and other attendant soft tissues (Hughes and 
Aubin, 1998).  Bone portions were washed with sterilized phosphate-buffered saline 
(PBS).  Then they were cut into pieces approximately 1 mm
3
, put in sterile universal 
tube and shaken vigorously to remove soft tissue pieces, blood, fat and debris.  If the 
PBS was not clear, then another wash was required.  The bone chips were transferred 
evenly into 6-well culture plates containing DMEM supplemented with 10% foetal 
bovine serum with glutamine and 1% P/S and incubated at 37
o
C in 5% CO2 incubator, 
left undisturbed for 48-72 hours until an ‘osteoid seam’ was noticed.  This usually 
occurs 3-5 days after the culture was set up.  When plentiful adherent cells of seam 
formation were observed, the bone chips were collected and followed by 
trypsin/collagenase digest procedure (Tsiridis et al., 2006).  Briefly, medium from 
dishes of bone chips were removed.  The bone chips were carefully transferred to a 20  
 




ml sterile universal tube.  The trypsin/collagenase was added to the chips, incubated on 
Rolamixer for 20 minutes.   
 
The trypsin/collagenase for osteoblast isolation was prepared as follows: 
 
Collagenase powder (C9891-100 mg)    100 units/ml 
Trypsin (Gibco 15400-054)     0.02% 
Hepes 1 M (H0887) (Final concentration 0.01 M)      1 ml 
PBS        100 ml   
      
The cloudy fluid in the universal tube was observed which indicated that the cells had 
been in the solution.  The supernatant was carefully transferred to a new universal tube 
and centrifuged at 2,000 rpm at 18
o
C for 5 minutes.  The chips were rinsed with culture 
medium and placed in 60 mm dishes with fresh culture medium for further growing.  
 
The cell pellet was observed at the bottom of the universal tube after centrifugation.  
The medium was removed.  The cell pellet was re-suspended, centrifuged at 2,000 rpm 
for 5 minutes and washed 2 times with culture medium.  The cells were further grown in 
culture medium supplemented with 10 ng/ml of FGF-2 in 6-well culture plate (Nunc) 
and incubated at 37
o
C in 5% CO2 incubator as summarised in Figure 2-3. 
 
Femur:  
The femur shafts were prepared as described (Hughes and Aubin, 1998; Tsiridis et al., 
2006).  Briefly, rats were put to sleep by Nitrous Oxide and killed by cervical 
dislocation.  Left and right femurs were removed aseptically and transferred to culture 
medium.  Attached muscles and soft tissue were removed with care to leave the 
periosteum intact.  The ends of the bone were sectioned identically to leave a 12 mm 
portion of the mid-shaft.  The marrows were taken out by flushing with syringe.  The 
bones were cut longitudinally into 2 pieces, and then cut into pieces approximately 1 
mm
3
 and transferred into 6-well culture plate in culture medium then incubated at 37
o
C 
in 5% CO2 incubator and left undisturbed for 48-72 hours until an ‘osteoid seam’ was 
noticed.  When plentiful adherent cells of seam formation were observed, the bone chips 
were collected and followed by trypsin/collagenase digest procedure and grown as 
previously described for further experiments. 







Figure 2-3: Bones from calvaria and femur were taken from 4 rats, matched pairs. The bones 
were cut into small pieces, explanted and grown in osteoblast culture medium supplemented 
with FGF-2. They were characterised and tested for their osteoblast-associated gene 
expression such as Runx2, Bglap and Spp1. In addition, Hoxa gene expression and 
transcription factors such as Msx2, Irx5 and Tbx3 were also tested. 
 
2.3 Cell doubling 
To test the effects of FGF-2 on further cell growth, at p5 cultures, were continued either 
remaining in medium including FGF-2, or without FGF-2 supplementation.  Cells 




 cells from each of 4 osteoblastic cells at p5 were seeded in T-75 flasks 
and grown separately; one group grown in osteoblast culture medium without FGF-2 
supplementation and other group grown in osteoblast culture medium supplemented 
with FGF-2.  
 
The cells from two groups were count using cell counter every 5 days.  Normally, the 
cells that have been grown in osteoblast medium supplemented with FGF-2 become 
confluent in 5 days, whilst the cells grown in osteoblast medium without FGF-2 




supplementation have not reached confluent in 5 days.  They were counted every 5 days 
from p5 to p9.  
 
The overall number of cell doublings was calculated.  Data were calculated for 
population doublings (PDs) = the log of the ratio of the final count (N) to the starting 
(baseline) count (Xo), divided by the log of 2 (Greenwood et al., 2004a, b); that is  
 
PD = [log(N ÷ Xo)] ÷ log 2. 
 
2.4 Non-Radioactive Cell Proliferation Assay 
The CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay (Promega, 
Southamton, Hampshire, UK) is a colorimetric method for determining the number of 
viable cells in proliferation or chemosensitivity assays.  It is composed of solutions of a 
novel tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H tetrazolium, inner salt; MTS] and an 
electron coupling reagent (phenazine methosulfate; PMS).  
 
The mitochondria in viable cells reduce MTS into a water-soluble coloured formazan 
product in tissue culture medium, the intensity of which is quantified by reading the 
absorbance of the formazan at 490 nm using a spectrophotometer (Dynex Technologies 
reader).  The MTS solution and the PMS solution were completely thawed 
approximately 90 minutes at room temperature.  The entire content of the 1 ml tube of 
PMS solution was transferred to the 20 ml bottle of MTS solution.  This mixture was 





The 96-well plates of treated experiments were taken from the incubator.  20 μl of the 
combined MTS/PMS solution was pipetted into each well containing 100 μl in culture 
medium.  The plates were then incubated at 37°C in a humidified, 5% CO2 atmosphere 
for 1 hour.  The plates were read at 490 nm using a spectrophotometer.  To eliminate the 
products from the MTS assay reaction, all wells were washed three times with PBS 
prior to determining total alkaline phosphatase activity. 
 




2.5 Determination of total alkaline phosphatase activity  
 
The osteoblastic activity of cells was determined by measuring alkaline phosphatase 
(ALP) activity using p-nitrophenyl phosphate.  The ALP activity was determined by 
measuring the conversion of the colourless substrate p-nitrophenyl phosphate into the 
yellow coloured reaction product p-nitrophenol (PNP) and inorganic phosphate by the 
ALP enzyme.  Briefly, the ALP cleaves the phosphate group to reaction product, p-
nitrophenol which is yellow at alkaline pH.  
The ALP substrate solution was freshly prepared per 96-well plate to be assayed: 8.2 ml 
distilled water, 2.4 ml 1.5 M alkaline reaction buffer (Sigma-Aldrich Company Ltd, 
Gillingham, Dorset, UK), 30 mg N-Nitrophenylphosphate disodium salt hexahydrate 
(Sigma-Aldrich), and 1.2 mM MgCl2.  
 
100 μl of substrate solution was pipetted into each well using a multichannel pipette.  
The plates were incubated at 37°C for 20 minutes (Hughes and Aubin, 1998) and the 
reaction stopped by pipetting 100 μl 0.5 M NaOH into each well.  Once the reaction had 
been stopped, the reaction product was measured using spectrophotometer at the 
wavelength of 405 nm. 
 
2.6 ALP Histological staining 
 
Medium was removed from 6-well plates and cells rinsed in cold PBS.  The cells were 
fixed in 10% cold neutral formalin buffer for 15 minutes on ice.  Buffer was removed 
and plates were rinsed once with distilled water and left in distilled water for 15 
minutes.  In the mean time, the substrate was freshly prepared, consisting of: 
a) Naphthol AS MX-PO4   5 mg 1 mg (Sigma N4875) 
b) DMF (N,N-Dimethylformamide)   200 µl 40 µl (Sigma D4551) 
c) 0.2 M Tris-HCL pH 8.3   25 ml 5 ml 
d) Distilled water    25 ml 5 ml 








Distilled water was removed.  Fast red salt was added to solution a, b, c, d and filtered 
with Whatman no 1 filter paper into a container just before staining.  The plate was 
incubated for 45 minutes at room temperature.  The plate was rinsed with distilled water 
3 times and left in distilled water for 1 hour. 
Preparation for 10% Neutral formalin buffer: 
a) Formalin/Formaldehyde    100 ml 10 ml 
b) Na2HPO4      16 gm 1.6 gm 
c) NaH2PO4.H2O     4 gm 0.4 gm 
d) Distilled water to     1 Litre 100 ml 
 
2.7 Osteopontin (OPN) ELISA 
 
Osteopontin (rodent), EIA Kit (Enzo
 
Life Sciences (UK) LTD, Matford Court, Exeter, 
UK) (Catalog No: ADI-900-090A) was used in this experiment that contained the 
following reagents: 
 
1. Assay Buffer (Tris buffered saline containing BSA and detergent) 
2. Osteopontin (rodent) Standard (lyophilized recombinant rodent osteopontin) that was 
reconstituted to concentrations of: 100, 50, 25, 12.5, 6.25 and 3.13 ng/ml 
3. Osteopontin (rodent) Clear Microtiter 96-well Plate coated with a monoclonal 
antibody specific for osteopontin 
4. Osteopontin (rodent) EIA Antibody, a polyclonal antibody specific for osteopontin 
5. Osteopontin (rodent) EIA Conjugate (streptavidin conjugated to horseradish 
peroxidase) 
6. Wash Buffer Concentrate (Tris buffered saline containing detergents) 
7. Tetramethylbenzidine (TMB) Substrate (3,3´ 5,5´ -tetramethylbenzidine) and 
hydrogen peroxide 
8. Stop solution (1N solution of hydrochloric acid in water) 
Six standards in the range of 3.13-100 ng/ml were prepared.  Samples were diluted at 
1:16 as recommended by the assay manufacturer.  Sample buffer (blank), standards, and 
samples (50 μl/well) were pipetted in the wells in duplicates.  The plate was sealed and 
incubated for 1 hour shaking (speed range from 120-700 rpm) at room temperature. 
 




After a thorough wash 4 times with wash buffer (400 μl/well), the plate was aspirated 
and firmly tapped on a lint free paper towel to remove any remaining wash buffer.  The 
secondary antibody (50 μl/well) was added to each well except the blank.  After that, 
the plate was sealed and incubated for 1 hour shaking at room temperature.  After a 
thorough wash 4 times as above, the conjugate (50 μl/well) was added to each well 
except the blank.  The plate was sealed and incubated for 30 minutes at room 
temperature with continuous shaking.  
 
After the final wash, the substrate solution was added to all wells and incubated for 30 
minutes at room temperature with continuous shaking.  Then the stop solution (50 
μl/well) was added to each well and absorbance measured at 450 nm. 
 
2.8 Osteocalcin (OCN) ELISA 
 
The concentrations of osteocalcin in rat osteoblast conditioned media range from ˂1 
ng/ml to 400 ng/ml.  The range depends on the cell type and culture condition.  
Washing and growing cells in serum free media for 24-48 hours were recommended 
prior to measuring osteocalcin levels as Bovine IgG and osteocalcin, the bovine serum 
products, can interfere with the assay.  
 
The samples were prepared by using cells lysing method.  The cells were grown in 
osteoblast differentiation medium for 14 days.  The medium was removed.  After that, 1 
ml of distilled water was added and frozen for 15 minutes at -80
o
C.  Then the samples 
were thawed for 20 minutes at 37
o
C.  The samples were resuspended with a sterile 
pipette.  The freeze-thaw procedure was repeated twice more and the cell lysate was 
frozen at -80
o
C until used. 
 
Rat Osteocalcin EIA Kit (Biomedical Technologies, Inc., Stoughton, MA, US) (Catalog 
No: BT-490) was used in this assay that contains the following reagents:  
 
1. Working sample buffer 
2. Phosphate-Saline Concentrate (wash buffer)  
 
 




3. Osteocalcin Standard 200 ng lyophilized was reconstituted with 2.0 ml of sample 
buffer to make working standards concentrations of 50, 25, 12.5, 6.25, 3.12, 1.5, 0.78 
and 0 ng/ml.  
4. Osteocalcin Antiserum Concentrate 
5. Donkey anti-Goat IgG Peroxidase  
6. Tetramethylbenzidine (TMB) Substrate (3,3´ 5,5´ -tetramethylbenzidine) and 
hydrogen peroxide 
7. Stop Solution 
8. Rat Serum Control 
9. One 96 well plate coated with osteocalcin antibody 
The experiment was performed as a same day procedure according to the 
manufacturer’s instructions as follows: 
 
Seven standards in the range of 0.78-50 ng/ml were prepared.  Sample buffer (blank), 
standards, controls and samples (25 μl/well) were pipetted in the wells in duplicates 
followed by 100 μl of osteocalcin antiserum in each well; the plate was sealed and 
incubated for 2.5 hours at 37°C.  The wells were aspirated completely and washed five 
times (by hand) with Phosphate-Saline wash buffer (300 μl/well).  Wash buffer was 
completely removed.  Diluted Donkey anti-Goat IgG Peroxidase (100 μl/well) was 
added to each well; the plate was sealed and incubated for 1 hour at room temperature.  
The wells were aspirated completely and washed five times with Phosphate-Saline wash 
buffer (300 μl/well).  Mixed solution (1:1 ratio) of TMB solution and Hydrogen 
Peroxide solution (100 μl/well) was immediately added and incubated in the dark at 
room temperature for 30 minutes.  The stop solution (100 μl/well) was added to all 
wells and measured absorbance at 450 nm within 15 minutes. 
 
2.9 Mineralised bone nodules with Alizarin red 
 
Alizarin Red S (Sigma-Aldrich) (Sigma A5533) was prepared by adding 1 g of Alizarin 
red to 90 ml of distilled water and stirred with a magnetic stirrer until dissolved, the pH 
adjusted to pH 4.2 by adding 0.5M of KOH.  After that the solution was transferred to a 
measuring cylinder and made up to a total volume of 100 ml with distilled water.  The 
solution was filtered through coarse Fisherbrand Filter paper QT 260 (Fisher Scientific 
Ltd, Loughborough, Leicestershire, UK) before using. 




For a 6 well-plate, the medium was removed.  The cells were washed with PBS 1-2 ml 
per well.  The PBS was removed and cells were fixed in 10% formal saline for 15 
minutes using 1-1.5 ml per well.  After that, formal saline was removed and the plate 
was washed with distilled water using 2 ml per well.  The cells were then stained in 1% 
Alizarin red for 5 minutes using 1 ml per well.  The excess stain was removed and 
washed 5 times with 50% Ethanol approximately 2 ml per well and the last wash was 
left for 15 minutes.  The plate was left to air dry in room temperature. 
 




 fluorescent probes (Invitrogen, Life Technologies Corporation, Paisley, 
UK) are not transferred to adjacent cells in a population and retained in living cells 
through several generations by the daughter cells inherited the dyes after cell fusion.  
These reagents pass freely through cell membranes, but once inside the cell, are 
transformed into cell-impermeable reaction products which claim to have excellent 
retention, strong fluorescence and relatively uniform cytoplasmic staining. 
2.10.1 Preparing dye working solution 
The lyophilized product was recommended to dissolve in DMSO to a final 
concentration of 10 mM.  The stock solution was diluted to a final working 
concentration of 0.5-25 µM in serum-free medium, warmed the working solution to 
37
o
C before using.  According to the manufacturers, for long-term staining (more than 
about 3 days) or the use of rapidly dividing cells 5-25 µM dye is required.  Less dye, 
0.5-5 µM is needed for shorter experiments. 
2.10.2 Staining protocol 
When the cells were approximately 80% confluent, the medium was removed from the 
flask and the pre-warmed CellTracker
TM
 dye working solution was added and incubated 
for 30 minutes in CO2 incubator.  The dye working solution was replaced with fresh, 
pre-warmed medium and the cells incubated for another 30 minutes at 37
o
C.  The cells 
were washed with PBS.  Then the cells were grown in culture medium.  CellTracker
TM
 
Green (C7025 Invitrogen), CellTracker
TM
 Red (C34552 Invitrogen) and CellTracker
TM
 
Orange (C34551 Invitrogen) were used in this study. 
 




2.10.3 The maintenance of fibroblast positional identity in heterotypic culture 
Fibroblasts were cultured in T-25 flask until they were at least 90% confluent.  The cells 
were then trypsinised and seeded in Falcon 12-well culture plates (Beckton Dickinson, 
Oxford, Oxfordshire, UK) at a density of 5×10
5
 cells per well in 10% FBS DMEM with 
1% P/S and glutamine.  After 24 hours, cells were stained with either CellTracker
TM
 
Green CMFDA (5-chloromethylfluorescein diacetate) or CellTracker
TM
 Red CMTPX. 
Briefly, the culture medium was removed and pre-warmed CellTracker
TM
 dye working 
solution was added.  During this time, the chloromethyl group of the dye underwent 
modification or secreted from the cell.  Working concentration of fluorescent probes 
was optimised.  Various concentrations (0, 0.5, 1, 2, 5 µM) of cell trackers were tested.  
2 µM was selected as an appropriate concentration for further used in fibroblasts 
staining experiments.  
The cells were incubated with dyes for 30 minutes at 37
o
C in 5% CO2 incubator, 
washed 3 times with PBS to remove access dyes before replacing with fresh medium for 
another 30 minutes up to overnight at 37
o
C in 5% CO2 incubator before trypsinisation 
and mixing them in heterotypic culture.  The cells were visualised using an Olympus 
AX70 fluorescence microscope at 4, 10, 20x magnification.  Photos were taken.  The 
cells were maintained in monotypic or heterotypic culture up to 1 week and observed 
under fluorescence microscope. 
2.10.4 The maintenance of osteoblast positional identity in heterotypic culture 
This experiment was to test how long the cells can maintain their identity during 
heterotypic culturing.  The calvarial and femoral osteoblastic cells were cultured in T-25 
flask until reached 80-90% confluence.  The cells were then trypsinised and seeded in 
Falcon 12-well culture plates (Beckton Dickinson) at a density of 5×10
5
 cells per well in 
10% FBS DMEM with 1% P/S and glutamine.  After 24 hours, cells were stained with 
either CellTracker
TM
 Green CMFDA or CellTracker
TM





Briefly, the culture medium was removed and pre-warmed CellTracker
TM
 dye working 
solution was added.  For long-term staining of more than 3 days, it was recommended to 
use 5-25 µM dye, whereas less dye 0.5-5 µM is needed for shorter experiments.  The 
working concentration of fluorescent probes was optimised.  Various concentrations (0,  
 




0.5, 10, 25, 50 µM) of cell trackers were tested.  The working concentration of 25 µM 
was selected as an appropriate concentration for further used in experiments.  
 
The cells were incubated with dyes for 30 minutes at 37
o
C in 5% CO2 incubator, 
washed 3 times with PBS to remove access dyes before replacing with fresh medium for 
another 30 minutes up to overnight at 37
o
C in 5% CO2 incubator before trypsinisation 
and mixing them in heterotypic culture.  The cells were visualised using an Olympus 
AX70 fluorescence microscope at 4, 10, 20x magnification.  Photos were taken.  The 
cells were maintained in monotypic culture or heterotypic culture up to 1 week and 
observed under fluorescence microscope.  However, the cells which stained with 
CellTracker
TM
 Green had started to decrease their fluorescence intensity within 1 week 
compared to the cells which stained with CellTracker
TM
 Red.  The photos taken at Day 
7 in culture of the cells that stained with CellTracker
TM
 Green had become problematic.  
Despite the fact that the cells were losing their labeling over time in culture and difficult 
to observe using fluorescence microscope, the cells were later analysed by using a more 
sensitive method, flow cytometry. 
 
2.11 Flow cytometry 
Fluorescence Activated Cell Sorters (FACS machines) make physical separation of sub-
populations of cells from a heterogeneous population, with a high degree of purity and 
high speed possible.  This technique can be used in many situations (Cram, 2002; Huh 
et al., 2005; Nunez, 2001; Rieseberg et al., 2001).  Various methods can be used in flow 
cytometric cell sorting:  
 
1) Mechanical sorting 
 
The mechanical device called a catcher tube can be used to sort the cells by moving into 
the stream to collect the cells when cells of interest passing through the laser beam.  The 
system can determine if each cell belongs to the selected population defined by their 
boundaries in the cytogram.  The catcher tube will capture the cell of interest and collect 
into a tube otherwise it will be dispatched to the waste tank.  This is a very slow method 
for sorting and is now rarely used.  It is however good for very large cells or known 
biohazardous cells, as the whole system is enclosed and no aerosols are generated. 
 
 




2) Electrostatic sorting 
By applying a vibration to the nozzle, the particles are forced to disintegrate into a 
stream of droplets.  The system can detect the droplets with particles of interest from 
the stream by applying a charge to those droplets.  When a charged droplet passes 
through an electrostatic field, it is redirected and collected into the corresponding 
collection tube.  The droplet is deflected in the direction of the opposite charged plate, 
so that this droplet is separated from uncharged and oppositely charged droplets. 
 
3. Other methods 
 
Another way to sort cells is to use magnetic beads.  It is possible to confidently select 
cells of interest by adding magnetically labeled antibodies to the study population or by 
negatively selecting a population using coupled antibodies to magnetic beads specific 
for the cells other than those of interest.  Cells are then passed between a magnetic field 
through a column to either elute or impede the population of interest. 
 
2.11.1 Flow Cytometry for analysis 
The BD FACSCanto II was used for flow cytometry analysis.  Briefly, the cells were 
stained at Day 0 which gave the strongest fluorescence intensity and used as a positive 
cell staining, whilst the unstained cells which gave the negative fluorescence were used 
as a negative control.  The cells stained with DAPI also been used to identify dead cells 
in our early experiments.  We found that our cells were healthy in general.  Therefore, 
DAPI were not need to be added in later experiments.  These cells were used to 
calibrate the FACS machine and gate unwanted cells before starting the analysis. 
 
To test for dye contamination, the experiments were set up using monotypic or 
heterotypic cultured cells which labelled with CellTracker
TM
 dyes.  They were counted 
and each cell type of 1x10
5
 cells were grown in T-25 flasks in monotypic or heterotypic 
cultures for 0, 3 and 7 days.  Then the cells were detached from tissue culture flasks 
with Trypsin/EDTA and collected into sterile FACS tubes.  The cell pellet was 
centrifuged for 5 minutes at 1,100 rpm.  The cells were re-suspended in 500 μl normal 
culture medium and ready to be analysed.  Standard flow cytometry was used for 
determining the percentage of cells in the population that are in S-phase.  BD 
FACSDiva been used for analysis. 




The spectral characteristics of the fluorescent CellTracker
TM
 probes are summarised in 










 Green CMFDA (5-chloromethylfluorescein diacetate) 492 517 
C34552 CellTracker
TM
 Red CMTPX 577 602 
C34551 CellTracker
TM
 Orange CMRA 548 576 
 
Table 2-2: Summary of the fluorescent CellTracker
TM
 probes used in this study. *Absorption and 
fluorescence emission, determined in aqueous buffer or methanol; values may be different to 
some extent in cellular environments. CMFDA is colourless and non-fluorescent until the 
acetate groups are cleaved by intracellular esterases; hydrolysis of the acetates yields a 




 Green was the FITC channel at 488 nm excitation, 530/30 collection.  
CellTracker
TM
 Red was the PE channel at 488 nm excitation, 585/42 collection.  
CellTracker
TM
 Orange was the PE channel at 488 nm excitation, 585/42 collection.  
 
2.11.2 Flow cytometry for cell sorting 
 
The BD FACSAria II was used for cell sorting according to different cell fluorescence 
labelling.  Briefly, the cells were stained at Day 0 which gave the strongest fluorescence 
intensity were used as a positive cell staining and the unstained which gave the negative 
fluorescence were used as a negative control.  The cells stained with DAPI also been 
used to identify dead cells in our early experiments.  We found that our cells were 
healthy in general and DAPI were not need to be added.  Unstained cells were used to 
set optimal side and forward scatter voltages on the FACS machine and to gate out 
unwanted cells before cell sorting.  The sorter was QC checked before each experiment 
using BD Cytometer Set up and Tracking Beads and the optimal drop delay was 
determined using BD Accudrop beads.  Cells were sorted on a 100 μm nozzle. 
 
All cell sorting experiments were kindly helped by Dr Susanne Heck, PJ Chana and  
Helen Graves, Flow Cytometry Lab, BRC Core facility, Guy’s & St. Thomas’ NHS 
Foundation Trust.  Briefly, the cells were labelled with CellTracker
TM
 dyes.  They were 
counted and each cell type of 5x10
5
 cells were grown in T-25 flasks in monotypic or 
heterotypic cultures for 0, 3 and 7 days.  Then the cells were detached from tissue 
culture flasks with Trypsin/EDTA and collected into sterile FACs tubes and pelleted by 




centrifugation for 5 minutes at 1,100 rpm.  The cells were re-suspended in 500 μl 
normal culture medium and kept on ice throughout sorting process.  Standard flow 
cytometry Electrostatic Sorting was used for cell sorting into designated containers.  BD 
FACSDiva software been used for analysis.  CellTrackerTM Green was the FITC 
channel at 488 nm excitation, 530/30 collection.  CellTrackerTM Red was the PE channel 
at 488 nm excitation, 575/26 collection.  CellTrackerTM Orange was the PE channel at 
488 nm excitation, 575/26 collection.  
 
2.12 RNA extraction 
 
Total RNA was extracted from cells using RNeasy® Mini Kit (Qiagen, Crawley, West 
Sussex, UK), in accordance with manufacturer’s instructions.  Briefly, cells were grown 
in a monolayer up to 80-90% confluent and disrupted by adding 350 µl of buffer RLT 
which contains 10 µl of β-mercaptoethanol (β-ME) in 1 ml of buffer RLT in the 
pelletted cells of less than 5x10
6
 cells.  The lysate was homogenized using 
QIAshredder
TM
 spin column (Qiagen).  One volume of 70% ethanol was added to 
homogenized lysate and transferred to RNeasy® spin column.  For genomic DNA 
contamination, 10 µl of DNase 1 stock solution in 70 µl of buffer RDD was added to 
RNeasy® spin column membrane for 15 minutes at room temperature.  The RNeasy® 
spin column was washed twice with buffer RPE.  Then RNeasy® spin column was 
placed in a new 1.5 ml collection tube and 20-30 µl of RNase-free water directly was 
added to spin column membrane, centrifuged for 1 minute at ≥10,000 rpm to elute 
RNA. 
 
2.13 Determination of quantity and purity of RNA  
RNA quantification was carried out immediately prior to cDNA synthesis.  RNA 
quantification and purity was determined using a NanoDrop ND-1000 
spectrophotometer (Thermo Scientific).  The spectrophotometer lens was wiped clean 
with lint-free tissue and subsequently added 1 μl RNase-free water for initialisation.  
The RNA stored at -80°C was thawed on ice.  Once thawed, 1 μl of each sample was 
transferred onto the pedestal, and the purity was assessed and concentration recorded.   
 
The purity was estimated using the reading ratio at 260 nm and 280 nm (A260/A280).  
All samples tested were considered acceptable for cDNA synthesis as A260/A280 ratios 




were between 1.8 and 2.2.  The DNase was treated as part of RNA extraction, gel 
analysis was not carried out to visually detect genomic DNA contamination. 
 
2.14 cDNA synthesis  
 
1 μg RNA of sample was used for cDNA synthesis.  Each RNA sample was diluted in 
RNase-free water for 1 μg RNA in 14 μl volume.  RNA samples were also used to make 
a control mixture by replacing reverse transcriptase with RNase-free water to make   
No-RT control.  This control was included to check any presence of contaminating 
genomic DNA in the q-PCR reaction.  The diluted RNA samples were pipetted into 0.5 
ml PCR tubes containing 1 μl of 0.5 μg/μl Oligo(dT) 15 primer (Promega).  The tubes 
were heated for 5 minutes on a block pre-set at 70°C before used to denature the RNA 
secondary structure, cooled on ice for annealing of primers to the RNA, and centrifuged 
briefly to assemble all contents to the bottoms of the tubes.  
 
To each tube, the following were added in order:  
 
3.75 μl RNase-free water  
5 μl M-MLV Reverse Transcriptase Reaction Buffer (Promega)  
1.25 μl PCR Nucleotide Mix containing 10 mM of each dNTP (Promega)  
1 μl M-MLV Reverse Transcriptase, RNase H Minus, Point Mutant (Promega) 
For No-RT control, the enzyme was replaced with 1 μl RNase-free water. 
 
The samples were then placed in a PCR machine programmed to heat the tubes to 42°C 
for 30 minutes for extension, then 85°C for 5 minutes to inactivate the enzyme, then 
cooling down to 4
o
C for 5-10 minutes.  The samples were then immediately stored at      









2.15 Quantitative real-time PCR (qRT-PCR) 
 
Gene expression in cells was quantified using qRT-PCR against the House Keeping 
Genes (HKGs) to compare the gene expression among different genes of interest before 
and after co-culturing.  The experiment demonstrated whether or not the cells with 
different gene expression can induce or be induced by other cells or still maintain their 
identity.  In all qRT-PCR experiments (Table 2-3) throughout this thesis a minimum of 
4 replicate samples were used for all tests in MicroAmp® Optical 384-well reaction 







HKGs Screening: FBTs for all samples 1 rat, 4 sites 1 0 
HKGs Screening: BMSCs for all samples 5 rats, 5 sites 1 0 
HKGs Screening: OBTs for all samples 4 rats, 2 sites 1 0 
Hoxa genes: FBTs at p-5 in 1 rat, 4 sites 1 0 
Hoxa genes: FBTs at p-5 in 4 rats, 3 sites 1 0 
Hoxa genes: BMSCs at p-3 in 5 rats, 5 sites 1 0 
Hoxa genes: OBTs at p-5 in 4 rats, 2 sites 1 0 
Hoxa genes: OBTs at p-10 in 4 rats, 2 sites 1 0 
Hoxa genes: FBTs in heterotypic CM in 1 rat, 2 sites, 2 time points 1 0 
Hoxa genes: OBTs in monotypic culture in 4 rats, 2 sites, 3 time points 2 2 
Hoxa genes: OBTs in heterotypic culture in 3 rats, 2 sites, 3 time points 3 3 
Hoxa genes: OBTs in heterotypic culture in 4 rats, 2 sites, 3 time points 2 2 
Osteoblast-associated genes in monotypic culture in 4 rats, 2 sites, 3 
time points 
2 2 
Osteoblast-associated genes in heterootypic culture in 4 rats, 2 sites, 3 
time points 
2 2 
Transcription factors  in monotypic culture in 4 rats, 2 sites, 3 time 
points 
2 2 




Table 2-3: Table of qRT-PCR experimental set-up 
 




2.15.1 Method of selection of reference genes  
 
Prior to detecting the genes of interest, the most stable reference genes were selected 
from a panel of 6 using a representative range of experimental cDNA samples from all 
the different tissue and cell types derived.  Using reference genes as internal controls to 
normalize data and control for variability between samples, plates, instrument and 
pipetting differences.  According to the similarity of their expression profile, two 
reference genes were selected using a pair-wise comparison to compare geometric mean 
as a normalisation factor using geNorm software analysis (Vandesompele et al., 2002). 
 
Six HKGs (Table 2-4) were screened in order to select two most stable HKGs to be 
further used (Vandesompele et al., 2002).  Five different primary BMSCs derived from 
different bony regions were tested.  Four different primary fibroblasts derived from 
different dermal regions were tested afterwards, whereas 8 primary osteoblastic cells 
matched pairs will be investigated for the genes listed in Table 2-5 and Table 2-6.  
 
Official Gene Symbol  Gene Name  Applied Biosystems Assay ID  
Ubc  ubiquitin C  Rn01789812_g1 




Eif4a2 eukaryotic translation initiation 
factor 4A2 
Rn01404755_gH 
Atp5b ATP synthase, H+ transporting, 
mitochondrial F1 complex, beta 
polypeptide 
Rn01756316_g1 
RN18S1 RNA, 18S ribosomal 1 Hs99999901_s1 
 
Table 2-4: A list of TaqMan Gene Expression Assays used for qRT-PCR detection of the most 
stable rat reference genes in samples. Regarding the ABI Assay IDs, “Rn” indicates Rattus 
norvegicus, “Hs” indicates Homo sapiens. “_g1” indicates assays that may detect genomic DNA. 
“_m1” indicates the assays whose probes span an exon junction and will not detect genomic 
DNA. “_gH” indicates assays designed belong to a gene family with high sequence homology. 




difference between the target gene 
and the gene with the closest sequence homology. An assay, therefore, will detect the target 
transcript with 1,000 to 30,000-fold greater discrimination (sensitivity) than the closest 
homologous gene. “_s1” indicates the assay whose primers and probes have been designed 








Official Gene Symbol  Gene Name  Applied Biosystems Assay ID  
Hoxa1 homeo box A1 Rn00565157_m1 
Hoxa2 homeo box A2 Rn00561390_m1 
Hoxa4 homeo box A4 Rn02088951_s1 
Hoxa5 homeo box A5 Rn01763079_m1 
Hoxa7 or Hoxa9 homeo box A7 or homeobox A9 Rn01451913_m1 
Hoxa10 homeo box A10 Rn01451894_m1 
Hoxa13 homeo box A13 Rn01326387_m1 
 
Table 2-5: A list of TaqMan Gene Expression Assays used for qRT-PCR detection of Hoxa 
genes in samples. Regarding the ABI Assay IDs, “Rn” indicates Rattus norvegicus. “_m1” 
indicates the assays whose probes span an exon junction and will not detect genomic DNA. 
“_s1” indicates the assay whose primers and probes have been designed within a single exon, 
and therefore will detect genomic DNA.  
 
Official Gene Symbol  Gene Name  Applied Biosystems Assay ID  
Msx2 msh homeobox 2 Rn00564331_s1 
Irx5 iroquois homeobox 5 Rn01538194_m1 
Tbx3 T-box 3 Rn00710902_m1 





Spp1 secreted phosphoprotein 1 Rn00563571_m1 
 
Table 2-6: A list of TaqMan Gene Expression Assays used for qRT-PCR detection of 
transcription factors and osteoblast-associated genes in samples. Regarding the ABI Assay IDs, 
“Rn” indicates Rattus norvegicus. “_m1” indicates the assays whose probes span an exon 
junction and will not detect genomic DNA. "_g1" indicates assays that may detect genomic 
DNA. “_s1” indicates the assay whose primers and probes have been designed within a single 
exon, and therefore will detect genomic DNA. 
 
The first strand of cDNA was synthesized from 1 µg RNA.  This was used for 
amplifications performed with specific primers for Hoxa genes (Applied Biosystems, 
Life Technologies, Cheshire, UK).  Primer sequences were designed with the Primer 
Express® programme from Applied Biosystems.  For qRT-PCR analysis in an ABI 
Prism® 7300 Sequence Detector, the TaqMan® Gene Expression Assays, TaqMan PCR 
reaction mixtures were set up as suggested by the manufacturer.  Briefly, a 5 µl aliquot 
of cDNA was used in a final volume of 25 µl reaction mixture containing 12.5 µl of 2x 
Taqman® Universal PCR Master Mix (P/N 4304437), 1.25 µl of Gene mix and 6.25 µl 
of nuclease-free water (all from Applied Biosystems).  Thermal cycler conditions 
consisted of AmpRease®UNG activation at 50
o
C for 2 minutes, AmpliTaqGold®DNA 
polymerase activation at 95
o
C for 10 minutes and 40 PCR cycles, each of which was 






C for 15 seconds and 60
o
C for 60 seconds.  All PCR reactions were performed in 4 
replicates.  Each of the signals was normalized to average of two most stable HKGs in 
the same reaction.  Data were presented as the relative expression to average control 
genes. 
 
2.16 qRT-PCR set-up  
 
In order to have adequate volume for the PCR reactions, 1,014 μl of ultrapure (18.2MΩ) 
water was added to the total 26 μl cDNA of each sample and the controls in 1.7 ml PCR 
tubes to make 40-fold dilutions as recommended from provider.  The necessary volumes 
of primers and probes were then mixed with the appropriate amount of PCR mastermix 
- ABsolute QPCR ROX Mix (2×) (ABgene Ltd.), to obtain 0.5 μl primers and probes 
and 5 μl PCR mastermix per well.  A separate stock mix for each primer and probe set 
was made.  The mastermix contained thermostable DNA polymerase, reaction buffer, 
dNTPs and ROX, a passive reference dye for normalisation of the FAM reporter dye 
signals.  
 
PCR reactions were carried in MicroAmp™ Optical 384-Well Reaction Plates (Applied 
Biosystems).  Pipetting was carried out using a digital pipetter.  Each cDNA sample was 
pipetted at a volume of 5 μl per well.  To check for non-specific signal arising from 
primer dimers or DNA contamination of q-PCR reagents, No template controls (NTCs) 
where cDNA was substituted with ultrapure water were also pipetted for each gene to be 
assayed.  Subsequently 5.5 μl of the stock mix containing primers, probes and PCR 
mastermix was added to create a final volume of 10.5 μl per well.  All reactions were 
carried out in singleplex which is only one type of primer pair per well.  Each sample 
was tested in 4 replicates. 
 
When finished pipetting, the plates were sealed with optical adhesive film to reduce the 
chance of contamination between well and prevent sample from evaporation, 








The PCR reactions were then carried out using the Applied Biosystems 7900HT Fast 
Real-Time PCR System.  The thermal cycling parameters used were an initial hold step 
of 10 minutes at 95°C to activate the DNA polymerase.  This was followed by 40 cycles 
of 15 seconds at 95°C to denature the DNA followed by 1 minute at 60°C for annealing 
and extension.  
 
Expression data from Applied Biosystem’s SDS2.3 software were retrieved and 
analysed using Microsoft Excel. 
 
2.17 Analysis of qRT-PCR data  
 
Data were normalised against the selected reference genes.  The fractional PCR cycle 
used for quantification, termed quantification cycle (Cq), for the means of the replicates 
was normalized to the average Cq of the controls per plate by subtracting the average 
Cq of the controls from each mean to give the Cq which is equivalent to the log2 
difference between endogenous control and target gene.  A raw Cq of 35 was set as the 
limit of detection in this study: individual replicates which gave Cq values >35 were 
considered not detected.  Relative expression to average control genes data were 
generated using comparative different genes within samples (2
-ΔCq
) method.  




2.18 Assumptions regarding qRT-PCR  
 
Applied Biosystems announce the efficiency for the product amplification using their 
assays is 100%, i.e. there is a doubling of PCR product at every PCR cycle and also 
state the 2
-ΔΔCq
 method for relative quantification is better related with expected gene 











2.19 EdU incorporation 
Previous methods used to measure a cell’s ability to proliferate by directly measuring 
DNA synthesis have been by incorporation of radioactive nucleosides; i.e. H-thymidine 
or by antibody-based detection of the nucleoside analogue bromo-deoxyuridine (BrdU).  
Click-iT® EdU Flow Cytometry Assay Kits (Invitrogen A10202) are new alternatives 
to the BrdU assay.  EdU (5-ethynyl-2´-deoxyuridine) is a nucleoside analogue to 
thymidine.  During active DNA synthesis, EdU is incorporated into DNA.  Detection is 
based on a click reaction, a copper catalyzed covalent reaction between an azide and an 
alkyne.  In this application, the EdU contains alkyne, while azide can be detected in the 
Alexa Fluor
®
 488 dye, Alexa Fluor
®
 647 dye, or Pacific Blue™ dye.  
Briefly, the cells were incubated with Click-iT
®
 EdU for 48 hours.  They were 
harvested, fixed and permeabilized for 15 minutes.  The detection of Click-iT
®
 EdU was 
incubated for 30 minutes at room temperature and prevented from light.  The cells were 
analysed by flow cytometry.  The BD FACSCanto II was used for flow cytometry 
analysis.  For the detection of EdU with Alexa Fluor
®
 647 azide, it was recommended to 
use 633/635 nm excitation with red emission filter (660/20 nm or similar).  The Alexa 
Fluor
®
 647 azide was the APC channel at 633 nm excitation, 660/20 collection to see 
proliferating cells that have incorporated EdU providing the percentage of cells in        
S-phase of DNA synthesis. 
 
2.20 Statistical analysis  
 
Data are expressed as means ± SD.  In Chapter 4, One-way ANOVA and Bonferroni's 
Multiple Comparison test used to compare more than two different sites for each gene 
expression.  Additional analyses in Chapters 4 and 6, Wilcoxon’s Sign-Rank test were 
used to analyse cells derived from each animal separately.  Paired t-test was used to 
determine whether differences between two different populations were statistically 
significant.  Statistical analysis was carried out using Prism 5 v5.0 software (GraphPad 
Software Inc.).  p˂0.05, p˂0.01 and p˂0.001 considered statistically significant unless 
stated otherwise. 
  












Chapter 3 Chapter 3: 
Establishment of osteoblast cultures 
 
Chapter 3: Establishment of osteoblast cultures  






The overall aim of the studies in this thesis is to investigate regional differences in 
osteoblasts derived from different sites, including programming of their “positional 
identity” and associated phenotypic variations between cells.  In order to carry out these 
studies, it was necessary to be able to isolate and culture osteoblastic cells from a range 
of regionally distinct sites, and to maintain them in culture for a sufficient period of 
time to have enough cells for experiments, whilst maintaining their original phenotypes.  
Throughout these studies we adopted a “matched pair” strategy, whereby pairs of 
primary osteoblast cultures from different sites were obtained from the same animal, so 
that comparison between cells were always controlled for between animal variations.  
This approach potentially provides a technical challenge, as the number of cells isolated 
from an individual site in a single animal is often quite low, and therefore it was 
necessary to determine if it was possible to do this and expand the cells sufficiently by 
long term culture. 
 
In previous studies in our laboratory, Rawlinson successfully isolated and established 
rat osteoblast primary cells from distinct bony regions using a collagenase isolation 
method (Rawlinson et al., 2009b).  These cells were subsequently tested by microarray 
to test for preferentially expressed genes between two distinct osteoblast populations 
from calvarial (paraxial mesodermal-derived) cells and femoral (lateral plate 
mesodermal-derived) cells.  
 
Use of mice as a source of cells has the potential benefit of better availability of 
reagents for further study, and ultimately potentially the availability of transgenic 
animals.  However, against this the initial donor tissues are even smaller than those for 
rats and thus harvested cells may not be sufficient for carrying out our planned 
experiments.  Failing that, we would need to isolate and establish calvarial and femoral 










Therefore the aims of this chapter are: 
 
1. To isolate and establish rodent primary osteoblast cultures from distinct bony regions 
as matched pairs; 
 
2. To test the capacity to expand these cultures extensively whilst maintaining their 














3.3 Materials and Methods 
3.3.1 Osteoblast cultures from mice 
 
Two different cell isolation methods were tested to establish an adult mouse derived 
primary osteoblast culture.  Firstly, tissues from 5 adult mice were obtained and cells 
released by collagenase digestion as described in section 2.2.1.  In further experiments, 
tissues were taken and explanted as described in section 2.2.2. 
 
3.3.2 Osteoblast cultures from rats 
 
A combination of explantation and collagenase isolation methods were used to establish 
adult rat osteoblastic cells from calvariae and femurs, as described in section 2.2.3.  The 
cells isolated by explants and collagenase digestion methods of cell isolation were 
grown separately in osteoblast culture medium.  In later experiments osteoblast culture 
medium was supplemented with 10 ng/ml of FGF-2. 
 
3.3.3 Maintenance of osteoblastic phenotype with continuous culture 
 
Successfully isolated continuous 8 different matched pairs of primary osteoblast 
cultures from 4 rats were grown up to passage 10 to check whether the cells could still 
maintain their osteoblastic phenotype up to this passage.  In latter experiments, the cells 
grown within these passages were used.  The cells were tested at passage 5 and passage 
10 for persistence of osteoblast phenotype, measuring proliferation (section 2.4), ALP 
staining (section 2.6), osteopontin and osteocalcin production by ELISA (section 2.7 
and 2.8), mineralised bone nodules (section 2.9), and expression of a range of genes 




















Figure 3-1: This flow chart summarised how adult rat osteoblastic cells were isolated, grown, 
frozen and tested at different passages. 
 
  






3.4.1 Adult mouse osteoblastic cells 
 
In initial experiments, calvarial and ulna bones of 5 adult mice were isolated and treated 
with collagenase to release osteoblastic cells.  A few cells were observed in cultures but 
failed to grow significantly.  In further experiments using explant culture of calvariae 
and ulnae, cells were initially observed to grow out of the explants from some mice 
(Figure 3-2) and maintained in culture for periods up to 28 days.  Cells derived from 
calvariae tended to have a round or cuboidal shape, whilst ulna-derived cells tended to 
appear more spindle shape.  However, none of the cultures approached confluence, and 
later became flattened and apparently senescent as the cells were not dead, but did not 
proliferate or grow as usual.  These cell isolations were repeated up to 5 times, without 




























Figure 3-2: Adult mice osteoblastic cells from calvaria and ulna matched pairs from 3 mice in 
group 2, 3 and 5 were observed using explant isolation method, magnification 100, scale bar = 
200 µm. Cells derived from calvaria (A) tended to have a round or cuboidal shape, whilst ulna-
derived cells (B) tended to appear more spindle shape, magnification 200, scale bar = 100 µm. 
  




3.4.2 Adult rat osteoblastic cells 
 
For rat osteoblast explant cultures, after about 3 days in culture marked outgrowths of 
osteoblastic cells were seen from both calvarial and femoral bone explants.  With 
prolonged culture for periods of up to 28 days cultures approached confluence, and were 
subcultured into T-25 flasks.  However cell proliferation tended to cease and cells 
underwent senescence typically at p1.  Occasionally cell cultures were maintained until 
a second passage into T-25 flasks but then ceased growth.  These experiments were 
































Figure 3-3: After explantation from 4 male rats (Rats 5-8) matched pairs. Occasionally cell 
cultures were maintained until a second passage into T-25 flasks up to 28 days but then ceased 
growth, magnification 100, scale bar = 200 µm, (A) at magnification x200, scale bar = 100 µm. 
  




3.4.3 Effect of FGF-2 supplementation 
 
In view of the failure of cultures to undergo sufficient growth in vitro prior to 
apparently reaching senescence, we next tested the effects of supplementing the culture 
medium with FGF-2 on growth of cultures.  In rat osteoblast explant cultures, after 
about 3 days in culture marked outgrowths of osteoblastic cells were seen from both 
calvarial and femoral bone explants (Figure 3-4).  It was apparent that cells grew more 
rapidly and could be maintained for multiple passages following the addition of the 
FGF-2 to the culture media.  Thus cells were grown in continuous culture and at 
passage 3 some of the cells were frozen for future uses.  Cells were tested for 
maintenance of osteoblast phenotype at p5 and again at p10.  
 
To test the effects of FGF-2 on further cell growth at p5, (all of which had been 
maintained in FGF-medium until that point) cultures were continued in medium either 
including FGF-2, or without FGF-2 supplementation.  Cells continued to grow and 
remained viable up to p9 at least, in both sets of cultures.  However the cell growth was 
greatly enhanced in cultures with FGF-2.  Briefly, 5x10
5
cells from each of 4 
osteoblastic cells at p5 were seeded in T-75 flasks and grown separately; one group 
grown in osteoblast culture medium without FGF-2 supplementation and other group 
grown in osteoblast culture medium supplemented with FGF-2.  The cells from two 
groups were counted using cell counter every 5 days.  Normally, the cells that have been 
grown in osteoblast medium supplemented with FGF-2 become confluent in 5 days, 
whilst the cells grown in osteoblast medium without FGF-2 supplementation had not 
reached confluent in 5 days.  They were counted every 5 days from p5 to p9.  The 
overall number of cell doublings was calculated.  Data were calculated for population 
doublings (PDs) = the log of the ratio of the final count (N) to the starting (baseline) 
count (Xo), divided by the log of 2 (Greenwood et al., 2004a, b); that is  
 
PD = [log(N ÷ Xo)] ÷ log 2. 
 
Data is shown in Figure 3-5.  Cells no longer in FGF-2 showed between 2-4 doublings 
from p5 to p9.  However those cultures still supplemented with FGF-2 showed over 8 
cell doublings over this time.  This number of cell doublings is the equivalent of a 
difference of around 16 (2
4
) times more cells produced over that culture period. 






Figure 3-4: Four male rats (Rats 9-12) matched pairs at day 3 after explantation and grown in 
culture medium supplemented with FGF-2, marked outgrowths of osteoblastic cells were seen 
from both calvarial and femoral bone explants, magnification 40, scale bar = 100 µm. Cells 
derived from calvaria (A) tended to have a round or cuboidal shape, whilst femur-derived cells 













































Figure 3-5: Cumulative cell doubling from adult rat calvarial and femoral osteoblastic cells from 
4 lines, counted every 5 days using cell counter. The cells grown in osteoblast medium without 
FGF-2 supplementation showed between 2-4 cell doublings from p5 to p9, whilst cells grown in 
osteoblast medium supplemented with FGF-2 showed 8 cell doublings over this time. Data 
presented in mean ± SD. Paired t-test was used to compare cell doubling between osteoblasts 









3.4.3.1 ALP Staining 
 
Rat calvarial osteoblastic cells (C-OBTs) and femoral osteoblastic cells (F-OBTs) from 
4 male rats at passage 10 demonstrated stronger positive ALP staining when compared 
to BMSCs obtained and established from femoral bones of 4 rats.  Rat dermal 
fibroblastic cells from scalp (S-FBTs), tissue overlying abdominal areas (Ab-FBTs) and 
femoral areas (Fe-FBTs) were used as negative controls and showed negative ALP 
staining.  Rat Osteosarcoma (ROS 17/2.8) cells were used as a positive control reaction 
and showed strongest ALP staining (Figure 3-6).  Microscopic examination showed 
strong ALP staining throughout the cultures in both calvarial and femoral osteoblastic 
cells at p5 (Figure 3-7) and p10 (Figure 3-8). 
 
 
Figure 3-6: Rat calvarial and femoral osteoblastic cells from 4 rats (Rats 9-12) at passage 10 
demonstrated stronger positive ALP staining as comparing to BMSCs, whilst rat dermal 
fibroblastic cells from scalp, tissue overlying abdominal and femoral areas were used as a 
negative control show negative ALP staining. ROS cells were used as a positive control show 
strongest ALP staining (C-OBTs = Calvarial osteoblastic cells, F-OBTs = Femoral osteoblastic 
cells, BMSCs = Bone Marrow Stromal Cells, ROS = Rat Osteosarcoma ROS 17/2.8 cells, S-
FBTs = Dermal fibroblastic cells from scalp, Ab-FBTs = Dermal fibroblastic cells from tissue 
overlying abdominal area, Fe-FBTs = Dermal fibroblastic cells from tissue overlying femoral 
area).  






Figure 3-7: Rat calvarial and femoral osteoblastic cells from 4 male rats (Rats 9-12) at passage 
5 showed positive ALP staining, original magnification x100, scale bar = 200 µm. A= R12C and 
B= R12F at magnification x200, scale bar = 100 µm. (R12C= Rat 12 calvaria, R12F= Rat 12 
femur). 






Figure 3-8: Rat calvarial and femoral osteoblastic cells from 4 male rats (Rats 9-12) at passage 
10 showed positive ALP staining with stronger red colour due to more numbers of cells, 
magnification x100, scale bar = 200 µm. A= R12C and B= R12F at magnification x200, scale 
bar = 100 µm. (R12C= Rat 12 calvaria, R12F= Rat 12 femur). 




3.4.3.2 Mineralised bone nodules 
Cells at passage 10 were grown for 28 days in osteoblast differentiation medium, no 
FGF-2 supplemented, whilst supplemented with dexamethasone and β-
glycerophosphate and stained with Alizarin red for bone nodules.  Evidence of bone 
nodule formation was seen in all cultures although this appeared to have a reduced 

























Figure 3-9: The primary osteoblast cultures were grown in osteoblast culture medium 
supplemented with FGF-2 up to p10. Then they were grown in osteoblast differentiation medium 
supplemented with dexamethasone and β-glycerophosphate, but no FGF-2 supplemented. At 
Day 28, mineralised bone nodules (arrows) stained with Alizarin red. The primary calvarial 
osteoblast cultures have less ability to form bone nodules (small arrows). Data represented from 
4 male rats (Rats 9-12) at passage 10, magnification 40, scale bar = 100 µm. 
 




3.4.3.3 Osteopontin production 
Osteopontin production was seen by both calvarial and femoral osteoblastic cells at 
passage 10 (Figure 3-10).  In contrast, rat dermal fibroblasts, used as negative controls, 
showed much lower osteopontin production.  In general, femoral osteoblast cells 
showed higher osteopontin production than calvarial osteoblasts at both Day10 and 
Day14 and further investigation of osteopontin expression is described in Chapter 6. 
 
 
Figure 3-10: Osteopontin production (ng/ml) measured by ELISA. The calvarial and femoral 
derived cells were grown at passage 10 in medium supplemented with FGF-2 for 10 and 14 
days. The cells were processed and collected for cell lysate. Data from 4 different male rats 
(Rats 9-12).  Osteopontin production in rat dermal fibroblastic cells from scalp was derived from 
1 rat as a negative control. 2 replicates were tested for each culture. Experiments were 
repeated 2 times and tested with 8 different primary osteoblast cultures each time. (FBTs = 
Dermal fibroblastic cells from scalp, R9C= Rat 9 calvaria, R10C= Rat 10 calvaria, R11C= Rat 
11 calvaria, R12C= Rat 12 calvaria, R9F= Rat 9 femur, R10F= Rat 10 femur, R11F= Rat 11 








3.4.3.4 Osteocalcin production 
Low concentrations of osteocalcin measured by ELISA were also detected in the culture 
media from cells at passage 10 grown in osteoblast culture medium supplemented with 
FGF-2 for 14 days.  There was no significant difference in osteocalcin production 




Figure 3-11: Osteocalcin production (ng/ml) measured by ELISA can be detected in rat calvarial 
and femoral derived cells at passage 10 grown in osteoblast culture medium supplemented with 
FGF-2. Data represented as mean ± SD from 4 different male rats (Rats 9-12). Data were 
generated from using 8 different primary osteoblast cultures and 2 replicates were tested for 
each culture. Paired t-test was used to compare osteocalcin production between two regionally 
distinct populations. This graph shows that osteocalcin can be detected in both cell types with 








3.4.3.5 Expression of osteoblast-associated genes 
Osteoblastic cells at p10 were tested for expression of Runx2, Bglap, and Spp1.  All 
lines showed expression of these osteoblast-associated genes, with some noticeable 
differences seen between femoral and calvarial osteoblasts.  These data are described 








3.5 Discussion and conclusion 
 
A key requirement for the planned future experiments in this thesis was the 
establishment of primary osteoblast cultures derived from defined sites and from 
individual animals.  Initial attempts to establish adult mouse and rat calvarial and 
femoral osteoblast cells were not successful using collagenase isolation and cell explant 
isolation methods.  This was likely due to the small amounts of primary tissue available, 
unlike many studies using foetal mice or rats to establish primary cells successfully 
(Bellows et al., 1986; Deboni et al., 1996; Declercq et al., 2004).   
 
A previous study compared extracts of human foetal and adult bones (40-year-old male) 
obtained by sequential demineralisation, on their effects on migration of osteoblast-like 
cells, demonstrated that extracts of human adult bones did not stimulate osteoblast 
migration and suggested that significant differences exist in protein composition and/or 
distribution between foetal and adult human bones (Somerman et al., 1983).  The data 
suggested that human bone chemotactic activity decreased with advancing age and 
supported the clinical evidences where healing of bone fracture and bone remodeling 
occured at a much faster rate in children than adults and where the incidence of 
nonunion is comparatively rare in children; these differences in different age group may 
influence the potential of these bones remodelling (Somerman et al., 1983).  
Osteopontin expression was significantly reduced in more mature bone of young adult 
rats (Chen et al., 1993).  Therefore, the age of the donor may be one factor that has 
influence on primary cell establishment in vitro. 
 
We also observed that adult rat calvarial and femoral osteoblast cells had different 
morphologies when examined under the microscope as shown in Figure 3-4.  The 
calvarial cells had a cuboidal shape, whilst femoral cells had a more spindle shape 
similar to other studies (Declercq et al., 2004; Nefussi et al., 1997). 
 
A recent study demonstrated that calvarial osteoblastic cells of neural crest origin have 
better potential for osteogenic differentiation and displayed a higher capacity to undergo 
osseous healing compared with osteoblasts of paraxial mesoderm origin (Quarto et al., 
2010).  In frontal bone compared with parietal bone, endogenous canonical Wnt 
signalling was enhanced both in vitro and in vivo in neural crest-derived frontal bone 




(Quarto et al., 2010).  In paraxial mesodermal-derived parietal osteoblasts, the 
constitutive activation of canonical Wnt signalling could mimic the osteogenic potential 
of frontal osteoblasts, when canonical Wnt signalling in neural crest-derived frontal 
osteoblasts was knocked down, impaired osteogenic potential was observed (Quarto et 
al., 2010).  The embryonic origin of the tissue makes a difference and active canonical 
Wnt signaling plays a major role in contributing to the superior intrinsic osteogenic 
potential and tissue regeneration in neural crest-derived frontal bone (Quarto et al., 
2010).   
 
In view of the persisting problems of establishing cultures we tested the effects of 
addition 10 ng/ml of Fibroblast growth factor-2 (FGF-2) to the osteoblast culture media.  
FGF-2 is an important modulator of cartilage and bone growth and differentiation 
(Montero et al., 2000).  Bone formation is controlled by FGF signalling which 
regulating the expression of various genes involved in osteoprogenitor cell replication, 
osteoblast differentiation and apoptosis (Marie, 2003).  FGF-2 is expressed and 
regulated in osteoblastic cells.  The disruption of the Fgf2 gene in mice results in 
decreased osteoblast replication, mineralised bone nodule formation, and new bone 
formation in vivo (Montero et al., 2000).  
 
Based on our finding in this experiment, FGF-2 was supplemented in osteoblast culture 
media to overcome the problems of absence of growth in cultures not supplemented 
with FGF-2.  In addition, primary osteoblast cultures showed positive ALP staining 
compared to primary fibroblast cultures (Figure 3-6).  Our data suggested that FGF-2 
did not inhibit ALP staining.  In contrast, the previous study by Kalajzic et al., 2003 has 
shown that FGF-2 and noggin inhibited ALP in primary murine osteoblasts 
differentiation (Kalajzic et al., 2003) by observing alkaline phosphatase (ALP) and type 
I collagen expression (Col1a1) at day 7 (preosteoblast stage), bone sialoprotein (BSP) at 
day 11 (early osteoblast) and osteocalcin (OC) at day 15–18 (mature osteoblast stage).  
They have shown that FGF-2 completely inhibited expression of ALP and the mRNA 
transcript for Col1a1, while noggin showed only a partial inhibition of these markers of 
preosteoblast differentiation.  However, the markers of differentiated osteoblasts (BSP 
and OC) were completely inhibited in both the FGF-2 and noggin treated cultures, 
suggested that noggin acts at later stage in the osteoprogenitor differentiation pathway 
than FGF-2.  In addition, the collagen promoters driving green fluorescent protein 




(GFP) that activate at different levels of osteoblast differentiation were analysed.  The 
pOBCol3.6GFP and pOBCOL2.3GFP transgene activity was totally inhibited by 
continuous addition of FGF-2, while noggin showed partial inhibition of 
pOBCol3.6GFP and complete inhibition of the pOBCol2.3GFP transgene (Kalajzic et 
al., 2003).  This work demonstrated that FGF-2 and noggin could reversibly modulate 
osteoblast lineage differentiation at different maturational stages (Kalajzic et al., 2003).  
 
However, Quarto et al., 2010  recently reported that phosphorylation of GSK-3beta was 
induced by FGF-2 and the nuclear levels of beta-catenin in osteoblasts was increased, 
suggested that FGF might mediate and enhance activation of Wnt signalling (Quarto et 
al., 2010).   
 
FGF-2 stimulation of osteoblast differentiation is partially through modulation of the 





 mice by Fei and co-workers have shown that loss of 
endogenous FGF-2 resulted in reduced Wnt10b mRNAexpression, reduced Lrp5/Lrp6 
mRNAexpression, reduced β-catenin mRNAand protein expression, and reduced 
inactive phosphorylated GSK3β protein expression that led to reduced Wnt/β-catenin 
signalling (Fei et al., 2011).  The reduction of Wnt/β-catenin signaling and Dkk2 
mRNA expression which was important for terminal osteoblast differentiation probably 





(Fei et al., 2011).  However, exogenous FGF-2 promoted β-catenin nuclear 
accumulation and induced inhibited glycogen synthase kinase-3β (GSK3β) which could 




BMSCs and probably contributed to rescue the 




 BMSCs (Fei et al., 2011). 
 
In addition, FGF-2 induced calvarial osteoblast proliferation and enhanced cranial 
suture fusion, promoted rat osteoblast attachment and normal cell morphology as well 
as induced cell proliferation (Moursi et al., 2002).  Wnt/β-catenin pathway directly 
regulated osteoblast transcription factors, including Runx2 and probably ATF4 (Fei et 
al., 2011).  In addition, Runx2 is phosphorylated and activated by FGF-2 via the MAPK 
pathway suggested that FGF-2 plays an important role in regulation of Runx2 function 
and bone formation (Xiao et al., 2002). 
  




In our study, supplementation of FGF-2 to the culture medium had a visibly marked 
effect on the cells resulting firstly in increased rate of proliferation, and secondly in 
maintenance of cultures through many passages, up to at least 10 passages here.  One of 
the most important points to address about this culture system is whether despite the 
extended proliferation the cells still retained their osteoblastic phenotype.  We therefore 
used a range of methods to test for osteoblast characteristics such as analysis of 
morphology, the presence of ALP activity, specific bone proteins (osteopontin and 
osteocalcin), production of mineralised nodules and expression of bone-associated 
genes such as Runx2, Spp1 and Bglap (Deboni et al., 1996).  
 
It was also apparent that there appeared to be significant differences in some of these 
phenotypic features between those cells derived from femurs and those from calvariae.  
We were able to show some osteoblast-associated genes such as Runx2, Spp1 and Bglap 
in our primary osteoblast cultures by qRT-PCR and also demonstrate specific bone 
proteins such as osteopontin and osteocalcin using ELISA.  These differences between 
calvarial and femoral osteoblasts are described and investigated further in Chapter 6. 
 
In conclusion, the addition of FGF-2 to culture medium markedly stimulated 
proliferation and expansion of cells whilst retaining their osteoblastic phenotype for at 
least 10 passages as shown by positive ALP staining, mineralised bone nodule 
formation, production of osteopontin, but a low level of osteocalcin suggesting the 
FGF-2 helped proliferation, but not differentiation.  FGF-2 supplementation was useful 
to enrich for and maintain a population of osteoprogenitor cells.  The difference 
between two regionally distinct osteoblast cultures in mineralised bone nodule 
formation and osteopontin production may suggest the maintenance of positional 
identity that persists during embryonic body patterning and is still maintain in adult 
organism.  This positional memory may effect on the plasticity in adult organisms and 
might also have an effect on bone regenerative capacity and regeneration. 
 
 












Chapter 4 Chapter 4: 
Persistence of positional identity 
 
Chapter 4: Persistence of positional identity  






FGF signalling is initiated by ligand-dependent dimerisation of the FGFR which results 
in the cross phosphorylation of tyrosine residues of the receptor tyrosine kinase in the 
intracellular domain, then phosphorylated residues are bound specifically by several 
intracellular signal transduction proteins such as PLCγ, FRS2 and Src family members 
which start several intracellular signalling pathways, including the PLCγ pathway, 
PI3K/PKB pathway and the Ras/ERK pathway (Dorey and Amaya, 2010). 
 
The cell responses to these different pathways are CamKII, calcium/calmodulin-
dependent protein kinase II; DAG, diacylglycerol; ERK, extracellular-signal related 
kinase; FGF, fibroblast growth factor; FGFR, fibroblast growth factor receptor; FRS2, 
fibroblast growth factor receptor substrate 2; Gab, Grb2-associated protein; Grb2, 
growth factor receptor-bound protein 2; HSPG, heparan sulphate proteoglycan; IP3, 
inositol (1,4,5)-trisphosphate; MEK, mitogenactivated protein kinase kinase (also 
known as MAP2K); PI3K, phosphoinositide 3-kinase; PIP3, phosphatidylinositol 
(3,4,5)-trisphosphate; PKB, protein kinase B; PKC, protein kinase C; PLCγ, 
phospholipase C γ; cRaf, v-raf-leukemia viral oncogene homologue 1 (also known as 
RAF1); Ras, rat sarcoma (also known as Harvey rat sarcoma virus oncogene 
homologue); SHP2, SH2 domain-containing tyrosine phosphatase 2 (also known as 
PTPN11); SOS, son of sevenless; Src, sarcoma proto-oncogene tyrosine kinase (Dorey 
and Amaya, 2010). 
 
During posterior body axis extension in mouse and chick embryos, FGF signalling is 
high and can maintain an undifferentiated state at the posterior end.  The ectoderm and 
mesoderm differentiation promoted by Retinoic acid (RA), the FGF antagonised by an 
inverse RA signalling, the RA signalling expresses over FGF signalling, the overlapping 
process of differentiation of neural plate, undifferentiated presomitic mesoderm (PSM), 
differentiated somitic mesoderm, and somatic mesoderm was evidenced.   
 
Wnt8c is expressed in the neural plate, whereas FGF-8 and Raldh2 are expressed in the 
mesoderm, and signal across germ layers (Dorey and Amaya, 2010).  FGF signalling 
preferentially regulates the 5' (more-posterior) Hox genes, whereas RA signalling 
preferentially regulates the 3' (more-anterior) Hox genes (Bel-Vialar et al., 2002).  In 




addition, FGF-2 and FGF-8 seem to play an important role in promoting proliferation 
and differentiation of cranial neural crest, but not trunk neural crest cells and that 
depends at least in part on the expression of trunk Hox genes (Abzhanov et al., 2003).  
For normal patterning of the 2
nd
 branchial arch, Hoxa2 expression was required for 
cranial neural crest cells fate to become cartilage (Abzhanov et al., 2003).   
 
The study of Hox genes expressed in the adult was carried out in individual CFU-F 
colonies derived from various organs and anatomical locations using hierarchical cluster 
analysis has revealed Hox expression are heterogeneous but highly specific for their 
anatomical origin and the Hox codes is maintained during differentiation suggested that 
they originate from anterioposterior axis, but may not originate from prevertebral 
mesenchyme and showed consistentcy with a role for Hox proteins in specifying 
cellular identity of MSC (Ackema and Charite, 2008).  
 
As previously discussed, Rawlinson and co-workers have recently demonstrated that 
regional gene expression profiles from different bones had significant differences.  
Furthermore they went on to show that isolated osteoblasts from these bones continued 
to show distinct gene expression profiles (Rawlinson et al., 2009b).  In particular one of 
the striking differences between cells derived from different anatomical sites was the 
expression of a range of markers associated with their embryonic origin.  Thus in that 
study skull bone-derived cells preferentially expressed genes reflecting their neural crest 
origin such as Dlx and Msx2, whilst limb bone-derived cells expressed Hox, Shox2 and 
Tbx genes.  They further investigated Hoxa gene expression profiles in adult bone-
derived cells in long bones and from the rib.  Differential Hoxa expression profiles 
(Hoxa2, Hoxa5, Hoxa7 and Hoxa10) were clearly evident in endochondral/mesoderm 
bones, whilst Hoxa13 was present only in the ulna and femur samples.  
 
In keeping with the results of these studies, Rinn and co-workers reported that the Hox 
gene profile in cultured human skin fibroblasts demonstrated specific and distinct 
expression patterns depending on the sites where those mesoderm-derived cells were 
established from (Rinn et al., 2006; Rinn et al., 2008a).    
 
The persistence of homeobox gene expression in the adult, as described in the studies 
above, may reflect positional information during embryogenesis and suggests that cells 




maintain a memory of their embryonic origin or body positioning.  Alternatively, these 
observations may indicate that the local environment of the cell is able to specify its 
positional identity.  In support of this option, the study of Leucht and co-workers used a 
transplantation assay to address the question of whether the embryonic origin of the 
graft influenced its cell fate (Leucht et al., 2008a).  They found that mesoderm-derived 
cells did not appear to demonstrate the same plasticity as neural crest-derived cells 
when they were transplanted into mandibular defects.  The grafted mesodermal cells 
becoming differentiated chondrocytes even though the environment fully supported 
osteogenic differentiation in vivo (Leucht et al., 2008a).  They suggested that there was 
a fundamental difference in the plasticity of neural crest-derived and mesoderm-derived 
progenitor cells.  
 
All of these observations may have significant physiological and possibly clinical 
implications.  The regulation of osteoblast behaviour at different sites may be different 
and systemic hormonal changes may have different effects on different skeletal sites.  
For example the maintenance of bone density in long bones is dependent on mechanical 
loading and is susceptible to post-menopausal osteoporosis, whereas maintenance of 
cranial bone is neither mechanical load dependent nor susceptible to osteoporosis.  
 
Previous studies have different opinions.  One group supported the idea that the local 
environment played a role in cell modulation (Leucht et al., 2008a).  In contrast, the 
other group supported the idea that the cells have already been committed, pre-
programmed and retained their positional identity even they have been detached from 
their in vivo environment to an in vitro environment (Rawlinson et al., 2009b).  
 
In order to explore the likely explanation for expression of positional identity markers, 
the aim of the studies described in this chapter is to investigate the stability and 
persistence of Hoxa gene expression patterns of regionally distinct osteoblasts when 
maintained in culture, removed from their normal environment in vivo.  Specifically, the 
experiments will test the hypothesis that the patterns of Hoxa gene expression from 
regionally distinct osteoblastic cells are stable in long term culture.  
 
In addition to looking at Hoxa gene expression pattern, we have also looked at some 
transcription factors that are differentially expressed embryonic markers.  Rawlinson 




and co-workers have found that Msx2 and Irx5 preferentially expressed in skull bone-
derived cells, whilst Tbx3 preferentially expressed in limb bone-derived cells 
(Rawlinson et al., 2009b). 
 
That is why we investigated further the results of Rawlinson and co-workers' study in 
depth to investigate whether the Hoxa gene can be maintained in cultures for long 
period of time and can be modulated to enhance osteogenic potential and improve bone 











The aims of this chapter are: 
 
1. To investigate the stability and persistence of Hoxa gene expression patterns of 
regionally distinct osteoblasts when maintained in culture; 
 
2. To investigate whether the patterns of Hoxa gene expression from regionally distinct 
osteoblastic cells are stable in long term culture or not; 
 
3. To investigate the transcription factors those are expressed in osteoblastic cells from 
distinct embryonic origin. 
  




4.3 Materials and Methods 
 
4.3.1 Cell cultures 
 
Initial pilot experiments were carried out on rat dermal fibroblasts derived from 
different anatomical sites and cultured in fibroblast culture medium as described in 
section 2.2.3.  When the cells were 80-90% confluent, the cultures were passaged and 
continued to grow up to passage 5, at which time cells were tested for their Hoxa gene 
expression profile. 
 
Rat bone marrow stromal cells (BMSCs) derived from different bony sites (humerus, 
tibia, femur, ulna and rib) were kindly provided by Dr Ian McKay.  Cells were 
originally established by aspirating bone marrow from medullary cavities of bones as 
previously described (Maniatopoulos et al., 1988).  Cells were grown until passage 3 
and then the samples were tested for their Hoxa gene expression profile.  Cells were 
derived from 5 different animals. 
 
The calvarial and femoral osteoblast cell cultures from 4 male rats were obtained by 
explants and collagenase digestion methods as described in section 2.2.3.  The cells 
were cultured in osteoblast culture medium supplemented with 10 ng/ml of FGF-2.  
When the cells reached 80-90% confluence, the cultures were passaged and continually 
cultured up to passage 5 and 10, when cultures were stopped, and samples taken for 
analysis of their Hoxa gene expression profile. 
 
4.3.2 RNA extraction, cDNA synthesis and qRT-PCR 
 
The cells were collected for RNA extraction, cDNA synthesis and assessed for Hoxa 
gene expression and transcription factors (Msx2, Irx5 and Tbx3) using qRT-PCR.  The 













Table 4-1: Validation of gene array with qRT-PCR from bone-derived cells, data shown in 
Skull/Limb ratio. Msx2 and Irx5 preferentially expressed by skull bone-derived cells, whilst Tbx3 




4.4.1 Dermal fibroblasts 
4.4.1.1 Initial experiments 
 
Dermal fibroblasts were isolated from one female Wistar rat, from explants of 4 
different sites: scalp, tissue overlying shoulder, abdominal and ulna area.  The cells 
were expanded and passaged in culture.  After initial plating the non-adherent cells were 
removed and cells were cultured until they reached 80-90% confluence.  Cultures of rat 
dermal fibroblasts were then lysed and total RNA extracted.  Gene expression was 
assessed by qRT-PCR (Taqman) to investigate levels of Hoxa1, Hoxa2, Hoxa4, Hoxa5, 
Hoxa7, Hoxa10 and Hoxa13.  
 
Distinct patterns of Hoxa gene expression between the different cultures (Figures 4-1-
4).  Firstly no expression of Hoxa genes was seen in cells derived from the scalp.  
Hoxa1 expression was highest in rat dermal fibroblasts derived from tissue overlying 
shoulder area (Figure 4-1).  Hoxa4 showed greatest expression in rat dermal fibroblasts 
derived from tissue overlying abdominal area (Figure 4-2).  No expression of Hoxa5 
was seen in cells from either the scalp or the shoulder.  Hoxa5 showed greatest 
expression in cells from tissue overlying abdominal area (Figure 4-3).  
 
No expression of Hoxa7 was seen in cells from scalp or the shoulder.  Hoxa7 showed 
greatest expression in cells from tissue overlying ulna area (Figure 4-4).  A summary of 
the Hoxa gene expression profiles is shown in Table 4-2. 
 






Figure 4-1: Relative expression of Hoxa1 gene to average control genes (Eif4a2 and UBC) in 
rat dermal fibroblasts derived from 4 different sites. Data represented from one female rat and 4 
replicates were tested for each culture. This showed no expression of Hoxa1 in rat dermal 




Figure 4-2: Relative expression of Hoxa4 gene to average control genes (Eif4a2 and UBC) in 
rat dermal fibroblasts derived from 4 different sites. Data represented from one female rat and 4 
replicates were tested for each culture. This showed no expression of Hoxa4 in rat dermal 
fibroblasts derived from scalp. Hoxa4 expressed highest in abdominal region. 





Figure 4-3: Relative expression of Hoxa5 gene to average control genes (Eif4a2 and UBC) in 
rat dermal fibroblasts derived from 4 different sites. Data represented from one female rat and 4 
replicates were tested for each culture. This showed no expression of Hoxa5 in rat dermal 




Figure 4-4: Relative expression of Hoxa7 gene to average control genes (Eif4a2 and UBC) in 
rat dermal fibroblasts derived from 4 different sites. Data represented from one female rat and 4 
replicates were tested for each culture. This showed no expression of Hoxa7 in rat dermal 
fibroblasts derived from scalp and shoulder regions. Hoxa7 expressed highest in ulna region. 
 






Table 4-2: Summary of Hoxa gene expression in rat dermal fibroblasts from tissue overlying 
different regions in the same animal. 
 
In this preliminary experiment Hoxa gene expression profile was tested in rat dermal 
fibroblasts and was useful to optimise our system before further study in primary 
osteoblast cultures.  The data showed the expression roughly followed colinearlity.  For 
example, the most anterior part of the body showed no Hoxa gene expression i.e. scalp, 
whilst the more posterior parts expressed a greater number of Hoxa genes.  The pattern 
of Hoxa gene expression which clearly evidenced in embryo was also evidenced in 
adult organism.  It was still maintained in fully developed animals. 
 
  




4.4.1.2 Further experiments with dermal fibroblasts 
 
On completion of the initial pilot study a further experiment was carried out with 
fibroblasts derived from 3 different anatomical sites (scalp, tissue overlying abdominal 
and femoral areas) from 4 rats, which had been established and grown in growth media 
up to passage 5.  Then the cells were collected for RNA extraction, cDNA synthesis and 
assessed for Hoxa gene expression by qRT-PCR as before.   
 
We have found that there is a pattern of Hoxa gene expression at passage 5 in culture.  
There is no Hoxa gene expression in rat dermal fibroblasts derived from scalp (see 
Appendix 4), whilst Hoxa7 and Hoxa10 are highly expressed in dermal fibroblasts 
derived from tissue overlying femoral area (Figure 4-5). 
 
Figure 4-5: Relative expression of Hoxa genes to average control genes (Eif4a2 and UBC) in rat 
dermal fibroblasts derived from 3 different sites; scalp, tissue overlying abdominal and femoral 
areas from 4 male rats (Rats 9-12). Data were generated from using 12 different primary 
osteoblast cultures and 4 replicates were tested for each culture. This showed a pattern of Hoxa 
gene expression in cultures at passage 5. No Hoxa gene expression seen in rat dermal 
fibroblasts derived from scalp (see Appendix 4), Hoxa7 and Hoxa10 highly expressed in rat 
dermal fibroblasts derived from tissue overlying femoral area (R9= Rat 9, R10= Rat 10, R11= 
Rat 11, R12= Rat 12, and Neg-RT= Negative RT). 
  




4.4.2 Bone Marrow Stromal Cells 
 
Expression of Hoxa genes was detectable in all cultures (Figure 4-6).  The pattern of 
Hoxa gene expression in the rib was distinct from other bones, showing highest 
expression of Hoxa4 and Hoxa5 and low levels of Hoxa7.  Patterns of expression of 
marrow from the femur, humerus and tibia were similar, with expression of Hoxa7 most 
abundant and slightly lower levels of Hoxa10.  Most notably, expression of Hoxa13 was 
restricted to the ulna (Figure 4-6).  Levels of Hoxa1 were uniformly low, whilst levels 




Figure 4-6: Relative expression of Hoxa genes to average control genes (Atp5b and Eif4a2) in 
BMSCs derived from 5 different sites; femur, humerus, tibia, ulna and rib. Data represented as 
mean ± SD from 5 different male rats, 4 replicates were tested for each culture. This showed a 
pattern of Hoxa gene expression in BMSCs cultures at passage 3. Hoxa2 gene expression was 
extremely low, nearly undetectable seen in all cultures, Hoxa7 and Hoxa10 highly expressed in 
all cultures, except in rib which showed different pattern and expressed Hoxa4 and Hoxa5 








Expression of Hoxa5 genes was detectable in all BMSCs cultures.  The highest 
expression of Hoxa5 expression was seen in the rib-derived cells, which was 




Figure 4-7: Relative expression of Hoxa5 gene to average control genes (Atp5b and Eif4a2) in 
BMSCs derived from 5 different sites; femur, humerus, tibia, ulna and rib. Data represented as 
mean ± SD from 5 different male rats, 4 replicates were tested for each culture. Hoxa5 
expression in rib was significantly different to others sites at **, p<0.01 using One-way ANOVA 
















In addition, the expression of Hoxa7 genes was also detectable in all BMSCs cultures.  
Hoxa7 expression in tibia and rib were significantly different to others sites (**, 




Figure 4-8: Relative expression of Hoxa7 gene to average control genes (Atp5b and Eif4a2) in 
BMSCs derived from 5 different sites; femur, humerus, tibia, ulna and rib. Data represented as 
mean ± SD from 5 different male rats, 4 replicates were tested for each culture. Hoxa7 
expression in tibia and rib were significantly different to others sites, but tibia and rib were not 
significantly different to each other at **, p<0.01 using One-way ANOVA and Bonferroni's 












Interestingly, the expression of Hoxa13 genes was detectable in all BMSCs cultures.  
Hoxa13 expression was highest in BMSCs derived from the ulna region.  Hoxa13 
expression in ulna and rib were significantly different to each other (***, p<0.001) 




Figure 4-9: Relative expression of Hoxa13 gene to average control genes (Atp5b and Eif4a2) in 
BMSCs derived from 5 different sites; femur, humerus, tibia, ulna and rib. Data represented as 
mean ± SD from 5 different male rats, 4 replicates were tested for each culture. Hoxa13 
expression in ulna and rib were significantly different to each other at ***, p<0.001 using One-













However, Alp, Bglap and Tgfbi gene expression were not significantly different to each 
others among 5 different sites (Figure 4-10 a-c). 
 
Figure 4-10: BMSCs from 5 different sites were tested for; (a) Alp gene expression; (b) Bglap 
gene expression; (c) Tgfbi gene expression. Alp, Bglap and Tgfbi expression among these 5 
different sites were not significantly different to each others at P<0.05 using One-way ANOVA 
and Bonferroni's Multiple Comparison Test. 




4.4.3 Osteoblastic cells  
4.4.3.1 Hoxa gene expression 
 
Rat calvarial and femoral osteoblastic cells from 4 male rats were tested for Hoxa gene 
expression at passage 5 and at passage 10.  There was no Hoxa gene expression in 
calvaria-derived osteoblast cultures seen at either passage 5 or passage 10 (see 
Appendix 5).  The femur-derived cells from the 4 different rats all showed a similar 
pattern of Hoxa gene expression at passage 5 and passage 10 (Figures 4-11 and 4-12).  




Figure 4-11: Relative expression of Hoxa genes to average control genes (Atp5b and Eif4a2) in 
adult rat calvarial and femoral osteoblastic cells from 4 male rats (Rats 9-12) matched pairs. 
Data were generated from using 8 different primary osteoblast cultures and 4 replicates were 
tested for each culture. There was no Hoxa gene expression in calvarial osteoblastic cells (see 
Appendix 5). This showed pattern of Hoxa gene expression at passage 5. Hoxa5 and Hoxa7 
gene expressed highest in all cultures of femoral osteoblastic cells (R9F= Rat 9 femur, R10F= 














Figure 4-12: Relative expression of Hoxa genes to average control genes (Atp5b and Eif4a2) in 
adult rat calvarial and femoral osteoblastic cells from 4 male rats (Rats 9-12) matched pairs. 
Data were generated from using 8 different primary osteoblast cultures and 4 replicates were 
tested for each culture. There was no Hoxa gene expression in calvarial osteoblastic cells (see 
Appendix 5). This showed pattern of Hoxa gene expression at passage 10. Hoxa7 gene 
expressed highest in all cultures of femoral osteoblastic cells (R9F= Rat 9 femur, R10F= Rat 10 












4.4.3.2 Expression of other transcription factors  
Calvarial and femoral osteoblastic cells were grown in osteoblast culture medium 
supplemented with 10 ng/ml of FGF-2.  The cells were tested at passage 5 and 10 for 
expression of reported preferentially expressed transcription factors; Msx2, Irx5 and 
Tbx3. 
 
a) Msx2 and Irx5 are preferentially expressed in calvarial osteoblastic cells 
 
Msx2 and Irx5 were preferentially expressed in calvarial osteoblastic cells both in p5 
(Figure 4-13 a and b) and p10 (Figure 4-14 a and b).  At passage 5, Msx2 was expressed 
at significantly higher levels in calvarial osteoblastic cells than in femoral osteoblastic 
cells (p˂0.05) (Figure 4-13 a), whilst at passage 10, Irx5 was significantly higher 
expressed in calvarial osteoblastic cells than in femoral osteoblastic cells (p˂0.05) 
(Figure 4-14 b). 
 
b) Tbx3 is preferentially expressed in femoral osteoblastic cells 
 
Tbx3 was preferentially expressed in femoral osteoblastic cells both at p5 (Figure 4-13 
c) and p10 (Figure 4-14 c).  At passage 5, Tbx3 expression was higher in femoral 
osteoblastic cells than in calvarial osteoblastic cells, but this did not reach statistical 
significance (p˂0.05) (Figure 4-13 c).  At passage 10, Tbx3 was significantly higher 
expressed in femoral osteoblastic cells than in calvarial osteoblastic cells (p˂0.05) 















Figure 4-13: Relative expression of transcription factors to average control genes (Atp5b and 
Eif4a2) in adult rat calvarial and femoral osteoblastic cells at passage 5. Data represented as 
mean ± SD from 4 different male rats matched pairs. Data were generated from using 8 different 
primary osteoblast cultures and 4 replicates were tested for each culture. This showed Msx2 
and Irx5 genes preferentially expressed in calvarial osteoblastic cells, whilst Tbx3 preferentially 
expressed in femoral osteoblastic cells. (a) Msx2 expressed significantly higher in calvarial 
osteoblastic cells (*, p˂0.05), (b) Irx5 also expressed higher in calvarial osteoblastic cells, but no 
significantly different (p˂0.05), whilst (c) Tbx3 expressed higher in femoral osteoblastic cells, but 
no significantly different (p˂0.05). Paired t-test was used to compare gene expression between 
adult rat calvarial and femoral osteoblastic cells (*, p˂0.05 was considered significant). 
 






Figure 4-14: Relative expression of transcription factors to average control genes (Atp5b and 
Eif4a2) in adult rat calvarial and femoral osteoblastic cells at passage 10. Data represented as 
mean ± SD from 4 different male rats matched pairs. Data were generated from using 8 different 
primary osteoblast cultures and 4 replicates were tested for each culture. This showed Msx2 
and Irx5 genes preferentially expressed in calvarial osteoblastic cells, whilst Tbx3 preferentially 
expressed in femoral osteoblastic cells. (a) Msx2 expressed higher in calvarial osteoblastic 
cells, but no significantly different (p˂0.05), (b) Irx5 expressed significantly higher in calvarial 
osteoblastic cells (*, p˂0.05), whilst (c) Tbx3 expressed significantly higher in femoral 
osteoblastic cells (*, p˂0.05). Paired t-test was used to compare gene expression between adult 
rat calvarial and femoral osteoblastic cells (*, p˂0.05 was considered significant). 




4.4.3.3 Additional analyses of transcription factor expression 
 
Although a number of the predicted differences in transcription factor expression did 
not show significant differences, the “direction” of the difference in expression of 
specific factors between femoral and calvarial cells appeared remarkably consistent.  In 
order to explore the possibility that lack of statistical significance was the result in the 
large standard deviations of data inherent in testing a number of different cells, further 
analyses were carried out pooling the data from p5 and p10 for each culture, and also 
including additional data obtained from monotypic cultures in further experiments 
described in Chapter 5.  This was considered justifiable as there were no consistent 
differences in overall expression patterns from different experiments.  Consequently, 
there were data from a total of 8 different experiments for these analyses.  Data were all 
normalised to describe expression patterns of femoral cells as a percentage of that for 
calvarial cells and results for cells derived from each animal were analysed separately.  
Differences between femoral and calvarial cells were then analysed by Wilcoxon’s 
Sign-Rank test. 
 
In these additional analyses, Msx2 and Irx5 expression were significantly higher in 
calvarial osteoblastic cells than in femoral osteoblastic cells (Figures 4-15 and 4-16) in 
3 of 4 rats, whilst Tbx3 expression was significantly higher in femoral osteoblastic cells 



















































































Figure 4-15: Relative expression of Msx2 to average control genes (Atp5b and Eif4a2) of 
femoral osteoblastic cells corrected to % of calvarial osteoblastic cells. Data represented as 
mean ± SD from 8 independent experiments for each rat matched pairs. Data were generated 
from using 8 different primary osteoblast cultures and 4 replicates were tested for each culture. 
This showed Msx2 expressed significantly higher in calvarial osteoblastic cells than in femoral 
osteoblastic cells. Wilcoxon’s Sign-Rank test was used to compare gene expression between 








































































Figure 4-16: Relative expression of Irx5 to average control genes (Atp5b and Eif4a2) of femoral 
osteoblastic cells corrected to % of calvarial osteoblastic cells. Data represented as mean ± SD 
from 8 independent experiments for each rat matched pairs. Data were generated from using 8 
different primary osteoblast cultures and 4 replicates were tested for each culture. This showed 
Irx5 expressed significantly higher in calvarial osteoblastic cells than in femoral osteoblastic 
cells. Wilcoxon’s Sign-Rank test was used to compare gene expression between adult rat 
















































































Figure 4-17: Relative expression of Tbx3 to average control genes (Atp5b and Eif4a2) of 
femoral osteoblastic cells corrected to % of calvarial osteoblastic cells. Data represented as 
mean ± SD from 8 independent experiments for each rat matched pairs. Data were generated 
from using 8 different primary osteoblast cultures and 4 replicates were tested for each culture. 
This showed Tbx3 expressed significantly higher in femoral osteoblastic cells than in calvarial 
osteoblastic cells. Wilcoxon’s Sign-Rank test was used to compare gene expression between 
adult rat calvarial and femoral osteoblastic cells (*, p˂0.05 was considered significant). 
 
  




4.5 Discussion and conclusion 
 
In agreement with previous findings (Rinn et al., 2008b), dermal fibroblasts showed 
patterns of Hox expression consistent with their regional origins.  Fibroblasts are 
differentiated based on their position along three anatomic divisions; anterior-posterior, 
proximal-distal, and dermal-nondermal (Rinn et al., 2006).  The “HOX code” may 
dictate the positional identity of skin and influence site-specific epidermal 
differentiation (Chuong, 1993). 
 
The results here demonstrated that adult rat fibroblasts showed persistence of 
embryonically programmed positional identity, as defined by Hoxa expression, in cell 
cultures.  Hoxa gene expression profiles persisted in fibroblasts consistent with their 
embryonic expression patterns.  There was no Hoxa expression seen in fibroblasts from 
the scalp.  In contrast, cells derived from distal forelimb region mainly express Hoxa7 
and Hoxa10, from abdomen Hoxa2, Hoxa4, Hoxa5 and Hoxa13 and from shoulder 
region Hoxa1.  Persistence of expression was stable for at least 5 subcultures.  
 
The rat dermal fibroblasts derived from different embryonic origins such as head 
connective tissues derived from ectoderm germ layers, whilst other connective tissues 
are derived from mesoderm germ layers, have also shown different positional identity in 
different sites in culture.  Adult rat connective tissues have been also shown to retain 
defined patterns of gene expression as part of the legacy of their differentiation. 
 
On the other hand, although the BMSCs here (femur, humerus, tibia, ulna) are derived 
from lateral plate mesoderm, we found that they retained their distinct positional 
identity markers even though they are derived from the same embryonic origin, except 
ribs which are derived from somites and paraxial mesoderm.  We identified Hoxa gene 
expression and gene expression pattern in BMSCs obtained from the marrow from 
distinct bony regions that are consistently expressed in all BMSCs primary cultures.  
Particularly, BMSCs obtained from the marrow from ribs showed a distinct expression 
pattern with greatest expression of Hoxa5, instead of Hoxa7 like other regions.  
However, Alp, Osteocalcin and Tgfbi genes were not differently expressed in BMSCs 
primary cultures established from the marrow obtained from distinct bony regions.  
 




Bone marrow is a complex tissue containing stem cells which reside in the marrow 
cavity and provide support for haematopoiesis (Dexter and Spooncer, 1987).  BMSCs 
are phenotypically and functionally heterogeneous (Dexter et al., 1977).  They are 
fibroblastic in appearance, may have self-renewal potential and can differentiate into 
several cell lineages including osteoblasts, chondrocytes, adipocytes, myelosupportive 
stroma, and myoblasts (Prockop, 1997).  BMSC cultures have often been used as a 
source of osteoblastic cells in culture, as they contain both endosteal osteoblasts and 
osteoprogenitor cells, and less differentiated cells capable of undergoing osteoblastic 
potential.  Significant differences in the pattern of gene expression in BMSC cultures 
were seen here.   
 
The pattern of Hoxa gene expression in the bone marrow largely matches the pattern of 
expression seen in osteoblast cultures isolated from these bones (Rawlinson et al., 
2009b).  Clearly, it will be important to understand if the expression seen in cultured 
bone marrow is restricted to cells of the osteoblast lineage or is representative of the 
entire population of the bone marrow stromal cells.  Thus bone marrow cells appear to 
show a positional identity which is related to the positional identity of their adjacent 
bone.  The question then arises as to whether this positional identity will persist in the 
event of cell migration and colonisation to sites distant from their site of origin. 
 
BMSCs that populate the medullary cavities of bones are able to contribute to the 
maintenance and repair of many tissues.  The possibility that the bone marrow cells 
retain regional identity raises interesting questions regarding the stability and effect of 
this identity when marrow cells colonise sites distant to their site of origin.  
 
FGF signalling preferentially regulates the 5' (more-posterior) Hox genes, whereas RA 
signalling preferentially regulates the 3' (more-anterior) Hox genes (Bel-Vialar et al., 
2002).  FGF signalling in mouse and chick embryos during posterior body axis 
extension have shown that FGF signalling is high and can maintain an undifferentiated 
state at the posterior end of the axis (Dorey and Amaya, 2010).  FGF may stimulate 
expression of Hoxa7.  Based on our data, the Hoxa gene expression pattern in calvarial 
and femoral osteoblastic cells obtained from different rats was notably consistent 
throughout the time in culture.  Hoxa gene expression was maintained even in the 
present of FGF-2.   




Significant differences of Hoxa gene expression between regionally distinct populations 
were seen.  There was no Hoxa gene expression seen in calvarial osteoblastic cells, 
which are of paraxial mesodermal-derived origin, whilst femoral osteoblasts cells, 
which are of lateral plate mesoderm-derived embryonic origin expressed the pattern of 
Hoxa gene expression throughout which matches the pattern of expression seen in 
osteoblast cultures isolated from these bones (Rawlinson et al., 2009b).  One of the key 
questions to be addressed by this experiment is whether this “positional identity” would 
persist with long term culture. 
 
From our data, the positionally determined expression of Hoxa genes persisted in adult 
cells and was maintained in cells in culture by the cells themselves may be due to cell 
memory, not because of the environment such as grown in FGF-2 supplemented in 
culture media which shown its useful for proliferation, but not differentiation.  At 
passage 10 there was no sign of even a decline in Hoxa gene expression and indeed 
although the expression data obtained at passage 5 and passage 10 may not be strictly 
comparable quantitatively, relative Hoxa expression was seen to be higher at passage 10 
than at passage 5 suggesting that the more mature the primary osteoblast cultures, the 
more stable of the pattern among individual rats and reaffirm the positional information. 
 
Interestingly, Hoxa13 was expressed in primary fibroblast cultures derived from dermal 
tissue overlying the abdominal region, whilst Hoxa13 was expressed in primary 
osteoblast cultures derived from ulnae and femurs.  Hoxa13 expression was low in ribs 
compare to ulna.  In fact, Hoxa13 should be expressed in the more posterior region.  
This may suggest that positional identity is more rigid for skeletal body patterning, 
whilst it is less fixed in retaining positional information in skin body patterning.  
Nevertheless, Hoxa13 expression was maintained and the embryonic Hox expression 
pattern persisted to adulthood, and somewhat followed colinearity.  
 
For transcription factors assessed by qRT-PCR, we have found that Msx2 and Irx5 
genes were preferentially expressed in calvarial osteoblastic cells.  Msx2 expression was 
significantly higher at passage 5, whilst Irx5 was significantly higher at passage 10.  
Interestingly, Tbx3 gene was preferentially expressed in femoral osteoblastic cells at 
passage 10.  Based on our data, less mature osteoblastic cells at p5 showed similar Tbx-
3 expression between calvariae and fumurs, whilst more mature osteoblastic cells at p10 




showed different Tbx-3 expression between calvariae and fumurs, close to a statistically 
significant difference.  In addition, the more mature calvarial osteoblastic cells at p10, 
the more difference in Msx2 and Irx5 expression.  The variation among inbred rats in 
gene expression profiles may be due to epigenetic factors and may have an impact on 
the Hoxa genes result outcome.  Therefore, we reanalysed our data using 8 independent 
experiments for each matched pair of rat cell cultures.  The results have confirmed that 
Msx2 and Irx5 were significantly higher expressed in calvarial osteoblastic cells, whilst 
Tbx3 was significantly expressed higher in femoral osteoblastic cells.  
 
These results suggest that osteoblasts derived from distinct sites are phenotypically 
different and may show important functional differences.  We could demonstrate the 
principle of positional identity in adult rat dermal fibroblasts, BMSCs, calvarial and 
femoral osteoblastic cells.  
 
Overall the results of the experiments described here suggest that expression of 
regionally distinct positional identity markers such as Hoxa may be the result of 
inherent cellular programming rather than being related to environmental cues.  Based 
on our data, Hoxa gene expression was maintained even in the present of FGF-2.  
Furthermore, these markers may be more a reflection of their anatomic location in the 
developing organism rather than being related specifically to their embryonic origin.  
More favourable clinical outcomes in bone grafting and tissue regeneration are expected 
with site matching between donor and recipient.   
 
In conclusion, adult rat dermal fibroblasts, BMSCs and primary osteoblast cultures 
derived from different embryonic origins showed persistence and distinct patterns of 
embryonically programmed positional identity in a site-specific manner.  FGF-2 did not 
interfere with Hoxa gene expression in adult rat primary osteoblast cultures as shown by 
persistence of positional identity in culture up to 10 subcultures.  The positional identity 
appeared to be more rigid for skeletal body patterning, whilst it was less stable in 
retaining positional information in skin body patterning.  The less mature osteoblastic 
cells showed similar Tbx-3 expression, whilst more mature osteoblastic cells showed 
differences in Tbx-3 expression between calvariae and fumurs.  In addition, the more 
mature the calvarial osteoblastic cells were, the greater the difference in Msx2 and Irx5 
expression was observed. 












Chapter 5 Chapter 5: 
Modulation of positional identity 
 
Chapter 5: Modulation of positional identity  






In Chapter 4, we have demonstrated that the positional identity persisted in cultures up 
to 10 passages.  There was a difference between adult rat calvarial osteoblastic cells and 
femoral osteoblastic cells in Hoxa gene expression.  The calvarial osteoblastic cells 
which were derived from paraxial mesoderm maintained their Hoxa negative gene 
expression, whilst lateral plate mesodermal-derived femoral osteoblastic cells showed 
persistence and pattern of Hoxa gene expression in vitro. 
 
Leucht and co-workers tested the modulation of positional identity by grafting the cells 
from different embryonic origin to determine whether they are interchangeable in bone 
grafting or not (Leucht et al., 2008a).  This study tested for wound healing and 
regenerative potentials by labelling neural crest-derived cells and mesoderm-derived 
cells, and then produced skeletal injuries in a mandible, which is a neural crest-derived 
bone, and in a tibia, which is a mesoderm-derived bone.  They found that bones heal 
through cells from their own embryonic origins (Leucht et al., 2008a). 
 
Interestingly, placing neural crest-derived periosteum into a mesoderm-derived injury 
site resulted in intramembranous bone formation, but placing tibial periosteum into a 
mandibular injury site resulted in endochondral ossification and transplanted cells 
underwent hypertrophy even though the environment fully supported osteogenic 
differentiation (Leucht et al., 2008a). 
 
In keeping with our results their results indicate that stem cells from skeleton have 
‘positional memory’, which influences the cells behavior when grafted into ectopic 
locations (Leucht et al., 2008a).  Therefore, this in vivo finding of enhanced 
osteogenesis in neural crest transplants may be explained by the increasing cell 
osteogenic potential.  The osteoprogenitor cells derived from neural crest formed new 
bone regardless of whether they were transplanted into a tibial defect or into another 
mandibular injury site (Leucht et al., 2008a).  
 
The question still remains at the molecular level as to why skeletal progenitor cells of 
mesoderm origin did not appear to exhibit the same plasticity as skeletal progenitor cells 
of neural crest origin when they were transplanted into mandibular defects.  The 




mesodermal cells differentiated into chondrocytes even though grafted in the 
environment that fully supported osteogenic differentiation.  These results suggested 
that there was a fundamental difference in the plasticity of progenitor cells from two 
distinct origins and suggest that the local environment may have induced previously 
Hox-negative cells to become Hox-positive because of the action of local signals. 
 
Given that our results described in Chapter 4 show persistence of positional identity 
markers even when maintained for long periods of time away from any potential 
environmental cues, the question arises that can Hoxa gene expression change and if so, 
what induces these changes?  These are challenging questions and therefore we tried to 
answer some of those questions by carrying out the experiments described in this 
Chapter.  We hypothesized that the Hoxa gene expression can be modulated in Hoxa-
negative cells due to soluble factors or local growth factors (Hughes et al., 2006) from 









1. To investigate whether soluble factors in conditioned medium can regulate 
expression of Hoxa genes; 
 
2. To investigate whether cell to cell contact in heterotypic cultures can modulate 








5.3 Materials and Methods 
 
5.3.1 The effect of soluble factors on Hoxa gene expression using a rat fibroblast model 
 
To address whether soluble factors in conditioned medium (CM) have an effect on 
positional identity or not, this pilot experiment was carried out using CM to treat Hox-
ve and Hox+ve rat dermal fibroblasts and then assess Hoxa gene expression by qRT-
PCR.  Briefly, the Hox-ve and Hox+ve rat dermal fibroblasts were grown in T-25 flasks 
in culture medium.  The conditioned media from Hox-ve and Hox+ve rat dermal 
fibroblasts were collected and added back to the cells.  In the first group, Hox-ve or 
Hox+ve without CM, only normal growth culture medium was added back.  They were 
used as a baseline control.  The second group, Hox-ve or Hox+ve with same CM were 
used to assess the relative effect of the test CM on Hoxa gene expression.  The third 
group, the heterotypic Hox cells were treated with different CM such as Hox+ve cells 
were treated with CM from Hox–ve cells, whilst Hox–ve cells were treated with CM 
from Hox+ve cells.  After 3 days in the CM, Hoxa gene expression was assessed by 




Figure 5-1: Hox-ve and Hox+ve rat dermal fibroblasts were grown separately until reached 80-
90% confluence. The conditioned medium (CM) were collected and added back to the cells. 
Briefly, the first group, Hox-ve or Hox+ve without CM (only normal growth culture medium 
added back) were used as a baseline control. The second group, Hox-ve or Hox+ve with same 
CM were used to assess the relative effect of the test CM on Hoxa gene expression. The third 
group, the heterotypic Hox cells were treated with different CM such as Hox+ve cells were 
treated with   Hox–ve CM, whilst Hox–ve cells were treated with Hox+ve CM. After 3 days in the 
CM mentioned earlier, Hoxa gene expression was assessed by qRT-PCR. 
  




5.3.2 Cell labelling 
 
In order to assess the effects of direct cell to cell contacts in heterotypic cultures of 
Hoxa-positive and Hoxa-negative cells in modulating positional identity we aimed to 
pre-label Hoxa-positive and negative cells with fluorescent dyes prior to mixing cells in 
heterotypic cultures.  The pre-labelled cell populations would then be sorted by flow 
cytometry back into their monotypic populations, and any changes in Hoxa expression 
determined.  Specifically these experiments test whether Hoxa-negative cells may 
become Hoxa positive following direct cell-cell contact in the heterotypic cultures.  The 
cell labelling method has been previously described in section 2.10. 
 
5.3.2.1 Persistence of cell labelling 
 
This pilot experiment was carried out to demonstrate that the live fibroblasts can be 
stained, maintained and the heterotypic fibroblast cultures can be distinguished under 
fluorescence microscopy.  CellTracker
TM
 Green and CellTracker
TM
 Red were used.  The 
cells were maintained in monotypic or heterotypic culture up to 1 week and visualised 
under fluorescence microscope as previously described in detail in section 2.10.3. 
 
A similar experiment was carried out to demonstrate that the live osteoblastic cells in 





 Red and CellTracker
TM
 Orange were 
used.  The cells were maintained in monotypic or heterotypic culture for up to 1 week 
and visualised under fluorescence microscope as described in details in section 2.10.4. 
 
  




5.3.3 Investigation of transfer of label from one cell type to the other 
Experiments were carried out to test if cross-contamination of labelled cells in 
heterotypic cultures occurred as followed: 
 
a) Using fluorescence microscope 
The two different populations were stained and grown together in heterotypic culture for 
0 and 3 days.  At each time point, the cells were visualised under fluorescence 
microscope, and photos were taken as previously described in section 2.10.4. 
 
b) FACS analysis of double stained heterotypic cultures 
The cells were stained and grown together for 0 and 3 days.  At each time point, both 
cell types were collected for flow cytometry analysis as described in section 2.11.  The 




 Cell culture inserts system and flow cytometry 
The two distinct populations were stained and grown in BD Falcon
TM
 Cell culture 
inserts system (Figure 5-2) for 0, 3 and 7 days and analysed by Flow cytometry at each 
time point as described in section 2.11. 
 
Figure 5-2: Falcon insert system composes of BD Falcon™ 6-well Cell Culture Insert 
Companion Plate and BD Falcon™ Cell culture inserts for 6-well plates, 0.4 µm pores, 
Transparent PET Membrane. From: (BD product catalog, no. 353502 and 353090). 
 




5.3.4 qRT-PCR assessed for Hoxa gene expression in monotypic and heterotypic 
cultures 
 
The two different populations from 4 rats were stained with CellTracker
TM 
Green and 
CellTracker™ Red, grown separately in monotypic culture or grown together in 
heterotypic culture for 0, 3 and 7 days.  In heterotypic culture the cells were sorted by 
cell sorter as described in section 2.11.  In monotypic cultures, the cells were stained 
and passed through the cell sorter, but not sorted according to staining in order to act as 
a control for the cell processing.  The cells were collected at each time point and further 
tested for Hoxa gene expression as previously described. 
 
Because of concerns about the possible leakage of CellTracker
TM
 Red and Orange 
stains, in later experiments we used only CellTracker
TM
 Green labelling on one of the 
populations, whilst the other population was unstained.  These were carried out for both 
monotypic culture used as control and heterotypic culture by first staining calvarial 
osteoblastic cells with CellTracker
TM
 Green, whilst femoral osteoblastic cells were left 
unstained (Figure 5-3).  In further experiments, femoral osteoblastic cells were stained 
with CellTracker
TM
 Green, whilst calvarial osteoblastic cells were left unstained.  The 
cells were grown separately in monotypic culture or grown together in heterotypic 
culture for 0, 3, and 7 days prior to sorting and testing for Hoxa gene expression. 
  







Figure 5-3: Calvarial osteoblastic cells stained with CellTracker
TM
 Green, whilst femoral 
osteoblastic cells were left unstained. In later experiments, femoral osteoblastic cells were 
stained with CellTracker
TM
 Green. They were grown separately in monotypic culture or grown 
together in heterotypic culture for 0, 3 and 7 days. After that, they were passed or sorted by cell 
sorter and continued to grow until they reached at least 80% confluence and collected for RNA 










5.4.1 The effect of soluble factors on Hoxa gene expression 
 
As previously demonstrated in Chapter 4, at baseline there was no Hoxa gene 
expression in rat dermal fibroblasts derived from the scalp region.  In rat dermal 
fibroblasts from the ulna area, the pattern of Hoxa gene expression can be seen and was 





Figure 5-4: There is no Hoxa gene expression in rat dermal fibroblasts derived from scalp. In rat 
dermal fibroblasts from ulna area, there is no Hoxa2 gene expression, Hoxa7 was expressed at 











There was no difference in Hoxa expression in ulna dermal fibroblasts when grown in 






Figure 5-5: After 3 days in conditioned medium (CM), Hoxa gene expression was assessed by 
qRT-PCR; (a) Hox+ve fibroblasts treated with normal growth culture medium used as a baseline 
control. Hoxa gene expression pattern was observed in Hox+ve fibroblasts; (b) Hox+ve 
fibroblasts treated with Hox-ve CM; (c) Hox+ve fibroblasts treated with Hox+ve CM. There is no 
effect of conditioned medium on rat dermal fibroblasts Hoxa gene expression as similar pattern 
of Hoxa gene expression pattern was evidenced in all conditions. Data were generated from 1 
male rat using 2 different rat dermal fibroblasts and 4 replicates were tested for each sample.   
 




Hoxa gene expression was compared between Hox+ve rat dermal fibroblasts treated 
with Hox-ve CM or Hox+ve CM to control in fold change.  This figure shows that there 
is no difference in the effect of Hoxa gene expression in Hox+ve rat dermal fibroblasts 
treated with different CM during 3 days of experiment.  A fold change of 1 indicates no 
difference from control (Figure 5-6). 
 
 
Figure 5-6: Hoxa gene expression was compared between Hox+ve rat dermal fibroblasts 
treated with Hox-ve CM or Hox+ve CM to control in fold change. This figure shows that there is 
no difference in the effect of Hoxa gene expression in Hox+ve rat dermal fibroblasts treated with 
different CM. A fold change of 1 indicates no difference from control. Data were generated from 
1 male rat using 2 different rat dermal fibroblasts and 4 replicates were tested for each sample.   
 
 
In addition, scalp-derived fibroblasts continued to show no detectable Hoxa expression 













5.4.2 Persistence of cell labels in fibroblasts 
 
5.4.2.1 Persistence of labelled fibroblasts in monotypic culture 
 
The rat dermal fibroblasts derived from scalp, tested as Hoxa negative were stained with 
CellTracker
TM 
Green.  The rat dermal fibroblasts from skin overlying ulna area, tested as 
Hoxa positive were stained with CellTracker
TM 
Red.  The cells maintained fluorescence 
staining up to 7 days and showed normal morphology when looked under fluorescence 
microscope (Figure 5-7).  
 
 
Figure 5-7: (a) Unstained rat dermal fibroblasts from scalp; (b) Rat dermal fibroblasts from scalp 
stained with CellTracker
TM
 Green; (c) Unstained rat dermal fibroblasts from skin overlying ulna 
area; (d) Rat dermal fibroblasts from skin overlying ulna area stained with CellTracker
TM
 Red, 
magnification 200, scale bar = 100µm. 
 
  




5.4.2.2 Persistence of labelled fibroblasts in heterotypic culture 
 
The rat dermal fibroblasts derived from scalp were stained with CellTracker
TM 
Green, 
whilst rat dermal fibroblasts from skin overlying ulna area were stained with 
CellTracker
TM 
Red and grown together in heterotypic culture.  The two distinct 
populations can be distinguished when examined under fluorescence microscope.  The 
photo was taken one colour at the time (Figure 5-8 a and b), and then merged using 




Figure 5-8: Rat dermal fibroblasts derived from; (a) scalp stained with CellTracker
TM
 Green; (b) 
tissue overlying ulna area stained with CellTracker
TM
 Red at Day 0 at magnification 200, scale 
bar = 100µm. 
 
 
Figure 5-9: Rat dermal fibroblasts derived from scalp stained with CellTracker
TM
 Green and rat 
dermal fibroblasts derived from tissue overlying ulna area stained with CellTracker
TM 
Red can 
be distinguished in mixed population at Day 0 in heterotypic culture observed under 
fluorescence microscope at magnification 200, scale bar = 100µm. 
 




5.4.3 Persistence of cell labels in osteoblast cultures 
5.4.3.1 Persistence of labelled osteoblasts in monotypic culture 
1) Green/Red 
Rat calvarial osteoblastic cells stained with CellTracker
TM
 Green (Figure 5-10 a); rat 
femoral osteoblastic cells stained with CellTracker
TM
 Red (Figure 5-10 b) observed 
under fluorescence microscope.  The cells can maintain their staining up to 7 days. 
 
 
Figure 5-10: (a) Rat calvarial osteoblastic cells stained with CellTracker
TM
 Green; (b) rat femoral 
osteoblastic cells stained with CellTracker
TM
 Red in monotypic culture observed under 
fluorescence microscope at Day 3, magnification 100, scale bar = 200µm. 
 
2) Green/Orange 
Rat calvarial osteoblastic cells stained with CellTracker
TM
 Green (Figure 5-11 a); rat 
femoral osteoblastic cells stained with CellTracker
TM
 Orange (Figure 5-11 b) were 




Figure 5-11: (a) Rat calvarial osteoblastic cells stained with CellTracker
TM
 Green; (b) rat femoral 
osteoblastic cells stained with CellTracker
TM
 Orange in monotypic culture observed under 
fluorescence microscope at Day 3, magnification 100, scale bar = 200µm. 
 




5.4.3.2 Persistence of labelled osteoblasts in heterotypic culture 
1) Green/Red 
Rat calvarial osteoblastic cells stained with CellTracker
TM
 Green (Figure 5-12 a); rat 
femoral osteoblastic cells stained with CellTracker
TM
 Red (Figure 5-12 b); rat calvarial 
and femoral osteoblastic cells stained with DAPI (Figure 5-12 c); mixed populations of 
rat calvarial and femoral osteoblastic cells (Figure 5-12 d) observed under fluorescence 
microscope.  Two populations can be clearly identified at Day 0.  The photo was taken 
one colour at a time and then merged using Photoshop software programme (Figure 5-
12 d). 
 
Figure 5-12: (a) Rat calvarial osteoblastic cells stained with CellTracker
TM
 Green; (b) rat femoral 
osteoblastic cells stained with CellTracker
TM
 Red; (c) rat calvarial and femoral osteoblastic cells 
stained with DAPI; (d) mixed populations of rat calvarial and femoral osteoblastic cells in 
heterotypic culture observed under fluorescence microscope at Day 0, magnification 40, scale 
bar = 100µm; (e) magnification 200, scale bar = 100µm. 
 




However, at Day 3 in heterotypic culture, double staining can be observed (Figure 5-
13).  Double labelled cells increased with time in culture.  Overall, the label was 
sufficiently retained for 1 week in both green and red dyes (data not shown). 
 
 
Figure 5-13: Rat calvarial osteoblastic cells stained with CellTracker
TM
 Green; rat femoral 
osteoblastic cells stained with CellTracker
TM
 Red; rat calvarial and femoral osteoblastic cells 
stained with DAPI; mixed populations of rat calvarial and femoral osteoblastic cells in 
heterotypic culture at Day 0 and Day 3 observed under fluorescence microscope. At Day 3, the 
double staining (orange cells) can be observed, magnification 100, scale bar = 200µm. A and B, 
magnification 200, scale bar = 100µm. 




5.4.4 Evidence of changes of Hox status in osteoblasts following heterotypic cultures 
 
5.4.4.1 Pilot experiment suggest modulation 
 
From our previous data, CellTracker
TM
 Green was the most stable dye.  Therefore we 
carried out these experiments using CellTracker
TM
 Green only to stain our osteoblastic 
cells from 3 male rats, Rat 9, Rat 11 and Rat 12 as previously described in Figure 5-3.   
 
Surprisingly, Hoxa gene expression in calvarial osteoblastic cells was switched on when 
two distinct Hox populations were grown together in heterotypic culture.  Hoxa gene 
expression pattern was observed in calvarial osteoblastic cells at Day 7 in heterotypic 
culture, similar to Hoxa gene expression pattern that expressed in femoral osteoblastic 
cells (Figures 5-14 and 5-15).  
 
Similar results were also evidenced when tested using osteoblastic cells derived from 
Rat 11 and Rat 12.  In Rat 11, Hoxa7 was expressed highest, followed by Hoxa10 and 
Hoxa13 (Figure 5-16 and 5-17), whereas in Rat 12 Hoxa10 was expressed highest, 
























Figure 5-14: Data from Rat 9 in heterotypic culture. The calvarial osteoblastic cells were stained 
green, whilst femoral osteoblastic cells were unstained. Vice versa, calvarial osteoblastic cells 
were unstained, whilst femoral osteoblastic cells were stained green. Then cells stained cells 
were sorted for RNA extraction, cDNA synthesis and qRT-PCR. Hoxa gene expression was 
switched on in calvarial osteoblastic cells. At Day 7 in heterotypic culture, Hoxa gene 
expression pattern was observed. Hoxa7 expressed highest, followed by Hoxa10 and Hoxa13. 
Data were generated from using 2 different primary osteoblast cultures and 4 replicates were 




Figure 5-15: Data from Rat 9 calvarial osteoblastic cells were stained green in heterotypic 
culture when looked closely at Day 7, Hoxa gene expression was switched on in calvarial 
osteoblastic cells. Hoxa gene expression pattern was observed. Hoxa7 expressed highest, 
followed by Hoxa10 and Hoxa13. Data were generated from using 2 different primary osteoblast 
cultures and 4 replicates were tested for each culture. 







Figure 5-16: Data from Rat 11 in heterotypic culture. The calvarial osteoblastic cells were 
stained green, whilst femoral osteoblastic cells were unstained. Vice versa, calvarial 
osteoblastic cells were unstained, whilst femoral osteoblastic cells were stained green. Then 
cells stained cells were sorted for RNA extraction, cDNA synthesis and qRT-PCR. Hoxa gene 
expression was switched on in calvarial osteoblastic cells. At Day 7 in heterotypic culture, Hoxa 
gene expression pattern was observed. Hoxa7 expressed highest, followed by Hoxa10 and 
Hoxa13. Data were generated from using 2 primary different cell cultures and 4 replicates were 
tested for each culture. 
 
 
Figure 5-17: Data from Rat 11 calvarial osteoblastic cells were stained green in heterotypic 
culture when looked closely at Day 7, Hoxa gene expression was switched on in calvarial 
osteoblastic cells. Hoxa gene expression pattern was observed. Hoxa7 expressed highest, 
followed by Hoxa10, Hoxa4 and Hoxa13. Data were generated from using 2 primary different 
cell cultures and 4 replicates were tested for each culture. 
 







Figure 5-18: Similar results were also observed in Rat 12 in heterotypic culture. The calvarial 
osteoblastic cells were stained green, whilst femoral osteoblastic cells were unstained. Vice 
versa, calvarial osteoblastic cells were unstained, whilst femoral osteoblastic cells were stained 
green. Then cells stained cells were sorted for RNA extraction, cDNA synthesis and qRT-PCR.  
Hoxa gene expression was switched on in calvarial osteoblastic cells. At Day 7 in heterotypic 
culture, Hoxa gene expression pattern was observed. Instead, Hoxa10 expressed highest, 
followed by Hoxa7, and Hoxa5, but no Hoxa13 gene expression. Data were generated from 




Figure 5-19: Data from Rat 12 calvarial osteoblastic cells were stained green in heterotypic 
culture when looked closely at Day 7, Hoxa gene expression was switched on in calvarial 
osteoblastic cells. Hoxa gene expression pattern was observed. Hoxa10 expressed highest, 
followed by Hoxa5, Hoxa7 and Hoxa4. Data were generated from using 2 primary different cell 
cultures and 4 replicates were tested for each culture. 




In order to verify this important result, we had to be sure that it is actually changed 
rather than due to cross contamination of labelled cells.  It was crucial to demonstrate 
that label does not leach from one cell type to the other.  Therefore, we carried out 
further experiments to test for this possibility: 
 
1. Investigation of transfer of label from one cell type to the other 
 
a) FACS analysis of double stained heterotypic cultures 
 
Results showed that the cells labelled green have gradually decreased their fluorescence 
intensities.  Crucially it was observed that by Day 3 many of the previously green 
labelled cells had become double labelled and picked up red staining in addition to the 
green label.  In contrast, the cells stained with red dye have maintained their 
fluorescence intensities from Day 0 through Day 3 in culture as shown in flow 


























Figure 5-20: Flow cytometry data show two distinct osteoblast populations previously labelled 
with CellTracker
TM
 Green and CellTracker
TM
 Red and grown in heterotypic culture. They were 
detected due to their fluorescence intensity signals through FITC-A and APC-A channels. At 




 in both colours. APC-A was 









Double labelling was also observed at Day 3 (C-OBTs= Calvarial osteoblasts, F-OBTs= 
Femoral osteoblasts). 
  






 Cell culture inserts system and flow cytometry 
The Falcon insert cultures system to investigate soluble passing of label from separated 
cell populations was used to check whether one cell population became labelled by 
another.  The results showed that red and orange dyes tended to lose their labels with 
time in culture.  There was some evidence that a small number of orange labelled cells 
appeared to also acquire green labelling by day 7 (Figure 5-21). 
 
 
Figure 5-21: The calvarial osteoblastic cells stained with CellTracker
TM
 Green, whilst the femoral 
osteoblastic cells either stained with CellTracker
TM
 Red or CellTracker
TM
 Orange. They were 
grown together in BD Falcon™ Cell culture inserts system. The two different cell populations 
were cultured for 0, 3 and 7 days. At each time point, the cells were collected and tested for dye 
leakage by using flow cytometry for analysis. The CellTracker
TM
 Green retained the dye in 
stained cells throughout 7 days culture period. The CellTracker
TM
 Orange retained the dye in 
stained cells at Day 0, but not at Day 3 and Day 7. Interestingly, the CellTracker
TM
 Red did not 
retain in stained cells. Double positive labelled was observed in red and orange dyes at Day 3 
and Day 7 (C= Calvarial osteoblasts, F= Femoral osteoblasts). 






 Cell culture inserts system and qRT-PCR 
In addition to dye leakage testing, in this set up we collected the cells which were grown 
in this system and assessed them for Hoxa gene expression.  The results showed that 
Hoxa gene expression did not change in this co-culture system, without cell to cell 
contact (Figures 5-22 and 5-23). 
 
 
Figure 5-22: The calvarial and femoral osteoblastic cells from Rat 9 were stained with green and 
red dyes, respectively. They were grown in this system. Hoxa gene expression was assessed 
as previously described. Hox-ve cells retain negative, whilst Hox+ve cells retain positive and 
showed pattern of Hoxa gene expression. 
 
 
Figure 5-23: The calvarial and femoral osteoblastic cells from Rat 9 were stained with green and 
orange dyes, respectively. They were grown in this system. Hoxa gene expression was 
assessed as previously described. Hox-ve cells retain negative, whilst Hox+ve cells retain 
positive and showed pattern of Hoxa gene expression. 






 Green only and flow cytometry 
 
As green labelling appeared to be the most stable of the dyes, and showed little evidence 
of leakage in heterotypic cultures analysed by flow cytometry, it was decided to 
continue further experiments using green labelling only.  The cells were stained, grown 
together and tested for dye leakage by flow cytometry.  The green labelled cells retained 
their labels in monotypic culture (C or F) and heterotypic culture (C/F) up to 7 days.  




Figure 5-24: The calvarial and femoral osteoblastic cells from 2 rats (Rat 9 and Rat 10) were 
grown, stained and tested for dye leakage by flow cytometry. The CellTracker
TM
 Green retained 
the staining in the cells both in monotypic culture (C or F) and heterotypic culture (C/F) up to 7 
days. The two populations of stained and unstained cells can be clearly distinguished. 
 
  




e) Flow cytometry sorting- heterotypic culture 
The cells were grown, stained and sorted as previously described in section 5.3.3.  The 
rat calvarial osteoblastic cells stained with CellTracker
TM
 Green from 4 rats have 
gradually decreased their fluorescence intensities.  However, the cell sorter can clearly 
distinguish stained-cells versus unstained from Day 0 through Day 7 in heterotypic 
culture as shown in Figure 5-25.  
 
 
Figure 5-25: Rat calvarial and femoral osteoblastic cells from 4 male rats (Rats 9-12) were 
grown and used at passage 6-9 in experiments. Calvarial osteoblastic cells were stained with 
CellTracker
TM
 Green, whilst femoral osteoblastic cells were unstained. The two different 
populations were grown together in heterotypic culture for 0, 3 and 7 days. Then they were 
sorted by cell sorter (BD FACSAria II) to separate two different cell populations. The rat calvarial 
osteoblastic cells stained with CellTracker
TM
 Green from 4 rats have gradually decreased their 




). However, the cell sorter can clearly 
distinguish stained-cells versus unstained femoral osteoblastic cells that maintained their low 
fluorescence intensities (FITC-A 10
2
) from Day 0 through Day 7 in heterotypic culture. 
 




Overall the results suggest that when two colours were used in heterotypic culture, the 
cells labelled green become red, especially at Day 7.  It appears that green dye is stable, 
but red dye is not. 
 
Therefore, we carried out the rest of the experiments using one colour label.  We 
considered that the cells labelled with green dye become unlabeled with time in culture.   
However, we were confident that sorted green labelled populations were neither 
contaminated nor a mixed population as the purity checked after sorting was more than 
96%.  Nevertheless, the unlabelled cells would be a mixture of populations particularly 
with time in culture, as some green labelled cells would lose their staining.  Therefore, 
we developed the heterotypic culture model with a single stain, green only.   
 
 
5.4.5 Experiments using single labelling to show that heterotypic cultures do not induce 
changes in Hoxa gene expression 
 




When we set up monotypic culture and used as controls, as expected gene expression 




















Figure 5-26: Relative expression of Hoxa genes to average control genes (Atp5b and Eif4a2). In 
monotypic culture, calvarial osteoblastic cells stained with CellTracker
TM
 Green, whilst femoral 
osteoblastic cells were unstained. At Day 0, Day 3 and Day7, the cells passed through cell 
sorter, grown and collected for RNA extraction, cDNA synthesis and qRT-PCR. Data 
represented as mean ± SD from 4 different male rats matched pairs. Data were generated from 
using 8 different primary osteoblast cultures and 4 replicates were tested for each culture. No or 
nearly undetectable level of Hoxa gene expression in calvarial osteoblastic cells (a-g). In 
contrast, there is a pattern of Hoxa gene expression in femoral osteoblastic cells (a-g), 
especially Hoxa7 (e) and Hoxa10 (f). Paired t-test was used to compare gene expression 
between calvarial and femoral osteoblastic cells, *, p˂0.05, **, p˂0.01 considered significantly 
different. 
 




In heterotypic cultures using single labelling the results obtained are as followed: 
 
The experiment was repeated two times independently.  The same results were obtained.  
There was no or nearly undetectable levels of Hoxa gene expression in calvarial 
osteoblastic cells (Figure 5-27).  In contrast, there is a pattern of Hoxa gene expression 
in femoral osteoblastic cells consistent with our results from Chapter 4.  Hoxa7 (Figure 
5-27 e) and Hoxa10 (Figure 5-27 f) were highly expressed.  A detectable level of Hoxa4 
and Hoxa5 gene expression was observed.  In addition, low levels of Hoxa1 and 
Hoxa13 gene expression was seen and no expression of Hoxa2 gene.  Interestingly, at 
Day 0 Hoxa5 and Hoxa7 were expressed at significantly higher levels, but gradually 


































Figure 5-27: Relative expression of Hoxa genes to average control genes (Atp5b and Eif4a2). In 
heterotypic culture, calvarial osteoblastic cells stained with CellTracker
TM
 Green, whilst femoral 
osteoblastic cells were unstained. The cells were grown together in culture for 0, 3 and 7 days. 
Then they were sorted by cell sorter, continued to grow and collected for RNA extraction, cDNA 
synthesis and qRT-PCR. Data represented as mean ± SD from 4 different male rats. Data were 
generated from using 8 different primary osteoblast cultures and 4 replicates were tested for 
each culture. No or nearly undetectable level of Hoxa gene expression in calvarial osteoblastic 
cells (a-g). In contrast, there is a pattern of Hoxa gene expression in femoral osteoblastic cells 
(a-g), especially highly expressed Hoxa7 (e) and Hoxa10 (f). Paired t-test was used to compare 
gene expression between calvarial and femoral osteoblastic cells. *,p˂0.05, **,p˂0.01 
considered significantly different. 








When we set up monotypic culture and used as controls, as expected gene expression 





































Figure 5-28: Relative expression of Hoxa genes to average control genes (Atp5b and Eif4a2). In 
monotypic culture, femoral osteoblastic cells stained with CellTracker
TM
 Green, whilst calvarial 
osteoblastic cells were unstained. At Day 0, Day 3 and Day7, the cells passed through cell 
sorter, grown and collected for RNA extraction, cDNA synthesis and qRT-PCR. Data 
represented as mean ± SD from 4 different male rats matched pairs. Data were generated from 
using 8 different primary osteoblast cultures and 4 replicates were tested for each culture. No or 
nearly undetectable level of Hoxa gene expression in calvarial osteoblastic cells (a-g). In 
contrast, there is a pattern of Hoxa gene expression in femoral osteoblastic cells (a-g), 
especially Hoxa7 (e) and Hoxa10 (f). Paired t-test was used to compare gene expression 
between calvarial and femoral osteoblastic cells, *, p˂0.05, **, p˂0.01, ***, p˂0.001 considered 
significantly different. 
 




Femoral osteoblastic cells were stained green.  Similar results with single staining were 
obtained when calvarial osteoblastic cells were stained green.  There was no or nearly 
undetectable level of Hoxa gene expression in calvarial osteoblastic cells (Figure 5-29).   
 
In contrast, there is a pattern of Hoxa gene expression in femoral osteoblastic cells, 
especially high expression of Hoxa7 (Figure 5-29 e) and Hoxa10 (Figure 5-29 f).  
Detectable levels of Hoxa4 and Hoxa5 gene expression were observed.  In addition, low 
































Figure 5-29: Relative expression of Hoxa genes to average control genes (Atp5b and Eif4a2). In 
heterotypic culture, femoral osteoblastic cells stained with CellTracker
TM
 Green, whilst calvarial 
osteoblastic cells were unstained. The cells were grown together in culture for 0, 3 and 7 days. 
Then they were sorted by cell sorter, continued to grow and collected for RNA extraction, cDNA 
synthesis and qRT-PCR. Data represented as mean ± SD from 4 different male rats. Data were 
generated from using 8 different primary osteoblast cultures and 4 replicates were tested for 
each culture. No or nearly undetectable level of Hoxa gene expression in calvarial osteoblastic 
cells (a-g). In contrast, there is a pattern of Hoxa gene expression in femoral osteoblastic cells 
(a-g), especially highly expressed Hoxa7 (e) and Hoxa10 (f). Paired t-test was used to compare 
gene expression between calvarial and femoral osteoblastic cells. *,p˂0.05, **,p˂0.01, 
***,p˂0.001 considered significantly different. 




5.5 Discussion and conclusion 
 
From the previous study by Leucht and co-workers using Wnt1Cre::Z/EG transgenic 
mice, testing for embryonic origin of the graft influences cell fate decision in a 
transplantation assay using Pentachrome staining and GFP antibody staining, they have 
found that homotopic transplantation of Hoxa11-expressing periosteum cells derived 
from tibia into tibial defects resulted in vigorous bone formation through 
intramembranous ossification at post-surgical day 10, and homotopic graft of 
mandibular periosteum into a mandibular injury site induced direct differentiation into 
bone (Leucht et al., 2008a).  
 
In addition, the majority of the regenerated tissue was derived from the GFP-positive 
grafted periosteum.  Interestingly, placing neural crest-derived periosteum into a 
mesoderm-derived injury site resulted in intramembranous bone formation, but placing 
tibial periosteum into a mandibular injury site resulted in endochondral ossification and 
underwent hypertrophy even though the environment fully supported osteogenic 
differentiation (Leucht et al., 2008a).  It was concluded that the disparity between the 
Hox status of the graft and the injury site correlated with a disruption in bone 
regeneration as the grafted cells failed to differentiate into osteoblasts. 
 
The results of that mouse study in vivo suggested that Hox-positive host cells might be 
responsible for this switch in molecular fate.  In contrast, we thought that the switch 
could be due to other growth factors or soluble factors in their new environment or the 
committed cell itself. 
 
To address the first question, we first established our rat dermal fibroblasts from scalp 
which previously tested Hox-negative, and rat dermal fibroblasts from tissue overlying 
ulna area which previously tested Hox-positive.  We carried out the experiment to test 
the effect of soluble factors on Hoxa gene expression in rat dermal fibroblasts by 
treating Hox-negative and Hox-positive fibroblasts with different condition media.  
 
However, we have found that there was no effect of soluble factors on Hoxa gene 
expression in our rat dermal fibroblasts model when Hox+ve fibroblasts were treated 




with different CM.  A fold change of 1 indicates no difference from control as shown in 
Figure 5-6.  Therefore, the soluble factors are not responsible for the Hox-switching. 
The Hox-switching may be due to cell to cell contact.  To address the second question, 
we carried out these monotypic and heterotypic experiments by staining two distinct 
embryonic origin osteoblasts with CellTracker
TM
 dye, sorted and assessed their Hoxa 
gene expression and also Hoxa gene expression pattern by qRT-PCR.  
 
We have found very interesting data from our pilot experiment from Rat 9, Rat 11 and 
Rat 12 that Hoxa gene expression in calvarial osteoblastic cells could be switched on by 
heterotypic culture.  However, femoral osteoblastic cells in Rat 9 after being grown in 
heterotypic culture for 7 days demonstrated low level of Hoxa gene expression and 
became like calvarial osteoblastic cells (Figure 5-14 and 5-15), but not in femoral 
osteoblastic cells of Rat 11 (Figure 5-16 and 5-17) and Rat 12 (Figure 5-18 and 5-19) 
which still maintained their Hoxa genes expression in these heterotypic cultures.  To be 
certain of this result, we considered other possibilities that might cause this modulation.  
Is it due to dye leakage in heterotypic culture?  Or the cells were dead and the dye was 
released, then some live cells that lost their labelling picked up the dye which caused 
cell contamination and false modulation. 
 
We tested our system by growing our cells in BD Falcon™ Cell culture inserts system, 
checking dye leakage by labelling and looking under fluorescence microscope, 
analysing by using flow cytometry, optimising the staining condition and checking for 
purity of cells after sorting and the effect of cell sorter on our rat osteoblastic cells. 
 
We have demonstrated that there was no effect of cell sorting on our rat calvarial and 
femoral osteoblastic cells after they were grown in heterotypic culture for 7 days and 
then sorted by flow cytometry.  The cells from all cultures showed normal morphology 
under microscope.  Many previous studies have also used fluorescence activated cell 
sorting (FACS) for flow cytometric analysis and cell sorting purposes (Fu et al., 1999; 
Herbertson and Aubin, 1997; Kulterer et al., 2007; Lopes et al., 1998; Manz et al., 1995; 
Nakano et al., 1989; Purpura et al., 2003; Zohar et al., 1997).  Rat BMSCs could be 
sorted due to their high or low alkaline phosphatase (AP) expression (Herbertson and 
Aubin, 1997).  Calvarial cells from 21-day-old foetuses of timed-pregnant Wistar rats 
and rat or mouse BMSCs were studied for their cell vitality, OPN mRNA expression, 




alkaline phosphatase activity and cell proliferation, limiting dilution analysis, colony 
assays, self-renewal capacity, electron microscopy and immunostaining after the cells 
passed through flow cytometer and sorting (Zohar et al., 1997).  It was concluded that 
the method of flow cytometry sorting provided a simple, reproducible approach to help 
define the stages of bone cell differentiation and ability to enrich for stem cells.   
 
When our rat osteoblastic cells were stained with different colours of CellTracker
TM
 
dye, we have found that CellTracker
TM
 Red caused a dye leakage problem analysed by 
flow cytometry showing doubling labelling.  We have also found the CellTracker
TM
 
Orange has decreased fluorescence intensity overtime during heterotypic culture in BD 
Falcon™ cell culture inserts system and also double labelling.  However, the 
CellTracker
TM
 Green was the most stable.  There was little sign of dye leakage.  
Nevertheless, CellTracker
TM
 Green showed decreased fluorescence intensity over time 




 Green was our best option to use for further experiments.  Taking the 
limitation of losing fluorescence intensity overtime in culture into consideration, we 
have designed and carried out these following experiments for both monotypic and 
heterotypic cultures by using CellTracker
TM
 Green only to stain calvarial osteoblastic 
cells and femoral osteoblastic cells, one colour was used to stain in monotypic or 
heterotypic cultures.  For example, if calvarial osteoblastic cells were stained with 
CellTracker
TM
 Green, femoral osteoblastic cells were left unstained and vice versa.  We 
repeated our experiments by using 4 male rats.  This time, we can solve a dye leakage or 
a cell contamination problem, but the Hoxa gene expression in calvarial osteoblastic 
cells could not be switched on by heterotypic culture as previously discovered.  Having 
repeated these experiments we propose that our initial results suggestive of switching on 
of Hoxa expression in calvarial cells in co-culture were likely to have been the result of 
dye leakage and transfer.  
 
These results appear to be in contrast to the study by Leucht et al., who found that 
posterior Hox genes were expressed in Hox-negative adult neural crest cells when 
placed into a Hox-positive environment, implying that injury sites have specific Hox 
codes.  In contrast, Hox status was maintained in mesodermal cells when grafted into 
the mandible and failed to differentiate into osteoblasts in vivo (Leucht et al., 2008a).  In 




addition, within 5 days in in vitro co-cultured of tibial periosteal Hoxa11-expressing 
cells with Hox-negative mandibular periosteal cells, the formerly Hox-negative 
mandibular periosteal cells began to express Hoxa11 in vitro (Leucht et al., 2008a).  
 
In conclusion, there was no effect of conditioned medium from heterotypic Hox+ve 
fibroblasts on each other’s gene expression as determined by qRT-PCR at least in this 
time frame.  Similarly when osteoblasts were placed in heterotypic cultures, there was 
no evidence of Hoxa switching.  In our pilot study, Hoxa genes in calvarial osteoblastic 
cells could be switched on by heterotypic culture, but latter repeated experiments 
confirmed no modulation in Hoxa gene expression in osteoblastic cells due to 
heterotypic culture.  From our data, there was no modulation of positional identity in 
heterotypic culture.  Hoxa5, Hoxa7 and Hoxa10 are the set of stable key gene 
throughout the study.  Our data also suggested that Hoxa in the more anterior region are 
more flexible than in the posterior region.  
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In Chapter 4, it was demonstrated that cells derived from distinct anatomical sites 
showed differences in Hoxa gene expression consistent with their embryonic origins.  
These differences in positional identity persisted and were retained in vitro for at least 
up to 10 subcultures.  These observations raise the important question of whether 
regionally distinct osteoblasts may also exhibit inherent functional differences as well.  
 
As previously discussed, Rawlinson et al. found the embryological development 
associated genes (in skull such as Zic, Dlx, Irx, Twist1 and Cart1; in Limb such as Hox, 
Shox2, and Tbx genes) in both adult bones and isolated adult bone-derived cells showed 
the differentially expression (Rawlinson et al., 2009b).  By using gene expression 
microarrays they found that skull bone-derived cells preferentially expressed genes 
associated with the craniofacial development of neural crest derived cells, whilst genes 
for limb development and patterning were preferentially expressed by limb bone-
derived cells.  In addition, the Spp1 gene, which codes for the bone matrix protein 
osteopontin, was more highly expressed in limb bone-derived cells (Rawlinson et al., 
2009b). 
 
It is well known (Albright et al., 1941; Ralston and de Crombrugghe, 2006; Warriner et 
al., 2011) that limb bones are susceptible to osteoporosis and they become weak and 
vulnerable to fractures when they are not maintained by weight bearing exercise.  
However skull bone, which bears almost no weight, remains largely resistant to both 
post-menopausal osteoporosis and disuse atrophy (Albright et al., 1941; Ralston and de 
Crombrugghe, 2006; Warriner et al., 2011).  However, the molecular and cellular 
mechanisms mediating this effect remain unclear.  These empirical observations support 
the idea that regionally distinct osteoblasts may exhibit phenotypic differences which 
may be inherently programmed or alternatively determined by their anatomical location. 
 
Osteopontin (OPN) is an arginine-glycine-aspartate (RGD) - containing glycoprotein 
encoded by the gene secreted phosphoprotein1(Spp1) (Liaw et al., 1998).  OPN plays 
an important role in bone formation under tensile mechanical stress (Morinobu et al., 
2003).  In OPN knockout mice, bone remodelling in response to mechanical stress was 
suppressed.  These results indicate the essential role of OPN in the process of bone 




remodelling (Fujihara et al., 2006).  In addition, OPN expression is increased in 
osteoblasts subjected to mechanical stimulation (Kubota et al., 1993). 
 
Osteoblasts derived from ulnae and cultured on plastic plates treated with dynamic 
strain of 600 cycles (1 Hz, 4000 mu epsilon) showed increasing in G6PD activity.  
There was not the same response in calvarial-derived cells even in similarly treated.  
Calvarial-derived bone cells do not respond to physiological strains in their regions with 
increased prostanoid release or G6PD activity either in situ or when seeded onto 
dynamically strained plastic plates which differ from those of the ulna (Rawlinson et al., 
1995). 
 
Compressive forces act on bone cells depend on the magnitude and provide a possible 
molecular model for the increasing bone strength observed in response to physical 
activity (Rath et al., 2008).  The study in biomechanical forces suggests that these forces 
are significant to develop fracture healing. 
 
Mice with ablated OPN gene do not lose bone after mechanical unloading (tail 
suspension) (Ishijima et al., 2001) or upon oestrogen withdrawal (ovariectomy) 
(Yoshitake et al., 1999), showing the importance of OPN in the regulation of bone 





mice do not lose bone with hind-limb unloading, which is an established model of 
disuse osteoporosis (Ishijima et al., 2001).   
 
The oestrogen and androgen have important roles in maintaining the adult skeleton.  
ER-related receptor-α (ERRα) is expressed in tissues such as the female and male 
reproductive organs, mature ovocytes in the ovary, and spermatocytes in the testis; in 
non-reproductive tissues such as mammary glands, heart, and nervous system 
(Bonnelye et al., 1997). 
 









 mice.  Data 
from this study also support the hypothesis that reduction in ERα expression or activity 
after oestrogen withdrawal results in a less osteogenic response to loading.  This may be 
important in the etiology of postmenopausal osteoporosis (Jessop et al., 2004). 




Based on their embryonic origins, adult skeletal progenitor cells from at least two 
populations can be distinguished.  Injured skeletal elements usually repair by using cells 
of their own embryonic origin (Leucht et al., 2008a).  The reparative strategies may 
have to consider the variable in osteoblastic cells from two distinct populations to 
improve clinical outcome and healing when using cells from the same embryonic origin. 
 
Overall, potential inherent phenotypic differences between regionally distinct 
osteoblasts may have important clinical implications in the long term for conditions 
such as osteoporosis, and in tissue engineering applications.  In Chapter 3, we noted 
some apparent phenotypic differences between calvarial and femoral osteoblastic cells, 
most notably in bone nodule formation capacity, but also in osteopontin production.  In 
contrast, there was no significant difference seen in osteocalcin production in our cells.  
In Chapter 5, we concluded that there is no effect of conditioned medium from 
heterotypic Hox+ve fibroblasts on each other’s gene expression as determined by qRT-
PCR.  In a pilot study, Hoxa genes in calvarial osteoblastic cells could be switched on 
when grown in heterotypic culture.  We have repeated these experiments, but could not 
demonstrate the modulation in Hoxa gene expression in osteoblastic cells.  There was 
no modulation of positional identity by heterotypic culture.  However, there may be a 
possibility that phenotypic differences might be modulated and changes such as 
proliferation, total ALP activity, mineralised bone nodules, transcription factors or 
osteoblast-associated gene expression might be observed.  Therefore in this chapter we 
explored potential phenotypic differences between these cell types further. 
  






The aim of the studies described in this chapter was to investigate if there are 
phenotypic differences between osteoblasts derived from distinct anatomical sites.  
Specifically objectives were: 
 
1. To investigate functional differences in osteoblasts derived from femurs and 
calvariae; 
 
2. To investigate differences in expression of osteopontin protein in osteoblasts from 
femurs and calvariae in vitro; 
 
3. To test for the persistence of osteoblast-associated genes between osteoblastic cells 
from femurs and calvariae in vitro; 
 
4. To test for differences in oestrogen responsiveness between osteoblastic cells from 
femurs and calvariae in vitro; 
 
5. To investigate whether cell to cell contact in heterotypic culture can modify 
proliferation and total ALP activity, change ability to produce mineralised bone nodule, 
and modulate expression of transcription factors and osteoblast-associated genes.  
  




6.3 Materials and Methods 
 
6.3.1 Overview 
To investigate potential phenotypic differences, matched pairs of femoral and calvarial-
derived osteoblastic cultures from 4 male adult rats were used as described previously.  
Cultures were tested for differences in proliferation rates, alkaline phosphatase activity, 
production of osteopontin , expression of osteoblast- associated genes; Runx2, Bglap 
and Spp1, differences in responsiveness to oestrogen stimulation, and finally using 
single labelling to test whether heterotypic cultures can induce changes in proliferation, 
total ALP activity, mineralised bone nodules, expression of transcription factors and 
osteoblast-associated genes. 
   
6.3.2  Proliferation and ALP activity  
Calvarial and femoral osteoblastic cells were grown in DMEM with 10% FCS 
supplemented with 10 ng/ml of FGF-2.  At around 80% confluence the cells were tested 
for proliferation by MTS assay followed by total ALP activity assay.  Briefly, 2000 
cells of each cell type were seeded in 96-well plates in triplicate and were grown for 
periods of 7 and 14 days prior to analysis for MTS and total ALP activity. 
 
6.3.3 Expression of osteopontin by ELISA 
Production of osteopontin by cultures was assessed by ELISA as described in section 
2.7 and 3.4.3.3. 
 
6.3.4 Expression of osteoblast-associated genes  
The calvarial and femoral osteoblastic cells were grown in osteoblast culture medium 
supplemented with 10 ng/ml of FGF-2 to 80% confluence.  They were then lysed and 
collected for total RNA extraction as described in section 2.12.  These experiments were 
carried out with cells at both passage 5 and passage 10.  Cells were then tested for 








6.3.5 Oestrogen stimulation 
The rat calvarial and femoral cells at passage 3 were taken out from liquid nitrogen, 
grown in T-75 flasks in DMEM with 20% FCS supplemented with 10 ng/ml of FGF-2 
up to 3-5 days.  At 80-90% confluence, cells were passaged and grown in T-75 flasks in 
DMEM with 10% FCS supplemented with 10 ng/ml of FGF-2 up to 5-7 days.  At 80-
90% confluence, cells were passaged and grown in T-75 flasks in Phenol Red-free 
DMEM with 10% FCS without FGF-2 for 1 week as described in Figure 6-1. 
To measure the effects of oestrogen stimulation on proliferation, a pilot study using 
cells from 4 rats was carried out.  Briefly, after the cells were grown in 10% FCS in 
Phenol Red-free DMEM for 1 week, the cells were seeded into 96 well plates, serum 









 M) and dexamethasone 10
-8
 M and grown for 3 and 7 days.  Then their 
responses were measured to different concentrations of oestrogen and dexamethasone 
using MTS as previously described in section 2.4.  As an initial exploratory experiment 
on ALP expression, cells from the osteoblastic cell line ROS 17/2.8 were tested with 
oestrogen concentrations from 0-10
-7
M, and with 10
-8
M dexamethasone as a positive 
control.  
For measuring oestrogen stimulation using EdU incorporation and flow cytometry 
analysis, the cells were seeded into 6-well plates at a density of 200,000 cells per well 
for test plates, 1 negative EdU control and 3 oestrogen positive controls using 
dexamethasone at 10
-8
 M.  Positive control cultures with ROS cells and cells from the 
human osteoblastic cell line Saos 2.  At 80% confluence, the cells were serum starved 
overnight in Phenol Red-free DMEM with 1% FCS.  









M).  For the pilot experiment, cells from one rat were used.  In later 
experiments, cells from 4 rats were used and tested whereby 3 µl of each concentration 
of oestrogen was added in 3 ml medium (1 in 1,000).  In addition, 3 µl of EdU was also 
added.  The cells were maintained in DMEM Phenol Red-free with 1% FCS with no 
FGF-2 supplemented for 48 hours.  After 48 hours, the cells were collected and 
analysed by flow cytometry for the percentage of EdU incorporated cell populations as 
previously described in section 2.19. 
















6.3.6 Experiments using single labelling to test whether heterotypic cultures may induce 
changes in proliferation, total ALP activity, mineralised bone nodules, expression of 
transcription factors and osteoblast-associated genes or not 
 
In these experiments cells were grown in CellTracker™ Green labelled heterotypic co-
cultures and then sorted by FACS as described in Chapter 5. 
 
6.3.6.1 Proliferation and total ALP activity in monotypic and heterotypic cultures 
The cells were grown in DMEM with 10% FCS supplemented with 10 ng/ml of FGF-2.  
At around 80% confluence the cells were tested for proliferation by MTS assay 
followed by ALP total activity assay.  Briefly, 2,000 cells of each cell type were sorted 
in 96-well plates in triplicate and were grown for periods of 7 and 14 days prior to 
analysis for MTS and total ALP activity in both monotypic and heterotypic cultures as 
previously described in section 2.4 and 2.5. 
 
6.3.6.2 Mineralised bone nodules after grown in heterotypic culture 
The cells were stained and grown together for 0 and 7 days in heterotypic cultures.  
Then they were sorted by cell sorter into 24-well plate at the density 100,000 cells/well.  
The mineralised nodule formation was induced in osteoblast differentiation medium 
(DMEM containing 10% FCS, no FGF-2, supplemented with 50 µg/ml of ascorbic acid, 
100 nM of dexamethasone, 10 mM of β-glycerophosphate) for 28 days and stained with 
Alizarin red to identify bone nodules as described in section 2.9. 
 
6.3.6.3 Transcription factors and osteoblast-associated gene expression by qRT-PCR 
Similar experiments to the investigation of Hoxa gene expression in monotypic and 
heterotypic cultures described in section 5.3.4 were carried out.  In these experiments, 
we followed the same protocol, testing for transcription factor and osteoblast-associated 
gene expression. 
  










The cells were grown at passage 5 and tested.  There was no different in proliferation 
between rat calvarial and femoral osteoblastic cells from 4 rats grown in culture for 7 
and 14 days (Figure 6-2).  
 
 
Figure 6-2: Cell proliferation of calvarial and femoral osteoblastic cells grown in culture for 7 and 
14 days. Results shown as mean ± SD, 3 replicates from each of 8 different primary osteoblast 
cultures were used to generate these data. No difference in cell proliferation between two 
populations in both days. Paired t-test was used to compare proliferation between calvarial and 









6.4.1.2 ALP activity 
 
Although the mean ALP activity was higher in femoral osteoblasts at both day 7 and 
day 14, this was not statistically significantly different (Figure 6-3).  
 
 
Figure 6-3: ALP activity of calvarial and femoral osteoblastic cells grown in culture for 7 and 14 
days. Results shown as mean ± SD, 3 replicates from each of 8 different primary osteoblast 
cultures were used to generate these data. No difference in ALP activity between two 
populations in both days. Paired t-test was used to compare ALP activity between calvarial and 
femoral osteoblastic cells (p˂0.05, considered significantly different). 
 
In addition, alkaline phosphatase activity was adjusted for viable cell number using 
MTS assay.  The data also showed the same results with no statistically significant 




Figure 6-4: Alkaline phosphatase activity of calvarial and femoral osteoblastic cells when 
corrected to viable cell number using MTS assay showed total ALP activity of the cells grown in 
culture for 7 and 14 days. Results shown as mean ± SD, 3 replicates from each of 8 different 
primary osteoblast cultures were used to generate these data. No difference in total ALP activity 
between two populations in both days. Paired t-test was used to compare total ALP activity 
between calvarial and femoral osteoblastic cells (p˂0.05, considered significantly different). 




6.4.1.3 Additional analyses of total ALP activity 
 
To analyse the data further and to exclude the possibility of type 2 statistical errors due 
to large standard deviations, the data obtained from monotypic cultures as described in 
Chapter 5 were used to pool the data from Day 0, Day 3 and Day 7 in monotypic culture 
for each culture.  Consequently there were data from a total of 6 different experiments 3 
different experiments for 7 days and 3 different experiments for 14 days for these 
analyses.  Data were all normalised to ALP activity corrected to MTS of femoral cells 
as a percentage of that for calvarial cells and results for cells derived from each animal 
were analysed separately.  Differences between femoral and calvarial cells were then 
analysed by Wilcoxon’s Sign-Rank test. 
 
In these additional analyses, there was no consistent statistically significant difference 
in total ALP activity in all 4 rats both in 7 days and 14 days grown in culture after 



















Figure 6-5: ALP activity corrected to MTS of femoral osteoblastic cells corrected to % of 
calvarial osteoblastic cells. Data represented as mean ± SD from 3 independent experiments for 
each rat matched pairs for (a) 7 days and (b) 14 days in culture after passing through cell sorter. 
Data were generated using 3 replicates for each culture. This showed no significant difference 
in total ALP activity among 4 rats. Wilcoxon’s Sign-Rank test was used to compare total ALP 








6.4.2 Osteopontin production 
 
In order to carry out comparisons of osteopontin production between calvarial and 
femoral cells derived from each individual animal at p10, the data were normalised to 
express femoral cell osteopontin production as a percentage of that produced from 
calvarial osteoblastic cells.  At day 10, femoral osteoblastic cells showed a borderline 
significant increase in osteopontin production (p<0.06) compared to calvarial 
osteoblastic cells.  At Day 14 femoral osteoblastic cells also showed significantly higher 
production of osteopontin (p<0.02) although the mean size of the difference was 
reduced (from approximately 400% at day 10, to 200% at day 14) (Figure 6-6). 
 
Osteopontin production



































Figure 6-6: Osteopontin production detected by ELISA. Data was normalised to % of 
osteopontin produced from calvarial osteoblastic cells. The calvarial and femoral osteoblastic 
cells at p10 were grown in osteoblast culture medium supplemented with FGF-2, but without 
dexamethasone for 10 and 14 days. The cells were processed and collected for cell lysate. 
Data were generated from using 8 different primary osteoblast cultures and 2 replicates were 
tested for each culture. Data represented as mean ± SD. This graph shows that osteopontin can 
be detected in calvarial and femoral osteoblastic cells. Paired t-test was used to compare 
osteopontin production between calvarial and femoral osteoblastic cells, *, p<0.06 considered of 









The cells at passage 10 were also tested in osteoblast culture medium supplemented 
with FGF-2 and 100 nM of dexamethasone for 10 days.  Femoral osteoblastic cells 
again showed higher osteopontin production than in calvarial osteoblastic cells in all 4 
rats.  In addition, rat dermal fibroblasts derived from scalp, used as a negative control, 


















































Figure 6-7: Osteopontin production (ng/ml) measured by ELISA. The calvarial and femoral 
osteoblastic cells were grown at passage 10 in osteoblast culture medium supplemented with 
FGF-2 and 100 nM of dexamethasone for 10 days. The cells were processed and collected for 
cell lysate. Data presented 4 different male rats (Rats 9-12), except osteopontin production in 
rat dermal fibroblasts derived from scalp was derived from 1 rat used as negative control. Data 
were generated from using 9 different primary osteoblast cultures and 2 replicates were tested 
for each culture. This graph shows that osteopontin can be detected in both cell types (FBTs = 
dermal fibroblasts derived from scalp, R9C= Rat 9 calvaria, R10C= Rat 10 calvaria, R11C= Rat 
11 calvaria, R12C= Rat 12 calvaria, R9F= Rat 9 femur, R10F= Rat 10 femur, R11F= Rat 11 















Again, when the data were normalised to 100% of osteopontin produced from calvarial 
osteoblastic cells, femoral osteoblastic cells showed significantly higher osteopontin 






































Figure 6-8: Osteopontin production detected by ELISA. Data was normalised to % of 
osteopontin produced from calvarial osteoblastic cells. The calvarial and femoral osteoblastic 
cells were grown in osteoblast culture medium supplemented with FGF-2 and 100 nM of 
dexamethasone for 10 days. The cells were processed and collected for cell lysate. Data were 
generated from using 8 different primary osteoblast cultures and 2 replicates were tested for 
each culture. Data represented as mean ± SD. This graph shows that osteopontin can be 
detected in calvarial and femoral osteoblastic cells. Paired t-test was used to compare 
osteopontin production between calvarial and femoral osteoblastic cells, **, p<0.01 significantly 
different (OBTs= osteoblastic cells). 
 
  




6.4.3 Osteoblast-associated genes 
 
The most two stable genes (Eif4a2 and Atp5b) were tested from 6 House Keeping 
Genes (HKGs) and selected as the reference genes (see Appendix 3) to test for 
osteoblast-associated gene expression (Runx2, Bglap and Spp1) in adult rat calvarial and 
femoral osteoblastic cells at passage 5 and passage 10.  
 
The calvarial and femoral osteoblastic cells were grown in osteoblast culture media 
supplemented with 10 ng/ml of FGF-2 and tested at passage 5.  Runx2 gene showed 
significantly higher expression in calvarial osteoblastic cells than in femoral 
osteoblastic cells (p˂0.05) (Figure 6-9 a), whilst Bglap gene expression was equally 
expressed in both cell types (Figure 6-9 b).  Mean Spp1 expression was higher in 
femoral osteoblastic cells than in calvarial osteoblastic cells, but this difference did not 
reach statistical significance (Figure 6-9 c).   





Figure 6-9: Relative expression of osteoblast-associated genes to average control genes (Atp5b 
and Eif4a2) in adult rat calvarial and femoral osteoblastic cells. The cells were tested at 
passage 5 in present of FGF-2 in culture media. Data represented as mean ± SD from 4 
different male rats. Data were generated from using 8 different primary osteoblast cultures and 
4 replicates were tested for each culture. Paired t-test was used to compare gene expression 
between two regionally distinct populations. (a) Runx2 gene expressed significant higher in 
calvarial osteoblastic cell than in femoral osteoblastic cells (*, p˂0.05). (b) Bglap gene 
expressed in both cell types with no significant differences (p˂0.05). (c) Spp1 gene expression 
was higher in femoral cells than in calvarial osteoblastic cells, but not statistically different (*, 
p˂0.05 considered significantly different). 




The two regionally distinct populations as mentioned earlier were grown in the same 
growth condition media supplemented with FGF-2 and were again tested at passage 10 
for their osteoblast-associated gene expression.  
 
As seen at passage 5, Runx2 gene expression was higher in calvarial than in femoral 
cells, but this was not significantly different (Figure 6-10 a).  However Bglap gene 
expression was significantly higher in femoral osteoblastic cells (p˂0.05) (Figure 6-10 
b).  Spp1 gene expression was higher in femoral than in calvarial osteoblastic cells, but 
this difference did not reach significance (Figure 6-10 c).  There was no difference in 






















Figure 6-10: Relative expression of osteoblast-associated genes to average control genes 
(Atp5b and Eif4a2) in adult rat calvarial and femoral osteoblastic cells. The cells were tested at 
passage 10 in present of FGF-2 in culture media. Data represented as mean ± SD from 4 
different male rats. Data were generated from using 8 different primary osteoblast cultures and 
4 replicates were tested for each culture. Paired t-test was used to compare gene expression 
between two regionally distinct populations. (a) Runx2 gene expressed in both cell types with no 
significant differences (p˂0.05). (b) Bglap gene expressed significant higher in femoral 
osteoblastic cell than in calvarial osteoblastic cells (*, p˂0.05). (c) Spp1 gene expression was 
higher in femoral cells than in calvarial osteoblastic cells, but not statistically different (*, p˂0.05 
considered significantly different). 




6.4.3.1 Additional analyses of osteoblast-associated genes 
 
Although a number of the predicted differences in osteoblastic gene expression did not 
show significant differences, the “direction” of the difference in expression of specific 
factors between femoral and calvarial cells appeared remarkably consistent as 
previously described for transcription factor expression in section 4.4.3.3.  Again further 
analyses were carried out pooling the data from p5 and p10 for each culture, and also 
including additional data obtained from monotypic cultures in previous experiments 
described in Chapter 5.  Consequently, there were data from a total of 8 different 
experiments for these analyses.  Data were all normalised to describe expression 
patterns of femoral cells as a percentage of that for calvarial cells and results for cells 
derived from each animal were analysed separately.  Differences between femoral and 
calvarial cells were then analysed by Wilcoxon’s Sign-Rank test. 
 
In these additional analyses, Runx2 expression was higher in calvarial osteoblastic cells 
than in femoral osteoblastic cells (Figure 6-11), and this was significantly different in 3 
of 4 rats.  Bglap and Spp1 expression was higher in femoral osteoblastic cells than in 
calvarial osteoblastic cells (Figures 6-12 and 6-13) and these results were also 























Figure 6-11: Relative expression of Runx2 to average control genes (Atp5b and Eif4a2) of 
femoral osteoblastic cells corrected to % of calvarial osteoblastic cells. Data represented as 
mean ± SD from 8 independent experiments for each rat matched pairs. Data were generated 
from using 8 different primary osteoblast cultures and 4 replicates were tested for each culture. 
This showed Runx2 expressed significantly higher in calvarial osteoblastic cells than in femoral 
osteoblastic cells. Wilcoxon’s Sign-Rank test was used to compare gene expression between 











































































Figure 6-12: Relative expression of Bglap to average control genes (Atp5b and Eif4a2) of 
femoral osteoblastic cells corrected to % of calvarial osteoblastic cells. Data represented as 
mean ± SD from 8 independent experiments for each rat matched pairs. Data were generated 
from using 8 different primary osteoblast cultures and 4 replicates were tested for each culture. 
This showed Bglap expressed significantly higher in femoral osteoblastic cells than in calvarial 
osteoblastic cells. Wilcoxon’s Sign-Rank test was used to compare gene expression between 












































































Figure 6-13: Relative expression of Spp1 to average control genes (Atp5b and Eif4a2) of 
femoral osteoblastic cells corrected to % of calvarial osteoblastic cells. Data represented as 
mean ± SD from 8 independent experiments for each rat matched pairs. Data were generated 
from using 8 different primary osteoblast cultures and 4 replicates were tested for each culture. 
This showed Spp1 expressed significantly higher in femoral osteoblastic cells than in calvarial 
osteoblastic cells. Wilcoxon’s Sign-Rank test was used to compare gene expression between 

















































































6.4.4 Oestrogen stimulation 
 
6.4.4.1 Assessment of metabolic activity using MTS 
 









 M) and dexamethasone 10
-8
 M, there were no differences seen in all oestrogen 


























































 M) and dexamethasone 10
-8
 M on calvarial and femoral osteoblastic cells after serum 
starving. The MTS assessed for proliferation after oestrogen stimulation in calvarial and femoral 
osteoblastic cells was no different in all stimulations compared to control, each concentration 



































































 M) and dexamethasone 10
-8
 M on calvarial and femoral osteoblastic cells after serum 
starving. The MTS assessed for proliferation after oestrogen stimulation in calvarial and femoral 
osteoblastic cells was no different in all stimulations compared to control (mean ± SD), each 
concentration using 3 replicates. 
 
  




6.4.4.2 Assessment of ALP activity using ROS cells 
 











 M) and dexamethasone 10
-8
 M for 7 days, there were no differences 
seen in all oestrogen stimulations compared to controls.  However, ROS cells showed 
high level of ALP activity when stimulated with dexamethasone 10
-8
 M (Figure 6-16). 
 





























































 M) and dexamethasone 10
-8
 M on ROS cells. The ALP activity was assessed. ROS 
cells showed high level of ALP activity when stimulated with dexamethasone 10
-8
 M. There was 
no different in all oestrogen stimulations compared to controls (mean ± SD), each concentration 
using 3 replicates.  
  




6.4.4.3 EdU labelling 
 
a) Pilot study in 1 rat 
 
The results of the initial pilot study on calvarial and femoral osteoblastic cells from one 
rat (Rat 9) are shown in Figures 6-17 and 6-18.  Unstimulated control cultures showed 
no significant EdU labelling.  However stimulation with oestrogen resulted in labelling 
of about 10% of cells, although there were no differences between calvarial and femoral 
osteoblastic cells except at 10
-10
M oestrogen, and no evidence of a dose-response across 
































Figure 6-17: Pilot data of oestrogen respond on calvarial and femoral osteoblastic cells from 









M). After 48 hours, EdU incorporated cells were analysed by flow cytometry. 





























































 M) on calvarial and femoral osteoblastic cells from one 





















b) Further experiments with cells from 4 animals  
Further definitive experiments were carried out as described in the pilot experiment, 
using the calvarial and femoral osteoblastic cells from 4 rats.  ROS cells and Saos2 cell 
lines were used as positive controls.  There was no evidence of oestrogen response in 
ROS cells or Saos2 cell lines compared to controls (Figure 6-19).  There was also no 
evidence in oestrogen response in both osteoblastic cells (Figures 6-20 and 6-21), unlike 
in the previous pilot experiment. 
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6.4.5 Experiments using single labelling show that heterotypic cultures did not induce 
changes in proliferation, total ALP activity, mineralised bone nodules, expression of 




At Day 0, Day 3 and Day 7 in monotypic culture, there was no different in proliferation 
between rat calvarial and femoral osteoblastic cells after passing through the cell sorter 
and continuing to grow for 7 and 14 days (Figure 6-22).  
 
In heterotypic culture, there was no significant difference between the two distinct cell 
populations.  In addition, when looking at days in cultures after cell sorting, both 























































Figure 6-22: Cell proliferation of calvarial and femoral osteoblastic cells in monotypic culture at 
Day 0, Day 3 and Day 7 after passing through cell sorter and continuing to grow in culture for 7 
and 14 days. Results shown as mean ± SD, each sample using 3 replicates. No difference in 
cell proliferation between two populations. Paired t-test was used to compare proliferation 
between calvarial and femoral osteoblastic cells (p˂0.05, considered significantly different). 


































Figure 6-23: Cell proliferation of calvarial and femoral osteoblastic cells grown in heterotypic 
culture at Day 0, Day 3 and Day 7 and continued to grow in culture after sorting for 7 and 14 
days. Results shown as mean ± SD, each sample using 3 replicates. No difference in cell 
proliferation between two populations. Paired t-test was used to compare proliferation between 
calvarial and femoral osteoblastic cells (p˂0.05, considered significantly different). 




6.4.5.2 ALP activity 
 
At Day 0, Day 3 and Day 7 in monotypic culture, there was no difference in ALP 
activity between rat calvarial and femoral osteoblastic cells after passing through the 
cell sorter and continuing to grow for 7 and 14 days (Figure 6-24).  
 
In heterotypic culture, there was no significant difference between the two distinct cell 
populations.  In addition, when looking at days in cultures after cell sorting, both 

















































Figure 6-24: ALP activity of calvarial and femoral osteoblastic cells in monotypic culture at Day 
0, Day 3 and Day 7 after passing through cell sorter and continuing to grow in culture for 7 and 
14 days. Results shown as mean ± SD, each sample using 3 replicates. No difference in ALP 
activity between two populations. Paired t-test was used to compare proliferation between 
calvarial and femoral osteoblastic cells (p˂0.05, considered significantly different). 



































Figure 6-25: ALP activity of calvarial and femoral osteoblastic cells grown in heterotypic cultures 
at Day 0, Day 3 and Day 7 and continued to grow separately in culture after sorting for 7 and 14 
days. Results shown as mean ± SD, each sample using 3 replicates. No difference in ALP 
activity between two populations. Paired t-test was used to compare proliferation between 
calvarial and femoral osteoblastic cells (p˂0.05, considered significantly different). 




6.4.5.3 Total ALP activity corrected for MTS 
 
Alkaline phosphatase activity of calvarial and femoral osteoblastic cells was adjusted 
for viable cell number.  The data showed the same results as before.  Total ALP activity 
when cells were grown in culture after passing through cell sorter showed similar levels 
between two populations in monotypic culture (Figure 6-26).  
 
In heterotypic culture, there was no significant difference between the two distinct cell 
populations.  In addition, when looking at days in cultures after cell sorting, both groups 





































Figure 6-26: Alkaline phosphatase activity of calvarial and femoral osteoblastic cells when 
corrected to viable cell number using MTS assay. Two different populations were grown at Day 
0, Day 3 and Day 7 in monotypic culture after passing through cell sorter and continuing to grow 
in culture for 7 and 14 days. Results shown as mean ± SD, each sample using 3 replicates. No 
difference in total ALP activity in this monotypic culture. Paired t-test was used to compare 
proliferation between calvarial and femoral osteoblastic cells (p˂0.05, considered significantly 
different). 

























Figure 6-27: Alkaline phosphatase activity of calvarial and femoral osteoblastic cells when 
corrected to viable cell number using MTS assay. Two different populations were grown in 
heterotypic cultures at Day 0, Day 3 and Day 7 and continued to grow separately in culture after 
sorting for 7 and 14 days. Results shown as mean ± SD, each sample using 3 replicates. No 
difference in total ALP activity in this heterotypic culture. Paired t-test was used to compare 
proliferation between calvarial and femoral osteoblastic cells (p˂0.05, considered significantly 
different). 




6.4.5.4 Mineralised bone nodules after heterotypic cultures 
 
To test the production of mineralised bone nodules by calvarial and femoral osteoblastic 
cells when grown together in heterotypic culture.  Cells were grown together in 
heterotypic culture for 0 day as a control group and 7 days as a test group as previously 
described.  The cells were sorted to separate two distinct populations into 24-well plates 
and then grown separately in osteoblast differentiation media with β-glycerophosphate 
for 28 days before Alizarin red staining for mineralised bone nodules.  All calvarial 
osteoblastic cells formed fewer and smaller bone nodules than femoral osteoblastic cells 
in all cultures at both day 0 and day 7 of co-culture (Figures 6-28 and 6-29).  There was 





























Figure 6-28: Rat calvarial and femoral osteoblastic cells from 4 male rats (Rats 9-12) were 
grown in heterotypic culture for 0 day as a control group and sorted by cell sorter and continued 
to grow separately for 28 days in osteoblast differentiation media with dexamethasone and β-
glycerophosphate, but no FGF-2 supplemented before Alizarin red staining for mineralised bone 
nodules (arrows). All calvarial osteoblastic cells presented less bone nodules (small arrows) 
than femoral osteoblastic cells in all cultures at 0 day grown in heterotypic culture, at 









Figure 6-29: Rat calvarial and femoral osteoblastic cells from 4 male rats (Rats 9-12) were 
grown in heterotypic culture for 7 days as a test group and sorted by cell sorter and continued to 
grow separately for 28 days in osteoblast differentiation media with dexamethasone and β-
glycerophosphate, but no FGF-2 supplemented before Alizarin red staining for mineralised bone 
nodules (arrows). All calvarial osteoblastic cells presented less bone nodules (small arrows) 
than femoral osteoblastic cells in all cultures at 7 days grown in culture, magnification 100, scale 








6.4.5.5 Transcription factors and osteoblast-associated gene expression 
 
We set up labelled monotypic and heterotypic cultures as previously described in 
Chapter 5.  
 




As expected gene expression did not change in monotypic cultures.  In monotypic 
cultures, rat calvarial osteoblastic cells were stained with CellTracker
TM
 Green, whilst 
femoral osteoblastic cells were unstained.  The cells were passed through a cell sorter, 
grown and collected for RNA extraction, cDNA synthesis and qRT-PCR. 
 
Relative expression of transcription factors (Msx2, Irx5 and Tbx3) and osteoblast-
associated genes (Runx2, Bglap and Spp1) to average control genes (Atp5b and Eif4a2) 
was assessed.  Data generated from 4 different male rats expressed as mean ± SD.  
 
Msx2 and Irx5 were preferentially expressed in calvarial osteoblastic cells (Figure 6-30 
a and b), whilst Tbx3 was preferentially expressed in femoral osteoblastic cells (Figure 
6-30 c) from Day 0 to Day 7 in all cultures.  At Day 0, Irx5 expression in calvarial 
osteoblastic cells was significantly greater than expression in femoral osteoblastic cells 
(p˂0.01).  At Day 3 and Day 7, Irx5 expression in calvarial osteoblastic cells was also 
significantly higher than in femoral osteoblastic cells (p˂0.05). 
 
On the other hand, at Day 3 Tbx3 expression in femoral osteoblastic cells was 
significantly higher than in calvarial osteoblastic cells (p˂0.01).  A similar pattern was 
seen at Day 7 (p˂0.05). 
 
From Day 0 to Day 7, Runx2 expression was higher in calvarial osteoblastic cells and 
significantly different at Day 3 (p˂0.05) (Figure 6-31 a), whilst Bglap and Spp1 









Figure 6-30: Relative expression of Msx2, Irx5 and Tbx3 to average control genes (Atp5b and 
Eif4a2). In monotypic culture, calvarial osteoblastic cells stained with CellTracker
TM
 Green, 
whilst femoral osteoblastic cells were unstained. At Day 0, Day 3 and Day7, the cells passed 
through cell sorter, grown and collected for RNA extraction, cDNA synthesis and qRT-PCR. 
Data represented as mean ± SD from 4 different male rats. Data were generated from using 8 
different primary osteoblast cultures and 4 replicates were tested for each culture. Msx2 and 
Irx5 were preferentially expressed in calvarial osteoblastic cells (a) and (b), whilst Tbx3 were 
preferentially expressed in femoral osteoblastic cells (c). Paired t-test was used to compare 
gene expression between calvarial and femoral osteoblastic cells, *, p˂0.05, **, p˂0.01 
considered significantly different. 





Figure 6-31: Relative expression of Runx2, Bglap and Spp1 to average control genes (Atp5b 
and Eif4a2). In monotypic culture, calvarial osteoblastic cells stained with CellTracker
TM
 Green, 
whilst femoral osteoblastic cells were unstained. At Day 0, Day 3 and Day7, the cells passed 
through cell sorter, grown and collected for RNA extraction, cDNA synthesis and qRT-PCR. 
Data represented as mean ± SD from 4 different male rats. Data were generated from using 8 
different primary osteoblast cultures and 4 replicates were tested for each culture. Runx2 
expressed higher in calvarial osteoblastic cells (a), whilst Bglap and Spp1 were expressed 
higher in femoral osteoblastic cells (b) and (c). Paired t-test was used to compare gene 
expression between calvarial and femoral osteoblastic cells, *, p˂0.05, considered significantly 
different. 








In further experiments rat femoral osteoblastic cells were stained with CellTracker
TM
 
Green, whilst calvarial osteoblastic cells were unstained.  The cells were passed through 
a cell sorter, grown and collected for RNA extraction, cDNA synthesis and qRT-PCR. 
 
Relative expression of transcription factors (Msx2, Irx5 and Tbx3) and osteoblast-
associated genes (Runx2, Bglap and Spp1) to average control genes (Atp5b and Eif4a2) 
was assessed.  Data generated from 4 different male rats expressed as mean ± SD.  
 
Msx2 and Irx5 were preferentially expressed in calvarial osteoblastic cells (Figure 6-32 
a and b), whilst Tbx3 was preferentially expressed in femoral osteoblastic cells (Figure 
6-32 c) from Day 0 to Day 7 in all cultures.  
 
Msx2 and Irx5 expression appeared to be higher in calvarial osteoblastic cells than in 
femoral osteoblastic cells, but this was not significantly different (Figure 6-32 a and b).  
Similarly Tbx3 expression was not significantly different between femoral and calvarial 
osteoblastic cells (Figure 6-32 c).  
 
From Day 0 to Day 7, Runx2 expression was higher in calvarial osteoblastic cells and 
significantly different at Day 3 (p˂0.05) (Figure 6-33 a), whilst Bglap and Spp1 
expression were not significantly different (Figure 6-33 b and c) from Day 0 to Day 7, 
except at Day 7 where Spp1 expression was significantly higher in femoral osteoblastic 
cells ( p˂0.01).  
 





Figure 6-32: Relative expression of Msx2, Irx5 and Tbx3 to average control genes (Atp5b and 
Eif4a2). In monotypic culture, femoral osteoblastic cells stained with CellTracker
TM
 Green, whilst 
calvarial osteoblastic cells were unstained. At Day 0, Day 3 and Day7, the cells passed through 
cell sorter, grown and collected for RNA extraction, cDNA synthesis and qRT-PCR. Data 
represented as mean ± SD from 4 different male rats. Data were generated from using 8 
different primary osteoblast cultures and 4 replicates were tested for each culture. Msx2 and 
Irx5 were preferentially expressed in calvarial osteoblastic cells (a) and (b), whilst Tbx3 was 
preferentially expressed in femoral osteoblastic cells (c). Paired t-test was used to compare 
gene expression between calvarial and femoral osteoblastic cells, *, p˂0.05 considered 
significantly different. 






Figure 6-33: Relative expression of Runx2, Bglap and Spp1 to average control genes (Atp5b 
and Eif4a2). In monotypic culture, femoral osteoblastic cells stained with CellTracker
TM
 Green, 
whilst calvarial osteoblastic cells were unstained. At Day 0, Day 3 and Day7, the cells passed 
through cell sorter, grown and collected for RNA extraction, cDNA synthesis and qRT-PCR. 
Data represented as mean ± SD from 4 different male rats. Data were generated from using 8 
different primary osteoblast cultures and 4 replicates were tested for each culture. Runx2 
expressed higher in calvarial osteoblastic cells (a), whilst Bglap and Spp1 were expressed 
higher in femoral osteoblastic cells (b) and (c). Paired t-test was used to compare gene 
expression between calvarial and femoral osteoblastic cells, *, p˂0.05, **, p˂0.01 considered 
significantly different. 




The results for heterotypic cultures using single labelling are described as follows: 
 




As before, Msx2 and Irx5 were preferentially expressed in calvarial osteoblastic cells 
(Figure 6-34 a and b), whilst Tbx3 was preferentially expressed in femoral osteoblastic 
cells (Figure 6-34 c) from Day 0 to Day 7 in all cultures.  At Day 0, Msx2 expression 
was significantly higher in calvarial osteoblastic cells than in femoral osteoblastic cells 
(p˂0.05).  Irx5 was significantly higher expressed in calvarial osteoblastic cells than in 
femoral osteoblastic cells at Day 0 (p˂0.05) and at Day 3 (p˂0.01).  At Day 0 and Day 
3, Tbx3 was significantly higher expressed in femoral cells than in calvarial osteoblastic 
cells (p˂0.01).  There was no evidence of changes in relative gene expression patterns 
in calvarial cells between day 0 and day 7 of heterotypic cultures. 
 
In osteoblast-associated genes the pattern of gene expression was similar to previously 
observed, with Runx2 expression higher in calvarial osteoblastic cells (Figure 6-35 a), 
and Bglap and Spp1 expression higher in femoral osteoblastic cells (Figure 6-35 b and 
c).  However, there was no significantly difference (p˂0.05) between calvarial 
osteoblastic cells and femoral osteoblastic cells in osteoblast-associated gene expression 
in heterotypic culture.  There was no evidence of changes in relative levels of gene 
expression in calvarial cells between day 0 and day 7 of heterotypic cultures. 





Figure 6-34: Relative expression of Msx2, Irx5 and Tbx3 to average control genes (Atp5b and 
Eif4a2). In heterotypic culture, calvarial osteoblastic cells stained with CellTracker
TM
 Green, 
whilst femoral osteoblastic cells were unstained. The cells were grown together in culture for 0, 
3 and 7 days. Then they were sorted by cell sorter, continued to grow and collected for RNA 
extraction, cDNA synthesis and qRT-PCR. Data represented as mean ± SD from 4 different 
male rats. Data were generated from using 8 different primary osteoblast cultures and 4 
replicates were tested for each culture. (a) Msx2 and (b) Irx5 were preferentially expressed in 
calvarial osteoblastic cells, whilst (c) Tbx3 was preferentially expressed in femoral osteoblastic 
cells. Paired t-test was used to compare gene expression between calvarial and femoral 
osteoblastic cells (*, p˂0.05, **, p˂0.01 considered significantly different). 





Figure 6-35: Relative expression of Runx2, Bglap and Spp1 to average control genes (Atp5b 
and Eif4a2). In heterotypic culture, calvarial osteoblastic cells stained with CellTracker
TM
 Green, 
whilst femoral osteoblastic cells were unstained. The cells were grown together in culture for 0, 
3 and 7 days. Then they were sorted by cell sorter, continued to grow and collected for RNA 
extraction, cDNA synthesis and qRT-PCR. Data represented as mean ± SD from 4 different 
male rats. Data were generated from using 8 different primary osteoblast cultures and 4 
replicates were tested for each culture. (a) Runx2 expressed higher in calvarial osteoblastic 
cells, whilst (b) Bglap and (c) Spp1 were expressed higher in femoral osteoblastic cells. Paired 
t-test was used to compare gene expression between calvarial and femoral osteoblastic cells 
(p˂0.05 considered significantly different). However, there were no significant differences 
between the two distinct osteoblast populations. 








When femoral cells were labelled, similar results were obtained to those with single 
staining of calvarial osteoblastic cells.  Transcription factors Msx2 and Irx5 were 
preferentially expressed in calvarial osteoblastic cells (Figure 6-36 a and b), whilst Tbx3 
was preferentially expressed in femoral osteoblastic cells (Figure 6-36 c) from Day 0 to 
Day 7 in all cultures.  
 
At Day 0 and Day 7, Msx2 expression was significant higher in calvarial osteoblastic 
cells than in femoral cells (p˂0.01) and also at Day 0, Irx5 expression was significantly 
higher  in calvarial than in femoral cells (p˂0.05).   On the other hand, at Day 0 Tbx3 
expression was significantly higher in femoral than in osteoblastic cells (p˂0.05).  
 
With osteoblast-associated genes Runx2 expression was higher in calvarial osteoblastic 
cells (Figure 6-37 a), whilst Bglap and Spp1 expression was higher in femoral 
osteoblastic cells (Figure 6-37 b and c).  Runx2 expression was significantly different at 
Day 0 (p˂0.05), whilst Spp1 expression was significantly higher in femoral osteoblastic 
cells at Day 0 (p˂0.05).  As with the calvarial cells, there was no evidence of changes in 
relative levels of gene expression in femoral cells between day 0 and day 7 of 
heterotypic cultures. 
 





Figure 6-36: Relative expression of Msx2, Irx5 and Tbx3 to average control genes (Atp5b and 
Eif4a2). Vice versa, in this heterotypic culture, femoral osteoblastic cells stained with 
CellTracker
TM
 Green, whilst calvarial osteoblastic cells were unstained. The cells were grown 
together in culture for 0, 3 and 7 days. Then they were sorted by cell sorter, continued to grow 
and collected for RNA extraction, cDNA synthesis and qRT-PCR. Data represented as mean ± 
SD from 4 different male rats. Data were generated from using 8 different primary osteoblast 
cultures and 4 replicates were tested for each culture. (a) Msx2 and (b) Irx5 were preferentially 
expressed in calvarial osteoblastic cells, whilst (c) Tbx3 was preferentially expressed in femoral 
osteoblastic cells. Paired t-test was used to compare gene expression between calvarial and 
femoral osteoblastic cells (*, p˂0.05, **, p˂0.01 considered significantly different). 





Figure 6-37: Relative expression of Runx2, Bglap and Spp1 to average control genes (Atp5b 
and Eif4a2). Vice versa, in this heterotypic culture, femoral osteoblastic cells stained with 
CellTracker
TM
 Green, whilst calvarial osteoblastic cells were unstained. The cells were grown 
together in culture for 0, 3 and 7 days. Then they were sorted by cell sorter, continued to grow 
and collected for RNA extraction, cDNA synthesis and qRT-PCR. Data represented as mean ± 
SD from 4 different male rats. Data were generated from using 8 different primary osteoblast 
cultures and 4 replicates were tested for each culture. (a) Runx2 expressed higher in calvarial 
osteoblastic cells, whilst (b) Bglap and (c) Spp1 were expressed higher in femoral osteoblastic 
cells. Paired t-test was used to compare gene expression between calvarial and femoral 
osteoblastic cells (*, p˂0.05 considered significantly different).  




6.5 Discussion and conclusion 
 
The variation between individuals in gene expression profiles may have an impact on 
the outcome of these results.  Therefore, we reanalysed our data using 8 independent 
experiments for each matched pair of rat cell cultures.  The results confirmed that Runx2 
expression was significantly higher in calvarial osteoblastic cells, whilst Bglap and 
Spp1 expression was significantly higher in femoral osteoblastic cells at later passages 
suggesting the difference in their embryonic origin.  In addition, Bglap was more highly 
expressed in more mature osteoblastic cells. 
 
Interestingly, our osteopontin production data (Figure 6-7) showed similar production 
among calvarial osteoblastic cells from 4 rats, whilst showing significant differences 
among femoral osteoblastic cells from 4 rats.  This may be due to variations in Spp1 
gene expression between individual rats or due to osteoblast maturity, with more mature 
osteoblastic cells showing higher osteopontin production. 
 
Rat 11 showed different expression of osteoblast-associated genes compared to other 
rats (Figure 6-11 and Figure 6-13).  For example, Runx2 expressed significantly higher 
in calvarial osteoblastic cells than in femoral osteoblastic cells, except for Rat 11 that 
there was not different between calvarial and femoral osteoblastic cells (Figure 6-11).  
In addition, Spp1 expressed significantly higher in femoral osteoblastic cells than in 
calvarial osteoblastic cells, except for Rat 11 that there was not different between 
calvarial and femoral osteoblastic cells (Figure 6-13).  This may be due to variation 
between individual rats or due to difference in osteoblast maturity. 
 
The data support and extend the results of our previous study using microarrays 
(Rawlinson et al., 2009b) in showing the long term stability and reproducibility of 
increased osteopontin production in femoral cells.  This may be of particular interest in 
view of the known role that osteopontin may have in mediating the role of mechanical 
stimulation in bone and might ultimately partly explain why long bones are more 
susceptible to osteoporosis than skull bones (Rawlinson et al., 2009b; Rawlinson et al., 
1995).   
 




Steroid hormones e.g. oestrogens, progesterone and androgens play a crucial role in 
maintenance of normal bone architecture and cell development (Riggs et al., 2002).  By 
administration of natural or synthetic oestrogen for postmenopausal osteoporosis, the 
bone loss can be stopped (Benayahu et al., 2000).  In this study, we investigated the 
responses of the regionally distinct cell populations to oestrogen stimulation.  The cells 
were tested and measured by using MTS and EdU incorporation analysed by flow 
cytometry, especially calvarial osteoblastic cells showed very sensitive or toxic 
response at 10 
-10
 M of oestrogen concentration.  This may be due to different batch of 
commercially perchased oestrogen.  Therefore, batch testing is recommended.  In 
addition, pharmacological dose needed to be optimised for each primary cell cultures. 
 
ROS cells (Cheng et al., 1999; Jessop et al., 2001; Migliaccio et al., 1992) and Saos 2 
cell lines (Nasu et al., 2000; Rao et al., 2001; Rao et al., 2003) were used as positive 
controls.  However we were unable to demonstrate any consistent effects of oestrogen 
stimulation on either of the cell populations, or indeed in the positive control cultures 
(ROS and Saos 2 lines).  The reason for this total lack of oestrogen responsive in our 
cells is surprising given the number of studies that have previously shown that 
oestrogen can regulate osteoblast functions.  Further studies including expression of 
oestrogen receptors to look at specific protein production such as osteopontin 
production would be more sensitive and valuable. 
 
Previous studies have demonstrated differences in oestrogen response between skull 
bones and long bones.  ER-α levels were elevated during matrix maturation and then 
declined during mineralization, whilst ER-β expression was relatively constant 
throughout differentiation and exhibited more constitutive expression (Wiren et al., 
2011).  In our studies, we were hoping to extend these observations by testing for 
differences in responsiveness between the isolated cell populations.  Furthermore, it has 
been reported that there is no difference between female and male rats in the distribution 
and expression levels of ER-β mRNA in bone (Onoe et al., 1997).  However, it might be 
valuable to investigate these questions again in the future with cells derived from 
females as well as males. 
 
Overall, our results demonstrate a number of phenotypic and functional differences 
between femoral and calvarial osteoblastic cells which persisted despite extensive 




culture in vitro. These include differences in Spp1, Runx2, and Bglap expression and 
osteopontin protein production.  Despite increased Bglap expression in femoral cells, 
we did not see any differences in osteocalcin production (Chapter 3).   
 
Femoral cells showed markedly increased production of mineralised bone nodules 
which clearly demonstrated the difference between two distinct osteoblast populations 
qualitatively.  In addition, the size and shape of mineralised nodules appeard to be 
different between individual rats.  Therefore, the mineralised nodules were not 
quantified by direct counting of nodules.  We did not detect any consistent differences 
in proliferation and ALP expression between the cell populations.  These differences 
match our results from Chapter 4 where the persistence of differences in Hoxa, Msx2, 
Tbx3 and Irx5 expression. 
 
In Chapter 5 we investigated whether Hoxa gene expression, as a marker of positional 
identity and embryological origin and might be reprogrammed by heterotypic cell co-
cultures.  Previous studies have shown that flow cytometry for sorting purposes 
provides a simple, reproducible approach to help delineate the stages of bone cell 
differentiation such as calvarial cells and BMSCs which have been studied for their cell 
vitality, OPN mRNA expression, alkaline phosphatase activity and cell proliferation, 
limiting dilution analysis, colony assays, self-renewal capacity, electron microscopy and 
immunostaining after cell sorting  (Zohar et al., 1997).  In our study, there were no 
differences in proliferation and gene expression between the two distinct regional 
populations in monotypic culture before and after passing through the cell sorter, similar 
to previous reported (Zohar et al., 1997).  
  
Although we did not demonstrate reprogramming of Hoxa expression in our studies, it 
might have a phenotype switching in heterotypic cultures such as changes in relative 
expression of populations of Spp1, Bglap, and Runx2.  Rather as expected given the 
negative results described in Chapter 5, there was no evidence of any changes in 








In conclusion, there was no difference in proliferation and total ALP activity in rat 
calvarial and femoral osteoblastic cells grown in monotypic or heterotypic cultures.  
Spp1 expression was highest among all tested genes and showed the trend of greater 
expression in femoral than calvarial osteoblastic cells.  Our results demonstrated the 
presence and persistence of potentially important phenotypic differences between the 
cell populations as seen in early primary osteoblast cultures with greater Runx2 
expression in calvarial osteoblastic cells, whereas Bglap, as a late osteoblastic marker, 
showed no difference between two distinct populations.  Moreover, in late primary 
osteoblast cultures Runx2 expression was maintained, but expression levels were not 
different between cell types, whilst Bglap expression was significantly higher in 
femoral osteoblastic cells which were not altered in heterotypic culture experiments.  
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7.1 Final discussion 
 
The studies described in this thesis have used novel approaches to investigate whether 
embryonic positional identity can be maintained, modulated to increase the osteogenic 
ability and improve regenerative capacity.  The findings presented in this thesis have 
aimed to provide an insight into bone regenerative capacity in tissue engineering by 
understanding the positioning identity of the cells from different embryonic origin and 
their modulation may gain more understanding and improve the strategy for bone 
grafting and some bone-related disease treatment such as osteoporosis. 
 
7.1.1 Cell isolation 
 
Several methods have been used to isolate cells from foetal or adult rats (Declercq et al., 
2004) or juvenile mice (Xu et al., 2007).  Cell isolation methods may have an effect in 
the results may be due to the fact that cell isolated from bony tissues were 
heterogeneous.  Some methods can potentially facilitate more homogeneity.  In 
addition, different animals, age of the animal, pooled or matched pairs, different animal 
species, different in animal sexes may have an effect on result outcome. 
 
Many studies have been done using cell lines e.g. Rat Osteosarcoma (Gu et al., 2001; 
Maliakal et al., 1994; Noda et al., 1988; Oldberg et al., 1986; Slootweg et al., 1997; 
Wheeler et al., 2008), MC3T3-E1 (Tobimatsu et al., 2006), Human Osteosarcoma cell 
line MG-63 (Bonewald et al., 1992; Lajeunesse, 1994; Lajeunesse et al., 1991) and 
Saos-2 (Hunt et al., 1996).  Rat models are well-established for varieties of experiments 
in vitro (Kartsogiannis and Ng, 2004).  The studies were carried out primarily using 
rodents as the findings from these mostly in vitro studies could potentially lead to future 
investigations where there genetics can be manipulated to test findings in vivo.  
 
7.1.2 Cell characterisation 
 
Martin and co-workers found that FGF-2 supplementation promoted BMSC 
proliferation and maintained their multi-lineage differentiation potential during 
expansion (Martin et al., 1997).   
 




FGF-2 induced GSK-3beta phosphorylation and increased the nuclear levels of beta-
catenin in osteoblasts, suggested that FGF may enhance activation of Wnt signalling 
(Quarto et al., 2010).  FGF-2 stimulation of osteoblast differentiation is partially 
through modulation of the Wnt/β-catenin pathway in Fgf-2_/_ mice (Fei et al., 2011).  In 
contrast, the previous study by Kalajzic et al., 2003 has shown that FGF-2 and noggin 
inhibited ALP in primary murine osteoblast differentiation (Kalajzic et al., 2003).  In 
FGF-2 supplemented cultures, the average size of colonies is increased, but colony 
number is reduced by approximately 30%, when BMSC clones are isolated and 
expanded in the presence of FGF-2, the frequency of pluripotent clones is increased, the 
capability of FGF-2 to sustain long-term BMSC cultures maintaining the capacity to 
differentiate (Muraglia et al., 2000).  The sequential supplementation of these cytokines 
into BMSCs culture might be suitable for cultured bone to use in bone tissue 
engineering (Maegawa et al., 2007).  FGF signalling during posterior body axis 
extension in mouse and chick embryos have shown that in the extreme posterior FGF 
signalling is high and maintain the stem zone at the posterior end of the axis in an 
undifferentiated state (Dorey and Amaya, 2010) that may have an effect on Hoxa7 gene 
expression.  Based on our data, FGF-2 did not have an effect on Hoxa gene expression.  
However, before using these cells for some other experiments, a wash out period from 
FGF-2 to avoid the carried-over effect may need to take to consideration.  The using of 
combination of methods to characterise primary osteoblast cultures such as ALP 
activity, ALP staining, osteoblast-associated markers, bone specific protein production 
and mineralised bone nodule formation are reccommended.  
 
7.1.3 Persistence of positional identity and transcription factors in vitro 
 
Fibroblasts are a mixed population of cells derived from mesenchymal origin and found 
in numerous tissues.  Similar morphology was evidenced in fibroblasts from different 
sites, but DNA-microarray studies have demonstrated that fibroblasts in different 
anatomical regions have their own gene-expression profile and characteristic 
phenotypes, synthesizing extracellular matrix (ECM) proteins and cytokines in a site-
specific manner (Chang et al., 2002).  The Hoxa gene expression pattern in our rat 
dermal fibroblast was similar to the study in human fibroblasts (Chang et al., 2002; 
Rinn et al., 2006; Rinn et al., 2008a; Wong et al., 2007).   
 
 




BMSCs obtained from different anatomical sites e.g. femur, humerus, tibia, ulna and rib 
have consistently expressed Hoxa genes in all BMSCs primary cultures.  The pattern of 
Hoxa gene expression in the bone marrow largely matches the pattern of expression 
seen in osteoblast cultures isolated from these bones (Rawlinson et al., 2009b).  
Significant differences in the pattern of gene expression in BMSCs culture populations 
were also seen in rib.  This may be due to different embryonic origin.   
 
The rat osteoblastic cells from different embryonic origin from 4 different rats matched 
pairs retained their positional identity in vitro up to 10 subcultures which similar to 
these studies (Kasperk et al., 1995; Rawlinson et al., 2009b).  In a study characterised 
human bone samples obtained from mandible and iliac crest from four healthy patients 
showed that phenotypically different human bone cell populations at different skeletal 
sites (Kasperk et al., 1995).   
 
Crucially, markers of “positional identity” in osteoblasts persisted after many cell 
doublings in culture despite removing the cells from any environmental cues from their 
local anatomy.  Hoxa13 was expressed in primary fibroblast cultures derived from 
dermal tissue overlying the abdominal region, whilst Hoxa13 was always expressed in 
primary osteoblast cultures derived from ulnae and femurs.  In fact, Hoxa13 should be 
expressed in the more posterior region.  This may suggest that positional identity is 
more rigid for skeletal body patterning, whilst it is less fixed in retaining positional 
information in skin body patterning.  Nevertheless, Hoxa13 maintained the Hox pattern 
of embryo until adult and followed colinearity.  
 
Interestingly, early osteoblast markers such as Runx2 showed higher expression in 
calvarial osteoblastic cells, whereas later osteogenic markers such as Bglap or 
osteoblast-associated genes such as Spp1 were more highly expressed in femoral cells.  
Thus, from our study neural crest-derived cells may proliferate more, but mesoderm-
derived cells may differentiate faster.  This is in contrast to Leucht and co-workers who 
found that neural crest-derived cells showed an increase in expression of osteogenic 
markers including Runx2, Col1, Spp1 and Bglap than in mesoderm-derived cells 
(Leucht et al., 2008a).   
 
 




In the studies described here, cells from one of the animals appeared to give different 
results from the other animals.   The large variation in expression levels among inbred 
rats was perhaps surprising but may be due to epigenetic factors.  In general, true 
individual variation provides an explanation why there is such a variable healing 
response to regenerative procedures.   
 
7.1.4 Can Hoxa gene expression and phenotype be modulated by heterotypic culture? 
 
There are a number of different studies previously reported that demonstrate modulation 
or switching of Hoxa gene expression in a range of circumstances.  For example, as 
previously discussed, the studies described by Leucht et al. (2008) demonstrate 
switching on of Hoxa gene expression in Hoxa-ve neural crest derived cells following 
transplantation or co-culture (Leucht et al., 2008a).   
 
Studies of heterotopic transplantations of rhombomere (r) within the rhombencephalic 
area of chick and quail embryos were investigated and the expression of Hoxb-4, Hoxb-
1, Hoxa-3, Hoxb-3, Hoxa-4 and Hoxd-4 was assessed after a rhombomere was 
transplanted from a caudal to a more rostral position which expressed the same set of 
Hox genes as in situ (Grapin-Botton et al., 1995).  In contrast, their Hox gene 
expression pattern is modified and expressed genes which activated at the new location 
of the explants if rhombomeres are transplanted from rostral to caudal and occured 
whether transplantation was carried out before or after rhombomere boundary formation 
(Grapin-Botton et al., 1995).  The fate of the cells of rhombomeres when caudally 
transplanted was modified; the rhombencephalic nuclei in the graft extend due to the 
new location (Grapin-Botton et al., 1995).  Transplantations to more caudal regions 
(posterior to somite 3) showed the induction of Hoxb-4 in the whole transplant in some 
cases suggested that neither the mesoderm lateral to the graft nor the notochord is 
responsible for the induction; the inductive signal emanates from the neural tube itself 
(Grapin-Botton et al., 1995).   
 
However in our current studies we were unable to demonstrate evidence of switching of 
Hoxa gene expression in heterotypic cultures.  This may be more the result of failing to 
provide the correct environmental cues for Hox switching, than the absence of the 
potential for switching of Hoxa expression in itself. 
 




7.1.5 Future work 
 
In the field of tissue engineering research, enormous work has been done in the past 
decade to improve three key components including cells, scaffolds and signalling 
molecules, and particularly to enhance cell capacity for regenerative potential. 
 
In the context of this thesis, we have successfully established rat adult osteoblastic cells 
matched pairs from two distinct embryonic origin populations.  We can grow them over 
serial subcultures in vitro with addition of FGF-2 and importantly they can retain their 
positional identity and osteoblastic phenotype.  These will allow us to further study in 
depth and try to understand their mechanisms. 
 
7.1.5.1 Experiments using KO-Hoxa genes or transfected Hoxa genes  
 
If the time allowed, studies of Hoxa-KO animal, GFP-transfected Hoxa genes, cell 
signalling, effect on Spp1 gene expression and osteopontin production would have 
allowed us to gain further insight about the cell modulation both at cellular and 
molecular levels.  The bones harvested from different sites are different as previously 
stated.  They may also have different bone regenerative capacity.  The results of this 
study contribute to our understanding of why current treatments in bone grafting may be 
limited in their success. 
 
7.1.5.2 Repeating latest Hoxa genes modulation experiments 
 
Surprisingly, in our pilot study, Hoxa genes in calvarial osteoblastic cells could be 
switched in heterotypic culture. However, we were concerned about a false modulation.  
Therefore, we have thoroughly developed our osteoblast heterotypic model and 
confirmed our results by repeating with more rat matched paired samples. However, it is 
still worth repeating these experiments. 
 
7.1.5.3 Experiments testing for cells responsiveness to mechanical loading 
 
Interestingly, Spp1 gene was more highly expressed of all genes tested and particularly 
was higher in femoral than calvarial cells.  In support of this, at the protein level, 
osteopontin can be detected by ELISA and also showed that osteopontin production was 




significantly higher in femoral than in calvarial cells.  It is of considerable interest that 
calvaria tend to maintain high bone mineral density (BMD) despite not being subjected 
to mechanical loading and are resistant to the effects of osteoporosis, whilst long bones 
such as femurs are dependent on mechanical loading for maintenance of BMD and are 
susceptible to osteoporosis (Rawlinson et al., 2009a).  Our data suggest that it would be 
valuable to study the difference between these two distinct populations in response to 
mechanical loading using a Bioreactor. 
 
7.1.5.4 Experiments testing for cells responsiveness to oestrogen stimulation 
 
The cells did not show any response to oestrogen stimulation.  This might be because 
these cells were derived from adult male rats.  The results could have been different if 
tested with foetal or young female rats.  Other reasons why we could not measure the 
oestrogen responsiveness could be that the measuring time is a snap-shot and MTS was 
not sensitive enough to measure the difference.  Other possible explanations may be due 
to the complexity of the system, such as a cascade of gene expression, a networking of 
hormones or other mechanisms involved that lead to different susceptibility seen at 
clinical level for example different susceptibility of skull bones and long bones in 
osteoporosis.  Certainly studies of ER receptor expression for specific protein would be 
more sensitive and useful. 
 
7.1.6 Clinical implications 
 
Although the findings presented in this study are at the 'bench' stage, they could 
potentially have significant implications for improving bone regenerative capacity for 
bone regeneration, bone grafting or tissue engineering in the clinic. 
 
The role of fibroblasts in tissue engineering for skin reconstruction has been developed 
since the 1970s, but little is known about the actual efficacy.  Tissue engineering in skin 
has provided benefits to patients with burns, accidents, infections and chronic wounds.  
‘‘Skingineering’’ has various potentials that has just begun to be recognised (Boettcher-
Haberzeth et al., 2010).  Skin from different anatomical regions have shown different in 
positional identity (Rinn et al., 2006), and data from our study also suggested that 
dermal fibroblasts taken from different sites are difference.  They can maintain their 




embryonic body patterning through adult.  This may have an effect on wound healing 
capacity and when skin grafting procedure performed. 
 
The role of BMSCs in tissue engineering to reconstruct defective bone by composing 
mixtures of graft materials and autogenous marrow with a variety of different vehicles, 
is a widely used procedure in orthopedics and oral surgery.  Our data suggest that 
BMSCs and bone from different regions are not the same.  This information may need 




The idea that specific cell phenotypes are similar throughout the body is considered to 
reflect our normal level of understanding, but our evidence here suggests that this is not 
the case.  The adult primary calvarial osteoblastic cells did not express Hoxa genes like 
femoral osteoblastic cells did.  This might be due to the diffence in embryonic origin of 
osteoblasts derived from paraxial mesoderm and osteoblasts derived from lateral plate 
mesoderm that seem to have memory to maintain their “HOX code” for body patterning 
from the embryo to the adult organism and may have phenotypic and functional 
differences.  
 
The Spp1 gene expression data and osteopontin production detected by ELISA suggest 
that noted phenotypic differences should lead to further studies of the effects of 
mechanical loading on the distinct cell populations.  The ability to enhance cell 
regenerative potential and alter the path of healing from repair to complete and 
predictable regeneration will have a significant impact on patients afflicted with 
unsuccessful bone grafting or regeneration.  It is hoped with cell modulation in 
combination with improvement of scaffold and growth factors, the complete tissue 
regeneration in tissue engineering triangle can be achieved and by understanding why 
different bones have different susceptibilities to diseases such as osteoporosis.  These 
























House Keeping Genes (HKGs) for fibroblasts 
 
Average expression stability values of six House Keeping Genes tested across all rat 
dermal-derived fibroblasts used in experiments analysed using geNorm software 
analysis.  The more stable the genes, the lesser the Y axis value.  Thus, the most two 
stable genes, Eif4a2 and UBC were selected as the reference genes for further 











House Keeping Genes (HKGs) for BMSCs 
 
Similar analysis was carried out.  Average expression stability values of six House 
Keeping Genes tested across all rat BMSCs derived from different anatomical sites used 
in experiments analysed using geNorm software.  As previously stated, the more stable 
the genes, the lesser the Y axis value.  Thus, the most two stable genes, Eif4a2 and 











House Keeping Genes (HKGs) selection for osteoblasts 
 
Similar analysis was carried out and similar results to BMSCs were obtained when 
tested across osteoblast sample from 4 male rats matched paired.  Average expression 
stability values of six House Keeping Genes tested across 8 primary calvarial and 
femoral osteoblastic cells used in experiments been tested and analysed using geNorm 
software.  Thus, the most two stable genes, Eif4a2 and Atp5b were selected as the 











Hoxa gene expression in primary dermal fibroblast cultures 
 
1. Data from 1 rat  
Hoxa gene expression in primary dermal fibroblast cultures derived from adult rat skin 
from different regions: scalp, tissue overlying shoulder, abdomen and ulna at passage 5. 
The data presents the relative expression to average control genes (Eif4a2 and UBC). 
Negative RT and water were run as negative controls. 
 
At passage 5 
 Scalp Shoulder Abdomen Ulna Negative RT w a   t  e   r 
Eif4a2 0.16965 0.220606 0.187484 0.197004 0 0 
UBC 5.958321 4.554302 5.335462 5.099861 0 0 
Hoxa1 0 0.002612 0.001499 0.000954 0 0 
Hoxa2 0 0 0 0 0 0 
Hoxa4 0 0.000821 0.001351 0.000413 0 0 
Hoxa5 0 0 0.00187 0.001182 0 0 
Hoxa7 0 0 0.005597 0.034982 0 0 
Hoxa10 0 0 0.002059 0.001904 0 0 
Hoxa13 0 0 0 0 0 0 
 







2. Data from 4 rats  
Hoxa gene expression in primary dermal fibroblast cultures derived from adult rat skin 
from different regions: scalp, tissue overlying abdomen, and tissue overlying femur at 
passage 5. The data presents the relative expression to average control genes (Eif4a2 
and UBC). Negative RT (-ve RT) and water were run as negative controls. 
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5 1.58 2.547 0 0 
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2 0.002 0.003 0 0 
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3 0.059 0.09 0 0 
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04 0.007 0.034 0 0 
 









Hoxa gene expression in primary osteoblast cultures 
 
Hoxa gene expression in primary osteoblast cultures derived from adult rat calvarial and 
femoral bones at passage 5 and 10. The data presents the relative expression to average 
control genes (Atp5b and Eif4a2). Negative RT (-ve RT) and water were run as negative 
controls. 
          
At passage 5 






a   
t  
e   
r 
Atp5b 0.424115 0.429882 0.419663 0.39274 0.455766 0.448435 1.323273 1.268769 0 0 
Eif4a2 2.35785 2.326222 2.382866 2.546214 2.194111 2.229976 0.755702 0.788166 0 0 
Hoxa1 0.000144 6.96E-05 0.000228 0.000128 0.002016 0.001181 0.003024 0.001465 0 0 
Hoxa2 0 0 0 0 3.98E-05 0 0 0 0 0 
Hoxa4 0.000681 0.000165 0.000199 0.000276 0.006968 0.009078 0.015527 0.015554 0 0 
Hoxa5 0.000206 0.000228 0 3.13E-05 0.024407 0.025873 0.141258 0.102494 0 0 
Hoxa7 4.01E-05 0 0 0 0.097139 0.05746 0.177919 0.127867 0 0 
Hoxa10 0 0 0 0 0.007593 0.005179 0.063296 0.062829 0 0 
Hoxa13 8.56E-05 0 0 3.64E-05 0.001076 0.002479 0.006993 0.002492 0 0 
 
At passage 10 






a   
t  
e   
r 
Atp5b 1.690268 1.66069 1.455144 1.332079 1.985965 2.100171 1.619744 1.733135 0 0 
Eif4a2 0.591622 0.602159 0.687217 0.750706 0.503534 0.476152 0.617382 0.576989 0 0 
Hoxa1 0.000827 0.000372 0.000475 0.000458 0.00334 0.002935 0.005484 0.004215 0 0 
Hoxa2 4.95E-05 0 5.03E-05 0 0.000302 0.000176 7.45E-05 0.000243 0 0 
Hoxa4 0.000160 0.000293 0.000384 0.000536 0.01826 0.02128 0.011524 0.013573 0 0 
Hoxa5 0.000608 0.000164 0.000181 0 0.050538 0.067169 0.035317 0.054598 0 0 
Hoxa7 0.000415 0 0.000262 0 0.281505 0.48733 0.257134 0.411652 0 0 
Hoxa10 0 0 0.000132 0 0.064842 0.048052 0.023712 0.045634 0 0 
Hoxa13 0.000989 0.000694 0.000653 0 0.012395 0.038286 0.058449 0.00026 0 0 
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